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CHAPTER 1
General Introduction: Airway epithelial cell function 
and respiratory host defense in chronic obstructive 
pulmonary disease (COPD).
Gimano D. Amatngalim and Pieter S. Hiemstra
Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands




Our lungs have a vital role in mediating the exchange of oxygen and carbon dioxide between 
the air we breathe in and the body. This function is under constant pressure as inhaled air 
contains numerous particles, gasses and micro-organisms that may cause injury and infection 
to the lungs. Removal and neutralization of potential harmful substances from inhaled air 
is mediated by the airway epithelium. This pseudo-stratified layer of cells covers the surface 
of the conducting airways and plays an important role in protecting the alveoli, where gas 
exchange takes place, from injury. The airway epithelium has a range of properties that 
contribute to lung defense, including constitutive host defense mechanisms and regulation of 
airway innate immunity. Moreover, epithelial cells display wound healing properties, which 
allow rapid recovery of airway tissues upon injury. Airway epithelial host defense functions 
are important to maintain proper gas exchange and lung homeostasis. Despite this protective 
function, extensive epithelial exposures to noxious particles and gasses may have detrimental 
outcomes. This is seen in chronic obstructive pulmonary disease (COPD), in which an 
impaired epithelial function and epithelial remodeling caused by smoking contributes to an 
accelerated decline in lung function. COPD is characterized by increased colonization and 
infections with opportunistic respiratory pathogens, which is caused in part by impaired 
epithelial host defense functions. However, the molecular and cellular mechanisms that are 
affected in the airway epithelium by smoking and that may lead to COPD are largely unclear.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
COPD is a severe inflammatory lung disease, regarded as one of the most prevalent burdens 
in global health (1). The disease has been ranked retrospectively in the top 10 causes of 
mortality in high-income countries between 1990 and 2013 (2), and COPD is predicted as 
the 3th cause of death and leading lung disease worldwide by 2030 (3). COPD is characterized 
by a progressive and largely irreversible decline in lung function. This is associated with long-
term airway exposures to cytotoxic particles and gasses resulting in an abnormal response 
to inhalation of these substances (3, 4). Airflow limitation in COPD is accompanied by 
persistent inflammation, airway remodeling and destruction of lung tissue, resulting in 
clinical symptoms such as dyspnea, chronic cough, and fatigue. Moreover, COPD patients 
may suffer from comorbidities, such as cardiovascular disease, that contribute to disease 
severity and mortality (5, 6). In addition to a progressive decline in lung function in stable 
COPD, acute worsening in lung function may occur during disease exacerbations. Microbial 
infections are in most cases the trigger of these exacerbations. Furthermore, it has been shown 
that exacerbations are also associated with gastro-esophageal reflux and heartburn and that 
patients with frequent exacerbations are more susceptible for recurrent exacerbations (7). 
COPD is a heterogenic disease in which airflow limitation may result from several mechanisms 
in which different, or multiple regions, of the respiratory tract are affected (8). Chronic 
bronchitis and small airway disease are characterized by remodeling and obstruction of the 
large and small conducting airways respectively. In contrast, emphysema is characterized 
by destruction of the alveoli located in the peripheral lung tissue resulting in airflow 




is in general associated with the exposure of the lung to cytotoxic particles and gasses that 
promote persistent inflammatory responses and induce lung tissue remodeling and damage 
(3). Exposure to biomass, occupational dusts, and chemicals are all cytotoxic insults that are 
associated with COPD development and progression (9-11). However, smoking is regarded 
as the main risk factor that is associated with the disease in Westernized societies. COPD can 
be largely prevented by non-smoking and it has been shown that smoking cessation decreases 
symptoms and to some extent may normalize the decline in lung function in smokers and 
patients with mild disease severity (12). Regardless of the significance of smoking in COPD 
pathogenesis, not all smokers develop the disease. Therefore, it is assumed that smokers 
can be divided into a susceptible and non-susceptible group which are likely defined based 
on additional risk factors such as genetic predisposition, (micro)nutrient deficiencies, 
environmental and lifestyle factors, and early life abnormalities in lung function (13-16).
MICROBIAL COLONIZATION AND RESPIRATORY INFECTIONS IN COPD
Microbial colonization and infections are an important pathophysiological aspect in certain 
COPD patients. Based on traditional culture-based techniques, it was shown that clinically 
stable COPD patients were colonized with opportunistic respiratory pathogens, most notably 
non-typeable Haemophilus influenzae (17-20). Colonization with respiratory pathogens were 
furthermore associated with elevated levels of inflammatory markers in upper- and lower 
airways fluid samples(18, 19, 21, 22). This suggests a role of microbial colonization in airway 
inflammation in COPD patients. Recent understanding of the presence of complex lung 
microbial communities (the lung microbiome), has further supported a role for microbial 
colonization in COPD pathogenesis. Compared to healthy individuals, it has been shown 
in various studies (23, 24) that COPD patients have altered microbiomes in the upper and 
lower airways, which are characterized by a less divers microbial composition. In line with 
culture-based studies, respiratory pathogens such as Haemophilus spp. were observed more 
frequently in the airway microbiome of COPD patients (25, 26). In addition, the COPD 
airway microbiome is characterized by the absence of microbes that are common in healthy 
individuals (25, 27). These promising findings suggest that imbalances in the microbiome - or 
dysbiosis - is a hallmark of COPD. Besides colonization in stable COPD, acute bacterial or 
viral infections are associated with approximately 50% of disease exacerbations. In particular, 
acquisition of new bacterial strains is assumed to cause acute worsening of patient symptoms 
(28). Also recent studies suggest alterations in the airway micobiome during COPD 
exacerbations, which are characterized by an increase in airway pathogens (29, 30). Overall, 
these observational studies highlight the importance of a better understanding of the role 
microbial colonization and infections in COPD pathogenesis. 
The underlying mechanism linking smoking with microbial colonization and infections in 
COPD can be explained by the vicious circle hypothesis (23). According to this hypothesis, 
smoking stimulates the development and progression of COPD by initiating a vicious circle of 
airway injury, microbial colonization/infections and inflammation (Figure 1). Cigarette smoke 
exposure of airway tissues induces damage, which promotes local inflammatory responses 
and impairs host defense. Microbes further amplify airway inflammatory responses, whereas 
chronic inflammation contributes to tissue damage and degenerative repair. The persistence 
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of this vicious circle due to repetitive smoking eventually modulates tissue repair and leads 
to remodeling of the airways, thereby causing progressive airflow obstruction. In line with 
this, endogenous lung tissue repair may be impaired in COPD as demonstrated by decreased 
nuclear β-catenin staining in emphysematous lung tissue (31).
THE AIRWAY EPITHELIUM
The airway epithelium is the first target of inhaled cigarette smoke. Furthermore, epithelial 
cells are the first defense lining of the respiratory tract that prevents microbial colonization 
and infections (32-34). Because the airway epithelium is also the first tissue to be exposed to 
inhaled toxicants such as those present in cigarette smoke, the airway epithelium has a central 
role in the vicious circle hypothesis, and alterations in host defense and epithelial remodeling 
may contribute to COPD development and progression. 
The airway epithelium is a continuous layer that covers the surface of the respiratory tract 
and consists of cells that are connected by adhesion- and tight junctions (35-37). Two 
morphological and functional distinct types of epithelium are located respectively at the 
conductive airways and respiratory units in the lung peripheral tissue (Figure 2A). The 
conductive airways starts at the nasal cavity and ends at the small bronchioles in the lower 
airways. In these regions, the epithelium facilitates the moistening and warming of inhaled 
air before reaching the alveoli in the respiratory units where gas exchange takes place. The 
airway epithelium of the conductive airways furthermore has an active role in protecting the 
lungs against inhaled micro-organisms, which in a large extent is based on the morphology 




















Figure 1. Vicious circle hypothesis of COPD. Model that explains the development and progression of COPD, focusing 
on a persistent cycle of microbial colonization and infections, inflammation and airway tissue injury. Adapted from: 




In contrast to the simple columnar and cuboidal lining of the bronchioles and alveoli, the 
epithelium of the large conducting airways is characterized by a pseudostratified morphology 
(35, 38). Based on this morphology, epithelial cells can be divided into luminal cells (LCs), 
which are in direct contact with the environment, and basal cells (BCs) that are superimposed 
by LCs and located above the basement membrane (Figure 2B). The main cell types that make 
up the LC population are the ciliated cells and the secretory cells, which include the club cells 
and the mucus-producing goblet cells, and are discussed in the next paragraph. LCs and BCs 
have distinct functions in airway host defense, which depend on the degree of microbial threat 
and also whether the epithelial layer is intact or damaged. Based on this, airway epithelial host 
defenses can be categorized into 1) constitutive host defense mechanisms by LCs, 2) inducible 
Figure 2. Schematic presentation of the airway epithelium. (A) The human respiratory tract, with the conductive airways 
highlighted in gray. (B) Composition of the pseudostratified airway epithelium, consisting of ciliated, secretory cells 
(i.e. goblet and club cells located in the upper and lower airways respectively), and basal cells. (C) Airway epithelial 
host defense mechanisms include: Constitutive host defense mechanisms, inducible innate immunity, activated for 
instance by microbes, and injury-induced host defense mechanisms, activated for instance by cigarette smoking. 
Both inducible innate immunity and injury-induced host defense mechanisms, lead to the chemo-attraction and 































innate immunity, and 3) injury-induced wound repair and defense by airway BCs (Figure 
2C). In addition, the airway epithelium plays a central role in instructing adaptive immunity 
by interacting with dendritic cells and innate lymphoid cells.
CONSTITUTIVE LUMINAL CELL HOST DEFENSES 
Constitutive epithelial host defense mechanisms are defined as those functions mediated 
by intact airway epithelium at baseline, homeostatic conditions (Figure 3A). This includes 
the physical barrier functions of connected epithelial cells, but also active mechanisms 
mediated by LCs that are directly exposed to environmental insults. LCs comprise mature 
high columnar cells with specialized functions. Ciliated cells are an abundant luminal cell 
type and are characterized by their multi-ciliated structures at the apical surface (35, 38). 
Moreover, the luminal epithelium includes specialized secretory cells, i.e. goblet and club 
cells, which are distinctively located in respectively the large and small airways (39). The 
constitutive defense of LCs dependents on the interaction between ciliated and secretory 
cells in regulating the fluid lining located at the epithelial surface. This airway surface liquid 
(ASL) consists of a mixture of host defense proteins and peptides that are secreted by the 
airway epithelium and immune cells (40-43). This mixture provides a chemical shield against 
micro-organisms and is responsible for the relatively low levels of microbes in the respiratory 
tract of healthy individuals. Antimicrobial proteins and peptides (AMPs) present in this ASL 
prevent microbial colonization and infections by displaying direct microbial killing activity 
or by reducing the availability of important micronutrients (44, 45). Another host defense 
mechanism is mediated by secreted gel-forming mucins, present in the ASL as discontinuing 
floating strands or rafts (46, 47). These mucins can entrap micro-organisms and large particles 
and are subsequently removed via mucociliary clearance. During this process, mucus is 
propelled from the airways towards the throat by the continuous ciliary beating of ciliated 
cells (48). MUC5B and MUC5AC, the main mucins of the mucus gel, are mainly produced 
by the goblet cells of the surface epithelium and by the submucosal glands (47). Moreover, 
it has been reported that club cells are able to produce MUC5B in the lower airways (49). 
The luminal airway epithelium and mucin gel are separated by a second constitutive defense 
lining that is formed by host defense mucins, tethered to the surface of the epithelium and 
in complexes with the glycosaminoglycan keratin sulfate (50). These complexes are mainly 
located at epithelial cilia and are assumed to shape a periciliary brush which creates an 
additional barrier that prevents penetration of particles and micro-organisms (51). LCs 
furthermore regulate the physiological conditions of the ASL. This is mediated by active ion 
transport, for instance by the cystic fibrosis transmembrane conductance regulator (CFTR) 
protein or calcium-activated chloride channels such as anoctamin-1 (ANO-1/TMEM16A) 
(52, 53). Chloride secretion and reabsorption of sodium by the epithelial sodium channel 
(ENaC), have been shown to regulate ASL volume (54). This has important consequences 
for mucociliary clearance as it determines the hydration state of the mucus gel, as well as the 
height of the periciliary layer which is an important determinant of ciliary movement (55). 
Moreover, transport of bicarbonate regulates the pH of the ASL (56), which may affect the 





Constitutive host defense mechanisms provided by LCs give baseline protection during 
relatively low microbial exposures. Evasion from host defense mechanisms or adaptation 
to the host micro-environment may allow microbial outgrowth, thereby overwhelming 
constitutive airway epithelial defense (59). Therefore, secondary host defense mechanisms 
are activated upon sensing of increased levels of microbes (Figure 3B) (60). This depends on 
recognition of microbes by host cell receptors, which is highly conserved between species. It 
was first observed in Drosophila that microbial recognition of the receptor toll, resulted in the 
expression of AMPs (61). Similar to Drosophila, human toll-like receptors (TLRs) are present 
at the surface of airway epithelial cells or located in membrane enclosed compartments (62). 
Moreover, other patter recognition receptors (PRRs), such as NOD-like receptors, MDA5 
Figure 3. Airway epithelial host defense. (A) Constitutive host defense mechanisms of the luminal airway epithelium 
including barrier function, a cellular and tethered mucin barrier, defense via mucociliary clearance and secreted 
antimicrobial proteins and peptides, and regulation of airway surface liquid physiological properties though ion 
transport channels. (B) Inducible innate immunity can be activated upon recognition of microbes by epithelial pattern 
recognition receptors, which activate signaling pathways, i.e. MAPK and NFκB, which promote the expression of 
inducible AMPs and pro-inflammatory mediators. (C) Epithelial injury results in activation of EGFR located on basal 
cells, via various EGFR-ligands (i.e. EGF, TGFα, HB-EGF, AREG) produced in an autocrine manner, by luminal cells, 
stromal cells, or immune cells. The release of EGF-ligands is in part mediated via shedded by matrix-metalloproteases. 
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and RIG-1 are located in the cell cytosol (63). Ligation of PRRs leads to activation of cellular 
signaling transduction pathways such as MAPK and NFkB (64). This subsequently leads to 
expression of AMPs that are not produced at baseline conditions or only at very low levels. 
These “inducible” AMPs increase the antimicrobial activity of the ASL, counteracting the 
increased levels of microbes (65, 66). In addition to AMPs, activation of downstream signaling 
pathways leads to epithelial expression of pro-inflammatory cytokines and chemokines (67). 
These factors increase the attraction of immune cells to the site where increased microbial 
exposure is detected. Initially innate immune cells, such as dendritic cells, macrophages and 
neutrophils are directed to the epithelium, but in later stages also adaptive immune cells such as 
T- and B-lymphocytes are attracted. In addition to activation of the inducible innate immune 
system by microbes, airway epithelial are furthermore activated by the attracted innate and 
adaptive immune cells, which produce cytokines such as IL-1β and TNF-α (68). Moreover, 
airway epithelial cells display an autocrine mechanism, in which expression of the pro-
inflammatory cytokine IL-17C leads to maintained innate immune defense mechanisms (69, 
70). Moreover, the micronutrient vitamin D can also induce antibacterial responses, in part 
via expression of the antimicrobial peptide LL-37 (71). Taken together, inducible secondary 
host defense mechanisms are increased in the epithelium upon microbial exposure, during 
inflammation, during repair processes (discussed in the next paragraph) and upon exposure 
to vitamin D, and thereby provide protection upon outgrowth of microbes in the airways.
INJURY-INDUCED INNATE DEFENSE BY AIRWAY BASAL CELLS
The importance of maintaining an intact airway epithelium is emphasized by the low 
epithelial turn-over at steady-state levels (72, 73). However, exposure to cytotoxic particles 
and micro-organisms may cause epithelial injury, leading to shedding and cell death of LCs 
(38). Shedding of LCs provides defense by removal of infected cells (74). Moreover, epithelial 
death induced by injury or infection leads to the release of damage-associated molecular 
patterns, which can activate the innate immune system (75). Nevertheless, elimination of LCs 
compromises epithelial host defense. In this case, airway epithelial BCs play a role in providing 
airway protection (Figure 3C). BCs comprises approx. 30% of the airway epithelium in the 
large conductive airways, whereas its numbers decline at distal regions of the conductive 
airways (72). The cells are largely quiescent in intact epithelium. However, upon epithelial 
injury, BCs contribute to epithelial host defense by mediating recovery of the epithelial 
lining (76). Initially BCs spread and migrate on denuded basement membranes, followed 
by proliferation and differentiation towards mature LCs. A central role in the activation of 
epithelial repair involves activation of the epidermal growth factor receptor (EGFR) (77). 
This Erb family member is restricted to BCs and is activated by various ligands, including 
epidermal growth factor, amphiregulin and transforming growth factor-alpha (78-80). These 
ligands are produced and secreted by stromal cells or immune cells, however EGFR is also 
activated in an autocrine manner. This occurs for instance through release of EGF located at 
the surface of damaged luminal airway epithelial cells, but also via shedding of membrane-
bound EGFR-ligands by matrix metalloproteases (77). In all cases, activation of EGFR leads 
to initiation of wound repair, particularly controlled by MAPK signaling transduction and 
downstream AP-1 family transcription factors. In addition, BCs contribute to airway innate 




Figure 4. Airway epithelial cell cultures. 
(A) Submerged cultured primary bronchial epithelial 
cells (S-PBEC) display an undifferentiated phenotype 
and resemble airway basal progenitor cells. (B) Culturing 
of undifferentiated cells on transwells at the air-liquid 







by promoting the expression of pro-inflammatory factors that lead to chemo-attraction of 
immune cells to the site of injury as well as epithelial expression of AMPs. High expression of 
integrins, and the cell type restricted expression of ICAM-1 allows homing of immune cells to 
BCs, which may provide protection against microbes at the site of injury (82, 83). Moreover, 
innate immune mediators produced by immune cells may increase wound repair or direct the 
differentiation of LCs (84, 85). 
AIRWAY EPITHELIAL CELL CULTURES
Our understanding of airway epithelial cell biology large depends on basic research using 
cell culture models. These models furthermore are a helpful tool to understand epithelial cell 
responses to stimuli related to chronic inflammatory airway diseases or examine and compare 
cell cultures from diseased patients and control subjects (86). 
Epithelial cells in conventional 2D submerged cultures are characterized by monolayers 
which lack differentiated luminal cells and display a basal cell phenotype (Figure 4A) (82). 
These undifferentiated airway epithelial cells have been used to study wound repair processes 
such as cell migration and proliferation (74). Moreover, studies examining the effect of 
pro-inflammatory stimuli have demonstrated innate immune activities of undifferentiated 
airway BCs (87, 88). Indeed, undifferentiated cells do not fully recapitulate the function of the 
differentiated epithelium because of the lack of specialized LCs. Therefore other cell culture 
approaches are required to study epithelial cell function. 
The air-liquid interface (ALI) culture model is a well-established method to recapitulate the 
mucociliary phenotype of airway epithelial cells in vitro (Figure 4B) (89, 90). In this model, 
undifferentiated cells are seeded on semi-permeable transwell membrane supports, which 
are coated with an extracellular matrix substrate, i.e. collagen and/or fibronectin. The cells 
are initially cultured in submerged conditions to obtain confluent monolayers. Removal of 
the culture medium at the apical surface and further culturing under air-exposed conditions 
results in the development of tight junctions, which prevents leakage of basolateral medium 
to the apical compartment and results in the development of an epithelial barrier. Using 
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culture medium containing serum substitutes, or using a semi-defined culture medium 
including retinoic acid, air-exposed epithelial cells can differentiate in approx. 2-4 weeks 
towards a mature epithelium that includes ciliated and secretory cells (91). Differentiated 
ALI-cultures have been shown to display similar functional properties as the epithelium in 
vivo. This includes epithelial host defense mechanism, such as antimicrobial activity, mucin 
production, mucociliary transport, and ion transport (54, 92, 93). Moreover, epithelial cells 
stimulated with microbes or pro-inflammatory cytokines display innate immune properties, 
such as production of AMPs, cytokines and chemokines (70, 93).
EFFECT OF CIGARETTE SMOKE AND COPD DISEASE STATUS ON AIRWAY 
EPITHELIAL HOST DEFENSE 
Both undifferentiated airway epithelial cells and differentiated ALI-cultures can be used to 
increase our understanding of how the epithelium is affected in COPD. This can be done 
for instance by studying the effect of cigarette smoke on cell cultures. In particular, aqueous 
solutions of cigarette smoke particles, i.e. extract or condensate, have been used to study this 
(94, 95). However, this approach primarily takes the effects of the soluble particulate phase of 
cigarette smoke into account and underestimates the effect of the vapor phase and especially 
that of short-lived oxidants (96). Therefore, instead of the conventional method of using an 
aqueous extract of cigarette smoke, we have set up a whole cigarette smoke exposure model 
(Figure 5) (97). In this model, epithelial cells are directly exposed to the particulate and 
vapor phase by leading smoke derived from a burning cigarette directly to the cells that are 
grown at the air-liquid interface. This allows the exposure of cells to airborne substances in 
a physiologically realistic fashion. Previous studies using a comparable exposure model have 
shown that cigarette smoke inhibits the antimicrobial activity of airway epithelial cells (98). 
These results suggest that further application of the whole cigarette smoke exposure model 
will give insight into how other airway epithelial cell host defense functions are affected by 
smoking. 
Although smoking is regarded as the primary risk factor of COPD, not all smokers develop 
the disease (4). Therefore, it can be speculated that epithelial cells from COPD patients and 
non-COPD smokers display differences in host defense properties that may explain disease 
development. Recent studies have suggested that differences in airway epithelial activities 
persist in cell culture, such as an impaired airway epithelial barrier integrity, reduced wound 
repair and alterations in cell differentiation (99-102). Based on this, we hypothesize that 
persistent differences are present in other airway epithelial host defense properties of COPD 


















Figure 5. Whole cigarette smoke exposure 
model. (A) Illustration of the whole cigarette 
smoke exposure model setup. (B) In this 
model, epithelial cells are placed in modified 
hypoxic chambers in a tissue culture 
incubator at 37°C and 5% CO2. During 
exposure, whole cigarette smoke (CS) 
derived from a Kentucky research cigarette 
is infused into the exposure chamber. This 
is mediated by a pump, which drives the 
flow of smoke using a continuous regulated 
flow. Simultaneously, cells are exposed in a 
separate chamber to room air, as negative 
control. The amount of exposed cigarette 
smoke is demonstrated by the deposition 
of particles on a filter located between the 





OUTLINE OF THE THESIS
In this thesis, studies are presented in which the impact of cigarette smoke exposure and 
COPD disease status on the innate host defense functions of the airway epithelium are 
explored. This was done by using cell culture experiments in which the effect of cigarette 
smoke was examined, or in which epithelial cultures of COPD patients and non-COPD (ex)
smokers were compared. Antimicrobial proteins and peptides (AMPs) are a major contributor 
to airway epithelial host defense, and therefore a literature overview is given in Chapter 2 
on the potential role of AMPs in COPD pathogenesis. Chapter 3 describes how microbial 
exposure and cigarette smoke induced injury increases expression of the antimicrobial protein 
ribonuclease 7 (RNase7), specifically in airway epithelial BCs. Chapter 4 describes work in 
which the effect of cigarette smoke is studied on microbial-induced antibacterial activity of 
airway epithelial cells. Moreover, in this chapter the antibacterial activity, and expression 
of AMPs is studied in differentiated airway epithelial cells from COPD patients and non-
COPD controls. In Chapter 5 it is described how expression of constitutively expressed innate 
defense proteins is restricted to luminal airway epithelial cells, and how chronic cigarette 
smoke exposure impairs epithelial defense by affecting cell differentiation. In Chapter 6 we 
examined the effects of cigarette smoke on wound repair and induction of RNase 7 by basal 
cells and how smoke-induced oxidative stress differentially affects host defense properties 
of the epithelium. Chapter 7 describes the influence of cigarette smoke-induced oxidative 
stress on regulation of the cytoprotective cellular mechanism known as the integrated stress 
response. Chapter 8 discusses work in which the effect of cigarette smoke was examined on 
COPD and non-COPD airway epithelial shedding of the IL-6 receptor and amphiregulin by 
the matrix metalloprotease ADAM17. Chapter 9 describes the influence of COPD related 
risk factors on the expression of the host defence protein WFDC12, which is dynamically 
regulated in an epithelial cell differentiation dependent manner. In Chapter 10, discussion on 
the therapeutic potential of targeting AMPs in infectious and non-infectious lung diseases is 
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Chronic obstructive pulmonary disease (COPD) is a frequent, chronic lung disease associated 
with significant morbidity and mortality. Respiratory infections play a central role in the 
disease, not only during exacerbations but also in the stable phase of the disease. These 
infections contribute to the development and progression of the disease, and many patients 
are colonized by respiratory pathogens. The pathogens are present in the lung, despite the 
presence of large numbers of neutrophils, especially during acute states of inflammation. 
These neutrophils may release antimicrobial peptides (AMPs) that may not only serve to kill 
these pathogens but also contribute to tissue injury and inflammation. In addition, smoke 
affects many elements of the host immune system, including the expression of epithelial 
AMPs. Furthermore, the activity of AMPs may be decreased in the purulent airway secretions 
often present in COPD patients. Possibly vitamin D treatment may contribute to restoring 
local AMP deficiency and thereby to reducing exacerbations in COPD.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a frequent respiratory tract disorder 
characterized by persistent airflow limitation (1). It is mainly caused by extensive exposure 
and an abnormal response toward harmful environmental substances and gases, most 
prominently, the exposure to cigarette smoke. Only ~20 % of the smoking population develops 
the disease, indicating the additional importance of genetics and other environmental 
predispositions. The progressive decrease in lung function in COPD is caused by airflow 
obstruction resulting from a variety of structural changes in the lung, including destruction 
of the alveoli and alveolar attachments (emphysema), mucus hypersecretion, and subsequent 
airway plugging especially in small airways, and changes in the airway wall. These structural 
changes are accompanied by a chronic inflammatory process in which a variety of cell types 
play a role. Small airway pathology is characterized by increased accumulation of neutrophils, 
macrophages, and T-cells during disease progression and the occurrence of B-cell lymphoid 
follicles in severe disease stages (2, 3). Neutrophils are regarded as one of the driving forces 
of emphysema, causing excessive tissue damage by an imbalance between neutrophil-derived 
proteases and protease inhibitors. This imbalance is also observed in genetically predisposed 
patients with alpha-1 antitrypsin deficiency development (4), a condition associated with 
liver disease and early onset emphysema.
RESPIRATORY INFECTIONS IN COPD
Chronic inflammation in stable COPD is frequently accompanied by bacterial and/or viral 
infections (5, 6). These infections contribute to persistence of airway inflammation and are 
thought to contribute to the etiology, pathogenesis, and clinical course of COPD. During 
acute exacerbations of COPD, a sudden decrease in airflow and an accompanying increase in 
airway inflammation is associated with the acquisition of new bacterial strains, most notable 
non-typeable Haemophilus influenzae (NTHi), Moraxella catarrhalis, and Streptococcus 
pneumoniae (7). Interactions between bacterial and viral pathogens may contribute to the 
intensity of exacerbations. This is illustrated by a study from Wilkinson et al., who showed that 
simultaneous detection of bacterial (mostly NTHi) and viral (mostly rhinovirus) pathogens 
during an exacerbation is associated with an increased bacterial load, inflammation, and 
symptoms and with decreased lung function (8). It is now clear that infections not only 
contribute to increased inflammation during exacerbations but also in the stable phase of 
the disease. This is illustrated by a study by Bresser et al., showing that NTHi colonization 
may contribute to airway inflammation and airflow obstruction in COPD (9). Various 
mechanisms may explain the observed bacterial persistence in COPD, including antigenic 
variation, acquisition of new strains, tissue invasion, and biofilm formation. The observation 
that COPD patients are frequently unable to eradicate bacteria from their airways despite the 
presence of antibacterial antibodies and the abundant presence of neutrophils suggests that 
tissue invasion and biofilm formation are important processes. Adherence to airway epithelial 
cells is an important process in bacterial persistence. NTHi may penetrate between epithelial 
cells (10) and even into epithelial cells (11), which may protect them from host defense 
systems in the lung as well as from antibiotics. This protection from host immunity and 
antibiotics is also achieved by formation of biofilms, in which bacterial adhesion is the first 
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essential step (12). Biofilms are microbial communities that adhere to a surface and in which 
the microorganisms are embedded in a self-produced matrix. Importantly, microorganisms 
present in biofilms are not always readily detected by conventional culture techniques. 
Therefore, molecular techniques including microbiome sequencing are important to gain 
insight into the lung microbiome in COPD. Several recent studies have used such techniques 
and provided important insight in the microbial population composition in COPD. Hilty 
et al. demonstrated in bronchial brushings and bronchoalveolar lavage (BAL) specimens of 
COPD patients an increase in Proteobacteria, mainly Haemophilus, Moraxella, and Neisseria 
species, and a decrease in the phylum Bacteroidetes compared to healthy controls (13). Erb-
Downward et al. furthermore showed in severe COPD that the diversity of the microbiome 
is reduced (14). These initial findings show some differences with other studies which may 
have been caused by differences in study design, sampling techniques, and small sample sizes 
(15). Nevertheless, the overall conclusions are the same, showing that the lung microbiome in 
COPD differs from that in healthy subjects and smokers with normal lung function. The COPD 
patient lung microbiome also differs from the microbiome in patients with cystic fibrosis. 
Further microbiome studies in COPD are needed to explore a wide range of topics, including 
changes in the composition of the microbiome over time, its relation to disease severity and 
response to therapy, the influence of antibiotic therapy on the microbiome compositions, its 
role in development and progression of the disease, as well as regional heterogeneity. 
ANTIMICROBIAL PEPTIDES IN COPD 
The prominent role of respiratory infections despite intense inflammation in the COPD 
lung suggests that the pulmonary immune system does not function optimally in COPD. 
Antimicrobial peptides (AMPs) play a central role in host defense against infection in the 
lung (16), which is also supported by, e.g., in vivo mouse studies showing that gene deletion 
or overexpression of AMP genes affects pulmonary host defense against NTHi (17) and 
Pseudomonas aeruginosa (18). Based on this role of AMPs, several studies have investigated 
expression and activity of AMPs in COPD in search for an explanation for the increased 
susceptibility to infection and increased inflammation in COPD. 
Neutrophil-derived antimicrobial peptides 
The excessive number of neutrophils in the lung consequently leads to high detectable quantities 
of neutrophil-derived AMPs. Α-defensins (human neutrophil peptides; HNP) are abundantly 
present in sputum samples of COPD patients and found elevated in more severe disease stages 
compared to mild-to-moderate COPD(19). Analysis of sputum and bronchoalveolar lavage 
fluid (BAL) from COPD patients using a proteomic approach specifically demonstrated 
an increase of HNP1 and HNP2 levels, while HNP3 levels were similar to those of healthy 
controls (20, 21). In addition, also in α-1 antitrypsin-deficient patients, higher levels of HNPs 
were observed (22, 23). Similar to HNPs, concentrations of the cathelicidin antimicrobial 
peptide LL-37 are elevated in induced sputum samples of mild-to-very severe COPD patients 
(24). Compared to nonsmokers, LL-37 was already increased to some extent in smokers with 
a normal lung function, an observation not noticed for HNPs (21). This suggests that cigarette 
smoking plays an important role in increasing LL-37 levels in the airway. Moreover, a study 
examining the relation of LL-37 with bacterial colonization during acute exacerbations 
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revealed that increased levels of LL-37 in sputum samples correlated with the acquisition 
of NTHi and M. catarrhalis (25). The usually protective role of neutrophils in host defense 
against pathogens may be dysfunctional in COPD. High levels of neutrophil-derived HNPs 
and LL-37 are suggested to contribute to the chronic inflammatory state (Figure 1) (26), and 
HNPs were found to increase bacterial adherence to epithelial cells (27). The combined release 
of AMPs with reactive oxygen species and other neutrophil granule–derived proteins, such 
as cathepsin G, elastase, and S100 proteins, causes extensive tissue damage that contributes 
to airway remodeling and the maintenance of inflammation (28). The release of neutrophil 
extracellular traps (NETs), consisting of complexes of DNA including high levels of LL-37 
and HNPs, has been shown to contribute to autoimmune diseases via the development of 
autoantibodies (29). However, although various studies have provided evidence for an 
autoimmune response in COPD [e.g. (30), it is unclear whether autoimmunity contributes 
to COPD development and progression or may be a response to tissue injury that in itself 
is not pathogenic. In vitro experimental data support the increased cytotoxic activity and 
Figure 1. Dysregulation of antimicrobial peptide expression and activity by cigarette smoke. Cigarette smoke-
induced chemoattraction of neutrophils causes excessive levels of neutrophil-derived AMPs in the lung, which 
may contribute to airway epithelial remodeling (including proliferation and mucus hypersecretion) and possibly 
carcinoma development, and further enhancement of neutrophilic inflammation. This mechanism may be increased 
by posttranslational modification of AMPs such as HNPs and LL-37, which may be increased in smokers and alter 
the activity of these peptides. Cigarette smoke furthermore not only impairs expression of AMPs by airway epithelial 
cells exposed to microbial stimuli but also decreases ciliary activity and increases mucus hypersecretion. These 
mechanisms contribute to an increased susceptibility to respiratory tract infections and may impair proper wound 
healing. Moreover, these respiratory infections lead to a further increase in airway inflammation.
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immunomodulatory properties of HNPs and LL-37 at high concentrations. Exposure of airway 
epithelial cells to HNPs may result in cell death, whereas lower concentrations increase the 
secretion of pro-inflammatory cytokines, including the neutrophil chemoattractant IL-8 (31, 
32). Furthermore, HNPs also increase the transcription and secretion of the mucin MUC5AC 
by an airway epithelial cell line (33, 34). This finding indicates a potential role in promoting 
mucus hypersecretion. A further role in decreased mucociliary clearance was suggested by 
the observation of an association between increased HNP levels and squamous metaplastic 
epithelium (35). This finding combined with the mitogenic activity of neutrophil defensins 
toward airway epithelial cells (33, 36) suggests a possible role in airway epithelial remodeling. 
HNPs can also contribute to the increased bacterial colonization in acute exacerbations as it 
has been demonstrated that the peptides increase the adhesion of NTHi, M. catarrhalis, and 
S. pneumoniae toward the airway epithelial surface (27, 37). Adhesion may be the first step 
in biofilm formation, or facilitate intra- or intercellular localization, mechanisms that may 
provide protection against the host immune system. Similar to HNPs, LL-37 can contribute 
to the increased neutrophilic infiltration in the lung by inducing the expression of IL-8 by 
airway epithelial cells and airway smooth muscle cells (38, 39) or via a direct chemotactic 
activity (40). Furthermore, it has been shown that LL-37 can drive macrophage differentiation 
toward a pro-inflammatory phenotype, thereby potentially increasing the inflammatory 
state in COPD (41). Similar to HNPs, it has been shown that LL-37 also increases airway 
epithelial cell proliferation (42), which may contribute to epithelial remodeling. The switch in 
function from antimicrobial effectors toward harmful mediators is not a unique property of 
HNPs and LL-37 at high concentrations. Several studies report that cigarette smoke-related 
posttranslational modifications of both AMPs may affect their function. The converting 
enzyme responsible for ADP-ribosylation of HNP1, arginine-specific ADP-ribosyltransferase 
1, is increased in smoking individuals, and levels of ADP-ribosylated HNP1 are increased in 
BAL fluid from smokers 43. This may have important functional consequences, since ADP-
ribosylation of HNP1 decreases the antimicrobial effect of the peptide, while increasing the 
cytotoxic and IL-8 inducing properties (43, 44). Recently, citrullination was described as a 
novel mechanism for posttranslational modification of LL-37 that may also be increased in 
smokers, and it was demonstrated that citrullination of LL-37 decreases antimicrobial activity 
and increases chemotactic activity (45). Citrullination of proteins is mediated by members 
of the peptidylarginine deiminase (PADI) family and expression of PADI2, and presence of 
citrullinated proteins was found to be increased in the lungs of smokers (45, 46). This points 
toward a potential mechanism by which modification of HNPs and LL-37 alters the activity of 
these peptides, which may contribute to the development and progression of COPD. 
Epithelial expression of antimicrobial peptides
In contrast to HNPs and LL-37, levels of human β-defensin-2 (hBD-2) are decreased 
in induced sputum samples and BAL of COPD patients (47). Furthermore, Herr et al. 
found an association between decreased hBD-2 levels and cigarette smoking in patients 
hospitalized with an acute pneumonia (48). The cigarette smoke–mediated suppression of 
hBD-2 expression seems to be persistent, as 1 year smoking cessation did not result in an 
increase in hBD-2 sputum levels in asymptomatic smokers (49). In COPD patients, hBD-2 
expression is predominantly decreased in the central airways, while in the distal airways the 
expression was increased compared to controls (50). A previous report showed that hBD-2 
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depletion in BAL supernatants increased the number of apoptotic neutrophils, suggesting 
a role of hBD-2 in protection of cells from apoptosis (51). In contrast to HNPs, hBD-2 
does not induce IL-8 expression in airway epithelial cells (52), so it remains to be further 
investigated if hBD-2 contributes to inflammation in COPD. In vitro antibacterial assays 
demonstrate efficient killing activity of hBD-2 toward acute exacerbation-associated bacteria 
(53). This suggests that the observed suppression of hBD-2 expression in COPD in central 
airways contributes to the increased bacterial colonization during acute exacerbations. As the 
airway epithelium is regarded as the main cellular source of hBD-2 in the airways (54), it is 
hypothesized that airway epithelial cells display an impaired host defense activity (Figure. 1). 
In vitro experiments demonstrate that prior cigarette smoke exposure of air–liquid interface-
cultured airway epithelial cells inhibits P. aeruginosa- and M. catarrhalis-induced expression 
of hBD-2 (48, 55). Furthermore, it was shown that apical surface fluid derived from these cells 
displayed decreased antimicrobial activity. Stimulation of epithelial cells with the cigarette 
smoke–derived compound acrolein similarly showed an inhibition of hBD-2 expression 
(56). In contrast to in vitro experiments, cigarette smoke exposure in murine models showed 
increased mouse β-defensin-2 expression in the lung (57), which is not in line with the 
findings in these in vitro studies, and observations in central airways and airway secretions 
in human studies (47, 48, 50). Recent studies have highlighted a role for vitamin D in the 
regulation of expression of antimicrobial peptides in epithelial cells and macrophages (58, 59). 
Furthermore, vitamin D deficiency is frequent in COPD and correlates with disease activity 
(60). This would suggest that vitamin D supplementation may be beneficial in COPD and may 
be a good strategy to prevent exacerbations that are so frequently associated with infections 
(61). A recent intervention study showed that high-dose vitamin D supplementation may 
indeed reduce exacerbations in those COPD patients with severe vitamin D deficiency (62). 
Genetic and Epigenetic Mechanisms
Several studies have investigated the association between genetic and epigenetic differences 
of AMPs with COPD development. Both α- and β-defensin-coding genes are localized at 
highly polymorphic regions (63). Genetic association studies assessing the role of single 
nucleotide polymorphisms (SNPs) in the gene encoding human β-defensin-1 (hBD-1) with 
COPD development revealed population-dependent outcomes. The hBD-1 gene contains 
polymorphisms in both the promoter region and the two coding exons (64). In a Japanese 
population study, the nucleotide polymorphism in exon 2, resulting in a change of valine to 
isoleucine at position 38, was more frequent in COPD patients compared to controls (65). 
A study in a Chinese Han population describes an association between a polymorphism 
localized at exon 1 (44 C/G) with COPD susceptibility (66). In Caucasians, an association 
between SNPs in the hBD-1 gene and COPD could not be found (67, 68). In addition, also 
polymorphisms in HNP1/3 were not associated with COPD development in such populations 
(67). This indicates that the relation between polymorphisms and disease may differ between 
populations and that further studies on the functional consequences of these polymorphisms 
are needed. Janssens et al. examined the association of copy-number variations of the hBD-
2 gene with COPD development (69). Using in vitro cultured epithelial cells, it was shown 
in this study that five and higher diploid copy numbers of the hBD-2 gene was significantly 
more often present in COPD patients compared to controls. Moreover, it was shown that 
epithelial cells with high diploid copy number displayed a higher expression of hBD-2 
induced by TNF-α and furthermore have a higher bacterial killing activity. These results are 
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in contrast with earlier mentioned observations of a decrease in hBD-2 levels in BAL and 
induced sputum and inhibition of hBD-2 expression by airway epithelial cells after cigarette 
smoke exposure. Therefore, the additional effects of environmental factors on the induced 
expression of hBD-2 in COPD patients with high copy numbers of the hBD-2 gene should 
be taken into consideration. Andresen et al. investigated the role of epigenetics in hBD-1 
expression in COPD (70). Using airway epithelium and cells derived from BAL, it was shown 
that mRNA levels of hBD-1 were higher in cells of COPD patients with mild to very severe 
disease compared to cells of healthy controls. The difference in mRNA levels was not due 
to a difference in DNA methylation of the hBD-1 gene promoter, but rather correlated with 
histone H3 lysine 4 methylation. These studies highlight that copy-number variations and 
epigenetic mechanisms may contribute to the control of expression levels of antimicrobial 
peptides in COPD.
Activity of Antimicrobial Peptides in COPD
During airway inflammation and infection, the local environment in which AMPs are 
active undergoes dramatic changes. Increased production of mucus as a result of smoking, 
inflammation, and infection may impact on local host defense against infection. Whereas 
the mucus layer that is positioned on top of the periciliary layer (Figure. 2) normally acts to 
trap and remove inhaled particles and pathogens, decreased mucociliary clearance in COPD 
prevents this process. Mucus itself does display antimicrobial activity because of its barrier 
and biochemical properties, but microorganisms have developed escape mechanisms such 
as flagella-mediated motility and enzymatic degradation of mucus (71). Mucins are large, 
heavily glycosylated glycoproteins that are essential components of mucus. Mucins have been 
shown to restrict the antimicrobial activity of LL-37 (72, 73), and therefore, these peptides 
may not contribute optimally to antimicrobial activity of mucus. In healthy airways, this is not 
Figure 2. Mucus, antimicrobial peptides, and microbial pathogens. In COPD, mucus hypersecretion and decreased 
mucociliary clearance may allow bacteria to escape from the mucus layer in numbers that are too large for efficient 
killing in the periciliary layer and epithelial surface
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a problem, since mucus is removed. Furthermore, the bacteria that escape from the mucus 
layer are likely to be killed by antimicrobial peptides present in the periciliary layer (Figure. 
2). However, because of excess mucus production and impaired ciliary activity, in COPD 
more bacteria may penetrate the mucus layer and reach the epithelial surfaces. However, 
also other factors in the inflamed airways of COPD patients may have a negative impact 
on the antimicrobial activity of AMPs. It has been shown that a wide range of microbial 
and host proteases are able to degrade and inactivate AMPs (74-76). In addition, products 
such as F-actin and DNA (77) that are released by dead cells, glycosaminoglycans (78, 79), 
and bacterial polysaccharides (80) may inhibit antimicrobial activity of AMPs. Finally, 
bacteria have evolved mechanisms to escape the antimicrobial activity of peptides. One such 
mechanism is the development of biofilms that provide protection against the action of the 
host immune system. Interestingly, bacteria in biofilms may not be fully protected against the 
action of antimicrobial peptides, since, e.g., LL-37 (81) and lactoferrin (82) have been shown 
to prevent biofilm formation and to act on bacteria present in biofilms. 
CONCLUDING REMARKS 
Recent studies point to a clear role of respiratory infection and AMPs in COPD. Microbiome 
analysis using unbiased molecular biological methods is still in its infancy but is pointing 
toward an altered microbiome also in stable COPD. Local excessive release of AMPs by, e.g., 
neutrophils may contribute to inflammation and possibly autoimmunity, whereas a local 
deficiency as a result of epithelial smoke exposure or inactivation of AMPs may contribute 
to respiratory infections. Biofilm formation impairs host defense against infection, but some 
AMPs may contribute to the fight against biofilm formation. Whether enhancement of local 
AMP production by, e.g., vitamin D treatment or administration of novel drugs based on the 
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Basal cells play a critical role in the response of the airway epithelium to injury and are recently 
recognized to also contribute to epithelial immunity. Antimicrobial proteins and peptides are 
essential effector molecules in this airway epithelial innate immunity. However, little is known 
about the specific role of basal cells in antimicrobial protein and peptide production and 
about the regulation of the ubiquitous antimicrobial protein RNase 7. In this study, we report 
that basal cells are the principal cell type producing RNase 7 in cultured primary bronchial 
epithelial cells (PBEC). Exposure of submerged cultured PBEC (primarily consisting of basal 
cells) to the respiratory pathogen nontypeable Haemophilus influenzae resulted in a marked 
increase in expression of RNase 7, although this was not observed in differentiated air-liquid 
interface cultured PBEC. However, transient epithelial injury in air liquid interface–cultured 
PBEC induced by cigarette smoke exposure led to epidermal growth factor receptor–mediated 
expression of RNase 7 in remaining basal cells. The selective induction of RNase 7 in basal cells 
by cigarette smoke was demonstrated using confocal microscopy and by examining isolated 
luminal and basal cell fractions. Taken together, these findings demonstrate a phenotype-
specific innate immune activity of airway epithelial basal cells, which serves as a second line 
of airway epithelial defence that is induced by airway epithelial injury
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INTRODUCTION
Mucosal epithelial cells are an essential component of the host defense barrier against microbial 
pathogens. In the lung, a pseudostratified layer of airway epithelial cells provides this host 
defense via a passive barrier function but also active innate immune defense mechanisms (1, 
2). These mechanisms are primarily executed by airway epithelial luminal cells (LCs), mainly 
composed of ciliated and secretory cells, which facilitate for instance mucociliary clearance, 
defense mediated by periciliary tethered mucins, production of innate immune mediators 
upon pathogen recognition, and Ig transcytosis toward the airway surface liquid (3-6). In 
contrast to LCs, it has been largely unexplored whether airway epithelial basal cells (BCs) 
have an innate immune function. BCs are characterized as epithelial progenitor cells and 
defined based on the expression of p63 and cytokeratin 5 (KRT5) (7-9). BCs display a low 
turnover at normal homeostatic conditions but rapidly expand and subsequently differentiate 
toward other epithelial phenotypes upon injury to restore the airway epithelial barrier. The 
basolateral localized BCs are shielded from direct microbial contact by the overlying LCs 
in intact airway epithelium. However, airway epithelial injury caused by disruption of the 
epithelial barrier because of the loss of cell–cell contact or shedding of LCs after extensive 
injury may increase microbial exposure. This may enhance the vulnerability of BCs and 
underlying tissues to respiratory infections. Recently, Byer et al. (10) demonstrated selective 
expression of the pro-inflammatory mediator IL-33 by a subpopulation of BCs in patients 
with chronic obstructive pulmonary disease. On the basis of this observation, we speculate 
that BCs might display other unique innate immune responses, which act as a second line of 
airway epithelial host defense in addition to the activity of LCs. Antimicrobial proteins and 
peptides (AMPs) are important innate immune mediators involved in airway epithelial host 
defense (11). AMPs display direct antimicrobial activity against bacteria, viruses, and fungi 
but also exhibit immunomodulatory and wound healing properties (12, 13). The antimicrobial 
RNase 7 is a secreted RNase A family member displaying antimicrobial activity toward a 
range of pathogens, including the respiratory pathogen Pseudomonas aeruginosa (14-16). 
Previous studies exploring the regulation of RNase 7 expression in skin, urinary tract, and 
ocular surface epithelial cells, demonstrated increased RNase 7 expression upon stimulation 
with microbes, microbial compounds, and pro-inflammatory cytokines (17-19). Moreover, 
mechanical injury and UV radiation induce expression of RNase 7 in keratinocytes (20, 21), 
demonstrating that epithelial injury is a potent inducer of RNase 7 expression. Although 
RNase 7 expression has been detected in cultured airway epithelial cells (14), it is currently 
unknown how RNase 7 expression is regulated in these cells. In this paper, we provide 
evidence that BCs are the principal cell producing RNase 7 in cultured human primary 
bronchial epithelial cells (PBEC) upon exposure to the respiratory pathogen nontypeable 
Haemophilus influenzae (NTHi) and epithelial barrier disruption caused by cigarette smoke 
exposure. Submerged cultured undifferentiated PBEC (S-PBEC), primarily consisting of BCs, 
but not mucociliary differentiated air-liquid interface–cultured PBEC (ALI-PBEC), expressed 
RNase 7 upon stimulation with UV-inactivated NTHi. Transient epithelial injury induced by 
whole cigarette smoke coincides with epidermal growth factor receptor (EGFR)–dependent 
expression of RNase 7 in ALI-PBEC, and this expression is specifically observed in BCs. These 
findings demonstrate a novel innate immune defense function of BCs, which act as a second 




Bronchial epithelial cell culture
Human PBEC were isolated from tumour-free resected lung tissue from anonymous donors 
by enzymatic digestion as reported previously (22). Mucociliary-differentiated ALI-PBEC 
were cultured as previously described (23), using semipermeable Transwell membranes with 
a 0.4-mm pore size (Corning Costar, Cambridge, MA). Transwells were coated with a mixture 
of 30 µg/ml PureCol (Advanced BioMatrix, San Diego, CA), 10 µg/ml BSA (Sigma-Aldrich, 
St. Louis, MO), and 10 µg/ml fibronectin (isolated from human plasma) diluted in PBS, at 
37°C, 5% CO2 for 2–24 h. PBEC (passage 2) were seeded on coated Transwells at a density 
of 40,000 cells and cultured in submerged condition using a 1:1 mixture of DMEM (Life 
Technologies, Bleiswijk, the Netherlands) and bronchial epithelial growth medium (Lonza, 
Verviers, Belgium) (B/D medium) with supplementation of BEGM BulletKit singlequots 
(0.4% [w/v] bovine pituitary extract, 1 mM hydrocortisone, 0.5 ng/ml human hEGF, 0.5 
µg/ml epinephrine, 10 µg/ml transferrin, 5 µg/ml insulin, T3, and 0.1 ng/ml retinoic acid) 
(Lonza), 1 mM HEPES (Lonza), 1 mg/ml BSA (Sigma-Aldrich), 100 U/ml penicillin and 
100 µg/ml streptomycin (Lonza), and additional supplementation of 15 ng/ml retinoic acid 
(Sigma-Aldrich) to induce mucociliary differentiation. After reaching confluence (~ 4–5 d), 
cells were cultured air exposed for an additional period of 2 wk before use. Undifferentiated 
S-PBEC were cultured in 12-well tissue culture plates in B/D medium including supplements 
as earlier described but without additional retinoic acid supplementation. Upon reaching 
80–90% confluence, S-PBEC were used for further experiments.
NTHi
NTHi strain D1 (24) was cultured on chocolate agar plates (bioMérieux, Craponne, France) at 
5% CO2 and 37°C overnight. A selected colony was resuspended in 10 ml Tryptone soya broth 
+ X- and V-factor (Mediaproducts BV, Groningen, the Netherlands) and incubated at 37°C 
while shaking overnight. Next, 1 ml of the overnight broth containing NTHi was transferred 
into new 10 ml Tryptone soya broth + X- and V-factor and incubated for 3 h at 37°C while 
shaking. Afterward, the bacteria containing broth was centrifuged for 10 min at 3000 rpm, 
and the pellet was washed with PBS. The bacterial pellet was resuspended in PBS after an 
additional washing step, and the concentration was adjusted to an OD600 1 (1 x 10
9 CFU/ml). 
The NTHi was subsequently inactivated by UV exposure for 2 h.
Whole cigarette smoke exposure and other stimuli
ALI-PBEC were exposed to cigarette smoke using 3R4F reference cigarettes (University of 
Kentucky, Lexington, KY) in a whole smoke exposure model adapted from Beisswenger et 
al. (25) as depicted in Figure 2A. ALI-PBEC were placed into modified hypoxic chambers 
(Billups Rothenberg, Del Mar, CA), further referred to as exposure chambers, localized inside 
an incubator at 37°C and 5% CO2. Next mainstream smoke derived from one cigarette or air 
as negative control was infused inside respectively a “Smoke” and “Air” exposure chamber by 
a mechanical pump using a continuous flow of 1 l/minute for a period of 4–5 min. A ventilator 
inside the exposure chambers equally distributed and mixed the infused air/smoke with 
humidified warm air derived from the incubator to prevent inflammatory responses by PBEC 
as reported previously (25). After exposure, residual smoke inside the exposure chamber was 
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removed for a period of 10 min by flushing the chambers with air derived from the incubator. 
The amount of smoke infused inside the exposure chamber was measured by determining the 
weight difference of a filter placed between the pump and exposure chamber before and after 
exposure. Approximately 2 mg cigarette smoke–derived particles were deposited on the filter 
as determined by measuring the filter of different exposures. After smoke or air exposure, the 
culture medium of ALI-PBEC was refreshed, and cells were incubated at 37°C and 5% CO2 for 
the indicated period of times. UV-inactivated NTHi or Pam3CSK4 (InvivoGen, San Diego, 
CA) was administered in a volume of 100 µl in PBS at the apical surface of ALI-PBEC or 
added to the culture medium when stimulating S-PBEC. To examine cell signalling pathways, 
the following chemical inhibitors were applied: AG1478, anti-EGFR neutralizing Ab, and 
U0125 (all Calbiochem, Darmstadt, Germany). Inhibitors were added into the basal culture 
medium and pre-incubated for 1 h prior to smoke exposure. Stimulation of ALI-PBEC with 
rTGF-α (PeproTech, Rocky Hill, NJ) was done by adding this growth factor to the culture 
medium. In confocal imaging and FACS experiments, 5 µg/ml brefeldin A (Sigma-Aldrich) 
was added in the culture medium to prevent protein secretion.
Cell cytotoxicity and viability assays
Lactate dehydrogenase (LDH) release in the apical surface liquid, collected by washing the 
epithelial cultures apical with 100 µl PBS, and culture medium was assessed using a cytotoxicity 
detection kit (Roche, Basel, Switzerland), according to the manufacturer’s protocol. One 
hundred microliters of 0.1% (v/v) Triton X-100 in PBS was applied on the apical surface as 
positive control. The transepithelial electrical resistance (TEER) was measured using the 
MilliCell-ERS (Millipore, Bedford, MA). Cell permeability was determined by the FITC–
dextran permeability assay. In this assay, 1 mg/ml FITC–dextran (4 kDa; Sigma-Aldrich) 
diluted in PBS was added to the apical side and incubated for 2 h. Next, 100 µl of the basal 
culture medium was transferred into solid black 96-well plates (Costar-Corning), and the 
fluorescence was measured with an excitation/emission wavelength of 490/521 nm using a 
Wallac Victor 2 Microtiter Plate Reader (PerkinElmer, Waltham, MA).
RNA isolation, reverse transcription, and quantitative real-time PCR
Total RNA was isolated using the miRNeasy Mini Kit (Qiagen, Venlo, the Netherlands) 
following the manufacturer’s protocol, and RNA quantities were measured using the 
Nanodrop ND-1000 UV-visible (UV-Vis) spectrophotometer (Nanodrop Technologies, 
Wilmington, DE). cDNA synthesis was performed by RT-PCR of 1 µg RNA reverse mixed with 
oligo (deoxythymidine) primers (Qiagen) and Moloney murine leukemia virus polymerase 
(Promega, Leiden, The Netherlands) at 37°C. Quantitative PCR (qPCR) was performed using 
IQ Sybr green supermix (Bio-Rad) and a CFX-384 real-time PCR detection system (Bio-Rad). 
Reactions were performed using the primers indicated in Table 1. The housekeeping genes 
RPL13A and ATP5B were selected using the “Genorm method” (Genorm; Primer Design, 
Southampton, U.K.). Bio-Rad CFX manager 3.0 software (Bio-Rad) was used to calculate 




Protein secretion by ALI-PBEC was determined in the apical surface liquid and in the basal 
medium. The secretion of IL-8 was determined by ELISA following the manufacturer’s 
protocol (Sanquin, Amsterdam, The Netherlands). RNase 7 secretion was assessed by ELISA 
as described previously (16). The OD values were measured with a microplate reader (Bio-
Rad).
Isolation of luminal and basal airway epithelial cells
The basal and luminal fraction of ALI-PBEC were isolated according to a method adapted 
from Jakiela et al. (26). Cultured ALI-PBEC were washed twice with calcium-free PBS. 
Next, calcium-free MEM (Life Technologies) was applied to the apical side (700 µl) and the 
basolateral compartment to break down the integrity of the intercellular junctions. This was 
monitored by TEER measurements, which reached background levels after ~15–20 min. Next, 
the apical medium was substituted by 700 µl Trypsin Versene (Lonza) and incubated for 7–10 
min until luminal cells started to detach. The detached luminal fraction was collected, and the 
apical surface was subsequently washed twice gently with 700 µl DMEM supplemented with 
5% heat-inactivated FCS (Life Technologies). The cells that were collected by this washing 
step were added to the luminal fraction, which was then centrifuged for 7 min at 1200 rpm. 
After removal of the supernatant, mRNA was isolated from the cell pellet (luminal fraction) 
and the epithelial cells that remained attached to the inserts (basal fraction).
Immunofluorescence staining and confocal imaging
For immunofluorescence staining, ALI-PBEC were fixed in 4% paraformaldehyde, 
permeabilized in 0.3% (v/v) Triton X-100 in PBS, and blocked in blocking solution consisting 
of 5% (w/v) BSA and 0.3% (v/v) Triton X in PBS. All incubation steps were 30 min at room 
temperature and contained washing steps with PBS in-between. Membranes containing ALI-
PBEC were detached from the Transwell using a razorblade and transferred to 24-well tissues 
Table 1. Primer sequences











RPL13A 5’-AAGGTGGTGGTCGTACGCTGTG-3’ 5’- CGGGAAGGGTTGGTGTTCATCC-3’
ATP5B 5’-TCACCCAGGCTGGTTCAGA-3’ 5’-AGTGGCCAGGGTAGGCTGAT-3’
Sequences of primers used for qPCR.
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culture plates for Ab staining. The primary Abs (mouse mAb against RNase 7 and rabbit mAb 
against p63 [Abcam, Cambridge, U.K.]) were diluted in blocking solution and added to the 
cells for 1 h at room temperature. The secondary Abs goat anti-mouse Alexa Fluor 488, goat 
anti-rabbit Alexa Fluor 568 (both Invitrogen), and DAPI, diluted in blocking buffer, were 
added to the cells for 30 min at room temperature in the dark. Next, the PBEC-containing 
membranes were placed on coverslips and mounted in Vectashield Hard Set Mounting 
Medium (Vector Labs, Burlingame, CA). Confocal images were taken using a Leica TCS SP5 
confocal inverted microscope (Leica Microsystems, Wetzlar, Germany) and processed using 
the Leica Application Suite Advanced Fluorescence software (Leica Microsystems).
Flow cytometry
ALI-PBEC were detached from the Transwell by trypsinization using soft trypsin, consisting 
of 0.3 mg/ml trypsin 250 (BD Biosciences, San Jose, CA), 0.1 mg/ml EDTA, 1 mg/ml glucose 
(both BDH Chemicals, Poole, U.K.), 100 U/ml penicillin, and 100 µg/ml streptomycin in PBS 
(pH 7.45). Trypsinization was stopped using 1.1 mg/ml soy bean trypsin inhibitor (Sigma-
Aldrich) in keratinocyte serum-free medium (Life Technologies). Cells were washed once 
in cold PBS and stained with live/dead stain aqua (Invitrogen). Then, cells were washed in 
PBS, permeabilized using 0.5% (v/v) saponin (Sigma-Aldrich) in PBS for 5 min on ice, and 
fixed with 3.9% (v/v) formaldehyde (Merck) in PBS for 15 min at room temperature. Next, 
primary Abs (mouse mAb against RNase 7 [Abcam, Cambridge, U.K.] and rabbit polyclonal 
Ab against KRT5 [Santa Cruz Biotechnology, Santa Cruz, CA]) were added, followed by 
secondary Ab treatment (goat anti-mouse Alexa Fluor 488 and goat-anti-rabbit Alexa Fluor 
647 [both Invitrogen]), both diluted in 0.5% saponin supplemented with human FcR binding 
inhibitor (eBioscience, San Diego, CA). Both primary and secondary Abs were incubated for 
30 min at room temperature. Cells were measured on a FACSCanto II (BD Biosciences), and 
analysis was performed using FlowJo (version 7.6.5) software (Tree Star, Ashland, OR). Gates 
were placed according to unstained and single stains with secondary Abs (Supplementary 
Figure 1).
SDS-PAGE and Western blot
SDS-PAGE gel electrophoresis and Western blotting was performed as described previously 
(27). In short, PBEC were washed with ice-cold washing buffer consisting of 5 mM Tris (pH 
6.4), 100 mM NaCl, 1 mM CaCl2, and 1 mM MgCl2, and cell lysates were prepared in lysis 
buffer consisting of 0.5% (v/v) Triton X-100, 0.1 M Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM 
MgCl2, 1 mM CaCl2 1 mM Na3VO4, and protease inhibitor mixture (Roche) and subsequently 
suspended in SDS-PAGE sample buffer consisting of 4% (w/v) SDS, 10% (v/v) 2-ME, 20% (v/v) 
glycerol, 0.5 M Tris (pH 6.8), and 0.003% (w/v) Bromophenol blue. SDS-gel electrophoresis 
was conducted using 10–12.5% glycine-based gels, and afterward, separated proteins were 
transferred to polyvinylidene difluoride membranes. Membranes were blocked with blocking 
buffer consisting of 5% (w/v) skim milk (Sigma-Aldrich) in PBS/0.05% (v/v) Tween 20 and 
incubated with primary Abs (rabbit polyclonal Ab ERK1/2, p-ERK1/2, p-EGFR, and mouse 
mAb b-actin [all Cell Signaling Technology, Leiden, The Netherlands], mouse mAb EGFR 
[BD Biosciences], and mouse mAb RNase 7 [Abcam]) in 5% (w/v) BSA TBS/0.05% (v/v) 
Tween 20 overnight at 4°C. Afterward, membranes were incubated with secondary HRP-
labelled Ab (Sigma-Aldrich) in blocking buffer for 1 h, and membranes were subsequently 
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developed with ECL substrate (ThermoScientific, Rockford, IL). Results were analysed by 
densitometry using Adobe Photoshop (Adobe Systems, San Jose, CA).
Statistical analysis
Graphs were made and statistical analysis was performed in GraphPad PRISM 6.0 (GraphPad 
Software, La Jolla, CA). Data are shown as means ± SEM. Differences were considered 
significantly different with p<0.05 explored by (un)paired Student t test or one/two-way 
ANOVA as appropriate.
RESULTS
NTHi increases expression of RNase 7 in undifferentiated S-PBEC but not in mucociliary 
differentiated ALI-PBEC
We first investigated whether the common respiratory pathogen NTHi induced RNase 
7 expression in cultured PBEC. Therefore, undifferentiated S-PBEC were exposed to UV-
inactivated NTHi for 6 and 24 h, and RNase 7 expression was assessed by qPCR. The results 
showed that NTHi induced RNase 7 mRNA expression by S-PBEC after 24 h but not 6 h 
of stimulation (Figure 1A). In contrast, mRNA expression of the well-defined bacterial-
induced antimicrobial peptide human β-defensin-2 (hBD-2) was increased by NTHi both 
at 6 and 24 h. As shown by others (28), we observed that undifferentiated S-PBEC primarily 
consist of p63+ BCs (data not shown). Because mucociliary-differentiated ALI-PBEC are 
more comparable to the pseudostratified airway epithelium in vivo (29), we subsequently 
compared RNase 7 mRNA expression in ALI-PBEC and S-PBEC. Interestingly, ALI-PBEC 
did not display an increase in RNase 7 mRNA in response to various concentrations of NTHi 
after 24 h of stimulation, whereas dose-dependent induction was observed in S-PBEC (Figure 
1B). In contrast, a dose-dependent NTHi-induced expression of hBD-2 was observed in both 
ALI- and S-PBEC. Further evaluation of the expression of other innate immune mediators 
demonstrated that NTHi induced mRNA expression of IL-8, IL-6, CCL20, and lipocalin 2 
(LCN2) in both S-PBEC and ALI-PBEC (Figure 1C). To explore baseline RNase 7 expression 
during mucociliary differentiation, mRNA levels of RNase 7 were measured in S-PBEC and 
in ALI-PBEC at 1 and 2 wk after initial air exposure. Compared with S-PBEC, no difference 
in mRNA levels was observed in ALI-PBEC cultured 1 wk in air exposed conditions, whereas 
after 2 wk a significant decrease in RNase 7 mRNA was observed (Figure 1D). As expected, 
airway epithelial cell differentiation furthermore resulted in a decreased mRNA expression of 
the BC marker p63 and increased expression of ciliated and goblet cell markers, respectively, 
FOXJ1 and MUC5AC. These findings suggest, that in contrast to other examined innate 
immune mediators, RNase 7 is selectively produced by airway BCs but not by mucociliary-
differentiated airway epithelial cells at baseline conditions and upon NTHi stimulation.
Cigarette smoke–induced transient epithelial injury results in induction of RNase 7 in ALI-PBEC
BCs display enhanced activity upon injury, and it has been demonstrated that injury induces 
RNase 7 expression in keratinocytes (7, 20, 21). Therefore, we hypothesized that injury of 
ALI-PBEC can reinitiate expression of RNase 7 by remaining undifferentiated BCs. Cigarette 
smoke is a well-known inhaled toxic mixture that induces airway epithelial injury (30, 31). 
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We therefore examined cigarette smoke–induced injury in ALI-PBEC using a whole cigarette 
smoke exposure model (Figure 2A). First, the cytotoxic effect of smoke exposure was 
determined by a LDH release assay (Figure. 2B). No significant increase in LDH release was 
detected in the basal medium of smoke-exposed cells compared with air controls. However, 
a significant increase in LDH release was observed in the apical surface wash. Despite this 
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Figure 1. Differential expression of RNase 7 depending on the airway epithelial differentiation status. (A) S-PBEC were 
stimulated with 1*109 CFU/ml UV-inactivated NTHi for 6 and 24 h. mRNA expression of RNase 7 and hBD-2 was 
determined by qPCR. Data is shown as fold change compared to unstimulated cells (n=4 donors). (B) S-PBEC and 
ALI-PBEC were stimulated with 0.25, 0.5 and 1*109 CFU/ml UV-inactivated NTHi for 24 h. NTHi was stimulated on 
the apical surface of ALI-PBEC in 100 µl of PBS. mRNA expression of RNase7 and hBD-2 (DEFB4) was subsequently 
assessed. Data is shown as fold change compared to unstimulated cells (n=5 donors). (C) S-PBEC and ALI-PBEC 
were stimulated with 0.5*109 CFU/ml UV-inactivated NTHi for 24 h. mRNA expression of IL-8, IL-6, CCL20 and 
LCN2 was subsequently determined. Data is shown as fold change compared to unstimulated cells (n=5 donors). (D) 
Baseline mRNA expression of RNase 7, the basal cell marker p63 (TP63), ciliated cell marker FOXJ1, and goblet cell 
marker MUC5AC measured in undifferentiated S-PBEC, 1 wk (1 wk ALI) and 2 wk (2 wk ALI) differentiated ALI-
PBEC, all cultured on transwells. Data is shown as fold change compared to undifferentiated cells (n=4 donors). All 
stimulations were performed in duplicate. * p<0.05, ** p<0.01, *** p< 0,0001.
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cytotoxic effect, no significant difference was observed in the TEER of air- and smoke exposed 
cultures after 24 h (Figure. 2C). In contrast, a significant decrease in TEER was observed in the 
first 2 h after smoke exposure, indicating transient injury. Further evaluation of the epithelial 
barrier function by FITC–dextran permeability also confirmed increased barrier disruption in 
the first 2 h after smoke exposure, whereas no difference in permeability was detected 24 h after 
exposure (Figure 2D). To examine whether transient epithelial damage induced by cigarette 
smoke affected the expression of RNase 7, mRNA expression levels were measured at different 
time periods after exposure. A time-dependent increase in RNase 7 mRNA expression was 
detected after smoke exposure, which peaked after 3 h and remained significantly different 
compared with air exposed cells after 6 h (Figure 3A). Similar to increased RNase 7 mRNA 
expression, protein expression was increased in lysates of ALI-PBEC at 6, 12, and 24 h after 
smoke exposure (Figure 3B,C). Moreover, increased RNase 7 secretion was measured in the 
apical surface liquid but not in the basolateral culture medium 24 h after exposure, indicating 
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Figure 2. Attenuation of the airway epithelial barrier integrity by whole cigarette smoke exposure. (A) Schematic 
representation of the whole cigarette smoke exposure model (See materials and methods for details). (B) LDH release 
was measured in the basal medium 24 h after air/smoke exposure. Data is depicted as percentage cytotoxicity compared 
to the positive control Triton-X (n=5 donors). (C) Trans-epithelial electrical resistance (TEER) measurements 15-120 
minutes and 24 h after air/smoke exposure. Data is shown as percentage compared to TEER measurements of air 
exposed cells (n=4-9 donors). (D) FITC-dextran was applied on the apical surface either directly or 24 h after air/
smoke exposure, and incubated for 2 h. Afterwards the fluorescence was measured in basal medium samples. Data is 
shown as the measured fluorescence (n=4 donors). All exposures were performed in duplicate. * p<0.05, ** p<0.01.
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polarized secretion of RNase 7 (Figure 3D). We further examined the expression of other 
mediators besides RNase 7 to delineate the innate immune response induced by cigarette 
smoke. In contrast to RNase 7, cigarette smoke did not increase mRNA expression of the 
AMPs hBD-2, hBD-3, LCN2, and Psoriasin/S100A7 (data not shown). However, smoke did 
induce mRNA expression of IL-8 and IL-6 (Figure 3E), in line with previous observations by 
others (25). Furthermore, cigarette smoke exposure increased mRNA expression of CCL20, 
which previously was reported to be induced in airway epithelial cells upon disruption of 
the airway epithelial barrier integrity (32). In line with mRNA expression, we also detected 
cigarette smoke–induced IL-8 protein secretion in the basal medium and apical surface liquid 
(Figure 3F). In summary, we demonstrated that transient injury induced by cigarette smoke 
exposure is paired with increased expression and polarized secretion of RNase 7 by ALI-
PBEC. This response is part of a distinct innate immune response including the expression of 
IL-8, IL-6, and CCL20, but lacks induction of other AMPs that were investigated.
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Figure 3. Production of RNase 7 and other innate immune mediators by ALI-PBEC in response to cigarette smoke. 
(A) ALI-PBEC were exposed to air or cigarette smoke and afterwards incubated for different time periods. mRNA 
expression levels of RNase 7 was determined by qPCR at 3, 6 and 12 h after air/smoke exposure. Data is shown as fold 
change compared to unexposed cells (n=6 donors). (B) RNase 7 protein detection in cell lysates of ALI-PBEC, 24 h 
after air/smoke exposure (data represents 3 independent donors). (C) RNase 7 protein expression was determined 
by ELISA in the basal medium and apical surface liquid 24 h after air/smoke exposure (n=5 donors). (D) qPCR of 
IL-8, IL-6 and CCL20, 3 h after air/smoke exposure. Data is shown as fold change compared to air exposed cells (n=6 
donors). (E) IL-8 secretion was measured by ELISA in the basal medium and apical surface liquid 24 h after air/smoke 
exposure (n=6 donors). Air/smoke exposures were performed in duplicate. *p<0.05, ** p<0.01.
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Smoke enhances RNase 7 expression specifically in BCs of ALI-PBEC
To determine whether cigarette smoke–induced RNase 7 was specifically expressed by BCs 
in ALI-PBEC, we analysed mRNA expression in the basal and luminal cell fraction of ALI-
PBEC that were separated based on a previous described method (26). To validate the nature 
of the isolated fractions, we initially examined the mRNA expression of the BC markers p63 
and KRT5. Both p63 and KRT5 mRNA levels were significantly higher in the basal fraction 
compared with the luminal fraction in smoke- and air- exposed cultures (Figure 4A). 
Interestingly, we observed a significant decrease in p63 and KRT5 mRNA levels in the basal 
fraction of smoke-exposed cultures. At later time points, these levels returned to baseline levels 
(unpublished data), suggesting that the effect of smoke exposure on these basal cell markers 
is only transient. In contrast, mRNA expression of RNase 7 was significantly increased 3 h 
after smoke exposure in the basal fraction, but not in the luminal fraction of ALI-PBEC, 
whereas smoke-induced mRNA expression of IL-8 was observed in both the basal and the 
luminal fraction. Examination of RNase 7 protein expression was subsequently determined 
by assessing co-localization of RNase 7 with p63 using immunofluorescence confocal 
imaging. Confocal imaging of the apical side of ALI-PBEC lacking p63+ cells, demonstrated 
that RNase 7 expression could not be observed in both air- and smoke-exposed ALI-PBEC 
after 6 h (Figure 4B). However, RNase 7 co-localized with p63+ cells at the basal side of ALI-
PBEC, which was more abundant in cigarette smoke–exposed cultures than air controls. In 
these confocal studies, we did not observe a decrease in p63 protein levels or the number of 
p63+ cells in smoke-exposed cultures compared with air controls, contrasting the observed 
decreased mRNA expression of p63. To quantify RNase 7 expression in BCs, we performed 
flow cytometric analysis examining RNase 7 expression in KRT5+ cells in ALI-PBEC, 6 h 
after air/smoke exposure (Figure 4C). Cigarette smoke significantly increased RNase 7 in 
the KRT5+ fraction compared with air exposed cultures (Figure 4D), whereas no effect was 
observed in the KRT5- fraction. Similar to p63 protein detection by confocal imaging, we did 
not observed a difference in the ratio of KRT5- and KRT5+ cells upon smoke exposure (data 
not shown). Supporting our hypothesis, we observed that smoke exposure induced RNase 7 
expression in ALI-PBEC selectively in BCs.
Bacterial stimulation does not further increase cigarette smoke-induced RNase 7 expression
We further evaluated the additional effect of bacterial stimulation on smoke-induced RNase 7 
expression. After smoke exposure, ALI-PBEC were stimulated with either NTHi or the TLR2 
ligand Pam3CSK4. Consistent with previous studies examining the effect of whole cigarette 
smoke on bacterial induced expression of IL-8 and hBD-2 (33), cigarette smoke inhibited 
NTHi- and Pam3CSK4-induced hBD-2 expression while increasing smoke-induced IL-8 
mRNA expression (Figure 5). In line with the observation in Figure 1B, NTHi did not induce 
RNase 7 mRNA expression at 3, 12, and 24 h after exposure (Figure 5A,B). Moreover, NTHi 
did not further increase smoke-induced RNase 7 mRNA levels. Similar to NTHi, TLR2 
activation with Pam3CSK4 did not affect RNase 7 mRNA expression after 3 h of stimulation 
(Figure 5C).
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Figure 4. BC-specific expression of RNase 7 in ALI-PBEC after smoke exposure. (A) ALI-PBEC were exposed to air 
or smoke, and the basal and luminal cell fraction were isolated 3 h after exposure. mRNA expression of p63, KRT5, 
RNase 7 and IL-8 was determined by qPCR. Data is shown as fold change compared to the air exposed basal fraction 
(n=4 donors). For protein detection, ALI-PBEC were exposed to air or cigarette smoke, and after 3 h refreshed with 
culture medium containing 5 µg/ml Brefeldin A to prevent protein secretion. After an additional 3 h, RNase 7 protein 
localization was determined by confocal imaging and flow cytometry. (B) For confocal imaging, ALI-PBEC were 
immunostained for RNase 7 (Green) and p63 (Red) and DAPI (Blue). Confocal images were made of the apical site 
without p63+ cells and basolateral site containing p63+ cells (data represents 3 independent donors). (C) For flow 
cytometry, ALI-PBEC were detached from the transwell inserts by treatment with soft trypsin and cell suspensions 
were subsequently stained for RNase 7 and KRT5. Flow cytometric analysis was performed excluding doublets and 
dead cells by aqua staining. Data is shown as the mean fluorescence intensity (MFI) of the KRT5- and KRT5+ positive 
fraction (n=6 donors). Air/smoke exposures were performed in duplicate. *p<0.05, ** p<0.01, *** p< 0,0001.
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Cigarette smoke–induced RNase 7 expression requires activation of the epidermal growth factor 
receptor
Airway epithelial BCs are characterized by selective expression of the EGFR, a receptor that 
is activated upon disruption of the epithelial barrier function by cigarette smoke (31, 34). 
Previous studies reported that cigarette smoke extract induced expression of IL-8 in airway 
epithelial cells, which required activation of EGFR and the downstream MAPK/ERK 1/2 
(ERK1/2) (35, 36). Therefore, we studied whether EGFR and ERK1/2 signalling were required 
in cigarette smoke–induced expression of RNase 7. Our results clearly showed that similar to 
cigarette smoke extract, whole cigarette smoke exposure increased phosphorylation of EGFR 
and ERK1/2 in ALI-PBEC 15 min after exposure (Figure 6A,B). Inhibition of EGFR using 
a neutralizing Ab, the EGFR tyrosine kinase inhibitor AG1478, and the ERK1/2-activating 
kinases MEK1/2 inhibitor U0126, attenuated activation of ERK1/2, demonstrating that 


















































































































































































































Figure 5. The effect of bacterial stimuli on smoke-induced RNase 7 expression by ALI-PBEC. After air/smoke exposure, 
(A) ALI-PBEC were stimulated apical with 100 µl of 10*107 CFU/ml NTHi for 3, 12 and 24 h (n=6 donors), (B) 100 
µl of different concentrations of NTHi (0.25, 0.5 and 1 *109 CFU/ml) for 3 h (n=6 donors) or (C) Pam3CSK4 (1 µg/
ml) for 4 h (n=5 donors). RNase 7, IL-8 and hBD-2 mRNA expression was assessed by qPCR. Data is shown as fold 
change compared to air exposed cells. All stimulations were performed in duplicate. *p<0.05.
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of EGFR with AG1478 and inhibition of the ERK1/2-activating kinases MEK1/2 with U0126 
caused a significant decrease in smoke-induced mRNA expression of RNase 7 (Figure 6C). 
Similar to RNase 7, and in line with previous studies, mRNA expression of IL-8 and CCL20 
was also impaired upon inhibition of EGFR and MEK/ERK1/2, while a trend was observed 
for IL-6 expression. To further support the conclusion that EGFR activation mediates RNase 
7 expression, we examined the effect of direct receptor activation by stimulating ALI-PBEC 




















































































































































































































































































Figure 6. Requirement of EGFR and ERK1/2 in cigarette smoke induced RNase 7 expression by ALI-PBEC. (A) ALI-
PBEC were pre-incubated for 1 h with AG1478 (EGFR inhibitor; 1 μM) or EGFR neutralizing antibody (2 μg/ml), 
prior to smoke exposure. Western blot analysis was performed of p-EGFR, p-ERK1/2 15 minutes after air/smoke 
exposure. Total EGFR and ERK1/2 were used as loading controls (data represents 3 independent donors). (B) PBEC 
were pre-incubated for 1 h with AG1478 (EGFR inhibitor; 1 μM) or U0125 (MEK1/2 inhibitor; 25 μM) prior to air/
smoke exposure. RNase 7, IL-8, IL-6 and CCL20 mRNA expression was assessed 3 h after exposure by qPCR. Data is 
shown as fold change compared to air exposed cells (n=6). * p<0.05.
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significantly enhanced RNase 7 mRNA expression and furthermore increased IL-8 expression; 
the increase in CCL20 did not reach statistical significance (Figure 6D). In conclusion, we 
observed that cigarette smoke–induced expression of RNase 7 requires activation of the BC-
specific receptor EGFR and the downstream ERK1/2 signalling pathway.
DISCUSSION
In this study, we examined the expression of the antimicrobial RNase 7 in cultured airway 
epithelial cells. We demonstrated that undifferentiated S-PBEC, primarily consisting of BCs, 
but not mucociliary-differentiated ALI-PBEC, expressed RNase 7 upon stimulation with the 
respiratory pathogen NTHi. This was in marked contrast to other examined innate immune 
mediators that were induced by NTHi in both S-PBEC and ALI-PBEC. Furthermore, 
differentiated ALI-PBEC displayed a decreased baseline RNase 7 expression compared with 
S-PBEC after 2 wk of culturing in air-exposed conditions. Cigarette smoke exposure, which 
caused transient disruption of the epithelial barrier function, reinitiated RNase 7 expression 
in the remaining undifferentiated BCs in ALI-PBEC, which was demonstrated using confocal 
microscopy and isolation of luminal and basal cell fractions. Moreover, we showed that this 
induction required activation of EGFR and the downstream ERK1/2 signalling pathway and 
furthermore demonstrated that direct EGFR activation by TGF-α also induced RNase 7 
expression. In contrast to the innate immune mediators IL-8 and hBD-2, bacterial co-
stimulation did not further affect smoke-induced RNase 7 expression in ALI-PBEC. This data 
suggest that expression of RNase 7 is a unique innate host defence property of BCs that is 
induced in conditions of airway epithelial injury. To our knowledge, we demonstrate for the 
first time that BCs display a phenotype-distinct antimicrobial response by producing RNase 
7. The epithelial phenotype–specific expression of AMPs has been well described in multiple 
mucosal tissues (37). For instance, intestinal Paneth cells selectively produce human 
α-defensin 5 and 6, which are not produced by enterocytes (38). In the lung, phenotype-
specific expression of AMPs has been observed in submucosal gland serous cells, which 
produce lactoferrin and lysozyme (39, 40) and also in alveolar cells producing antimicrobial 
surfactant protein A and D (41). Phenotype-specific expression of RNase 7 has been reported 
in the skin and urinary tract, demonstrating specific expression by respectively suprabasal 
keratinocytes and α- and β-intercalated cells (16, 18). In contrast to these epithelial cells, 
phenotype-distinct expression of AMPs by airway epithelial BCs has not yet been reported. 
Similar to previous in vitro observations demonstrating BC specific expression of IL-33 and 
EGFR (10, 34), we observed decreased expression of RNase 7 after mucociliary differentiation 
of PBEC. Consistent with this observation, it was shown in a previous transcriptome analysis 
that RNase 7 transcripts were increased in BCs but not in differentiated airway epithelial cells 
(28). Another transcriptome analysis demonstrated enhanced mRNA expression of RNase 1, 
4, and 6 in differentiated airway epithelial cells compared with undifferentiated cultures (42), 
suggesting that RNase 7 production by BCs is unique among other secreted RNases. 
Interestingly, we did not observe a difference in RNase 7 mRNA expression after 1 wk of 
mucociliary differentiation of ALI-PBEC. As the amount of BCs declines during the first week 
of differentiation, we reasoned that the attenuation of RNase 7 expression after 2 wk of 
differentiation was not caused by a decrease in the number of BCs in cultured ALI-PBEC but 
because of another mechanism. Because undifferentiated ALI-PBEC initially display a low 
epithelial barrier function that progresses during differentiation, we hypothesized that RNase 
 59 
INNATE IMMUNE ACTIVITY OF AIRWAY BASAL CELLS
3
7 expression by BCs in ALI-PBEC is attenuated because of an enhanced airway epithelial 
barrier function. Our finding that cigarette smoke can reinitiate RNase 7 expression by BCs in 
ALI-PBEC supported this hypothesis. Previous data demonstrate that E-cadherin–mediated 
cell–cell contacts inhibit EGFR signalling in airway epithelial cells (43). Because we observed 
that cigarette smoke decreases epithelial barrier function, which has been shown to be related 
to interference with the function of E-cadherin (30), and because smoke-induced RNase 7 
expression involved EGFR activation, we reason that smoke-induced barrier disruption 
contributes to RNase 7 expression. In skin host defence, it is well established that injury 
enhances EGFR-dependent innate immune responses by keratinocytes that provide protection 
against infections during wound repair (44, 45). Also, in airway epithelial cells, it has been 
shown that EGFR activation promotes innate immune responses that are depending on the 
MAPK/ERK1/2 signalling pathway, which also facilitates epithelial wound healing (36, 46). 
These studies primarily demonstrate EGFR-dependent expression of pro-inflammatory 
innate immune mediators such as IL-8, IL-6, and CCL20, which were also induced by cigarette 
smoke in our model. However, to our knowledge, this is the first study reporting EGFR-
dependent AMP expression in airway epithelial cells. Although smoke-induced RNase 7 
expression was specifically detected in BCs, we observed secretion of RNase 7 in the apical 
surface liquid. This may be the result of polarized secretion to the apical side, which can be 
mediated in part by trans-epithelial projections between the lateral intracellular spaces 
formed by BCs (47). These projections might explain the apical secretion of RNase 7. However, 
this requires further investigation. Besides decreased baseline RNase 7 expression in ALI-
PBEC, we furthermore demonstrated that in contrast to S-PBEC, ALI-PBEC did not induce 
RNase 7 expression after stimulation with NTHi. Also, additional stimulation with NTHi or 
the TLR2 ligand Pam3CSK4 did not further enhance cigarette smoke–induced RNase 7 
expression, whereas expression of IL-8 was further increased. It can be speculated that the 
inability of bacterial stimuli to induce RNase 7 expression in BCs of ALI-PBEC is caused by a 
lack of direct microbial contact of BCs because of apical application of the NTHi and 
Pam3CSK4. Similar to the pseudostratified airway epithelium in vivo, undifferentiated BCs in 
cultured ALI-PBEC are superimposed by differentiated LCs. In intact airway epithelium, this 
mechanism might protect BCs from direct microbial contact and subsequently prevents 
RNase 7 expression. Another explanation of the absence of bacterial induced RNase 7 
expression in BCs of ALI-PBEC might be that pattern recognition receptors such as TLR2 are 
localized at the basolateral site of BCs because of cell polarization. Finally, we cannot formally 
exclude the possibility that, in contrast to UV-inactivated bacteria, life-NTHi may promote 
RNase 7 expression in basal cells in vivo (e.g., as a result of epithelial barrier disruption). In 
contrast to RNase 7, NTHi-induced hBD-2 in airway epithelial cells was independent of the 
epithelial differentiation status. Furthermore, cigarette smoke exposure impaired bacterial-
induced hBD-2 (33). This finding is in line with a decreased antimicrobial defence of airway 
epithelial cells exposed to cigarette smoke, which provides an explanation for the increased 
susceptibility of smokers and chronic obstructive pulmonary disease patients toward 
respiratory infections (33). We argue that the decreased antimicrobial defence caused by 
smoking results from the attenuation of a large number of AMPs including hBD-2, which 
cannot be compensated by RNase 7 expression. To further explore the significance of RNase 
7 in airway epithelial host defence upon barrier disruption, other environmental factors 
should be examined that affect the epithelial barrier function but do not attenuate the 
expression of other AMPs. On the basis of our observations, we propose a novel model of 
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airway epithelial host defence that includes a second line of defense mediated by airway BCs, 
which is induced upon injury. In the intact airway epithelium, LCs are the main cells that 
mediate host defence via, for example, production of AMPs such as hBD-2 and mucociliary 
clearance (Figure 7A). LCs furthermore prevent microbial contact of the basolateral localized 
BCs, thereby preventing RNase 7 expression. However, BCs do produce RNase 7 upon 
disruption of the epithelial barrier integrity by inhaled substances such as cigarette smoke 
(Figure 7B). Moreover, in damaged epithelium lacking LCs, microbial exposure of BCs 
induces innate immune responses including cell type–specific expression of RNase 7. This 
way BCs provide additional innate immune defence against microbial infections during the 
course of epithelial wound repair.
A
B
Figure 7. Proposed model. (A) Innate host defense of undamaged airway epithelium mediated by LCs containing 
ciliated and secretory/goblet cells, for instance providing protection against bacteria via production of hBD-2 and 
mucociliary clearance. (B) Second line of airway epithelial innate host defense upon injury mediated by BCs, which 
selectively producing RNase 7. Expression of RNase 7 is induced upon disruption of the epithelial barrier caused by 
cigarette smoking or upon bacterial exposure in regions lacking LCs.
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SUPPLEMENTARY FIGURES
Supplementary Figure 1. Controls FACS analysis. (A) Unstained sample. (B) Staining with the secondary APC-labeled 
antibody in the absence of the KRT5-specific primary antibody. (C) Staining with the secondary FITC-labeled 
antibody in the absence of the RNase 7-specific antibody.
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Antimicrobial proteins and peptides (AMPs) are a central component of the antibacterial 
activity of airway epithelial cells. It has been proposed that a decrease in antibacterial lung 
defense contributes to an increased susceptibility to microbial infection of smokers and 
patients with chronic obstructive pulmonary disease (COPD). Whether reduced AMP 
expression in the epithelium contributes to this lower defense is however largely unknown. 
We investigated the bacterial killing activity and expression of AMPs by air-liquid interface 
cultured primary bronchial epithelial cells from COPD patients and non-COPD (ex)smokers 
that were stimulated with non-typeable Haemophilus influenzae (NTHi). In addition, the 
effect of cigarette smoke on AMP expression and activation of signaling pathways was 
determined. COPD cell cultures displayed reduced antibacterial activity, whereas smoke 
exposure suppressed NTHi-induced expression of AMPs and further increased IL-8 
expression in COPD and non-COPD cultures. Moreover, smoke exposure impaired NTHi-
induced activation of NF-κB, but not MAP-kinase signaling. Our findings demonstrate that 
the antibacterial activity of cultured airway epithelial cells induced by acute bacterial exposure 
is reduced in COPD and suppressed by cigarette smoke, whereas inflammatory responses 
persisted. These findings help to explain the imbalance between protective antibacterial and 
destructive inflammatory innate immune responses in COPD.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a severe inflammatory lung disorder in 
which colonization and infections with opportunistic respiratory bacteria are a major disease 
hallmark (1). It is hypothesized that a vicious circle of attenuated antibacterial lung defense, 
enhanced bacterial colonization, and induction of lung inflammation and injury, contribute 
to the disease (2). However, the underlying mechanisms remain incompletely understood. 
Smoking is the main risk factor for COPD development, and is furthermore associated with 
an increased susceptibility to respiratory infections (3). Despite the strong association, only a 
subpopulation of approximately 15-20% of the smokers develops the disease. This suggests that 
there are differences between susceptible smokers and smokers with a normal lung function 
that may help to explain disease etiology. These differences may persist in cell culture (4, 5), 
for that reason, comparison of cell cultures from COPD patients and non-COPD smoker may 
reveal differences in host defense activities that may help to explain the increased microbial 
susceptibility.
Airway epithelial cells contribute to innate lung defense by displaying direct antibacterial 
activity, which is mediated in part by the production of antimicrobial proteins and peptides 
(AMPs) (6, 7). In addition to AMPs that are expressed at a steady-state basis, others are induced 
for example upon recognition of microbes or microbial structures by pattern recognition 
receptors. This response is highly similar amongst species, and murine models have shown 
that the inducible antibacterial activity of airway epithelial cells provides full protection against 
various pathogenic microbes without further involvement of immune cells (8). Impairment 
of this induced activity in COPD might therefore contribute to the increased susceptibility to 
infection with respiratory pathogens. Observational studies in lung tissue, airway secretions 
and tracheal washings have shown that the expression of several AMPs is reduced in smokers 
and patients with COPD, including the microbial-induced antimicrobial peptide human 
beta-defensin-2 (hBD-2) (9-12). Moreover, it has been demonstrated that cigarette smoke 
exposure attenuated the antibacterial activity and microbial-induced expression of hBD-
2 in cultured airway epithelial cells (12-14). This suggests that the inducible antibacterial 
activity is affected in airway epithelial cells from smokers and COPD patients. However, it is 
unclear whether this activity differs between airway epithelial cells from non-COPD smokers 
and COPD patients. Interestingly, microbial-induced expression of the pro-inflammatory 
mediator IL-8 is not reduced by cigarette smoke (14, 15). Conflicting to this, cellular signal 
transduction pathways regulating the expression of AMPs and pro-inflammatory mediators 
largely overlap (16, 17), and it is unknown whether imbalances in these signaling pathways 
reflect the alterations in AMP and pro-inflammatory mediator expression.
To gain more insight in the role of the inducible antibacterial defense function of airway 
epithelial cells in COPD, we examined the antibacterial activity and expression of AMPs 
following acute bacterial exposure of cultured airway epithelial cells from mild-to-moderate 
COPD patients and (ex)smokers with a normal lung function (non-COPD). To understand 
the mechanism underling reduced AMP expression, we determined the effect of cigarette 





Primary bronchial epithelial cell cultures and stimuli
Primary bronchial epithelial cells (PBEC) were isolated from tumor-free resected lung 
tissue and cultured in an air liquid interface model (further referred to as ALI-PBEC) to 
obtain mucociliary-differentiated cultures, essentially as previously described (14, 18). PBEC 
cultures were used from a total of 28 patients, all undergoing lung resection surgery for lung 
cancer. Clinical history and lung function data were obtained from anonymized patients. 
Disease status was determined based on lung function according to the Global Initiative for 
Chronic Obstructive Lung Disease classification (19). The patients included 15 COPD and 
13 non-COPD subjects (Tables 1 and 2 for indicated experiments). Both groups included 
current smokers and ex-smokers. Non-typeable Haemophilus influenzae (NTHi) strain D1 
(20) was cultured and UV-inactivated as described earlier (14). UV-inactivated NTHi was 
applied to the apical surface of ALI-PBEC in a volume of 100 µl; PBS was used for dilutions 
and as negative control. ALI-PBEC were exposed to mainstream cigarette smoke (CS) from 
3R4F reference cigarettes (University of Kentucky, Lexington, KY, USA) using an exposure 
model previously described (14, 15). In brief, epithelial cultures were placed in air (control) or 
CS exposure chambers, localized in a tissue incubator at 37°C and 5% CO2. In these exposure 
chambers, ALI-PBEC were respectively exposed to air or CS from one cigarette (approximately 
2 mg of CS particles), which was infused by a mechanical pump with a continuous flow of 1 
liter/minute for a period of 4-5 minutes. Residual CS was removed by flushing the chamber 
Table 1: Patient characteristics bacterial killing assay.
COPD non-COPD p-value
N= 5 5
Gender (Females/Males) 2/3 2/3
Age, years 66±11 64±7 0.6
FEV1 , % predicted 68±17 96±14 0.05
FEV1/FVC % 58±7 78±4 < 0.01
Characteristics of COPD and non-COPD patients used the bacterial killing assay. 
Table 2: Patient characteristics NTHi-induced AMP expression.
COPD non-COPD p-value
N= 5 5
Gender (Females/Males) 2/3 2/3
Age, years 66±11 64±7 0.6
FEV1 , % predicted 68±17 96±14 0.05
FEV1/FVC % 58±7 78±4 < 0.01
Characteristics of COPD and non-COPD patients. Age and lung function are shown as means ± SEM. The mean 
differences in FEV1 (% predicted) and FEV1/FVC (%) were compared using the non-parametric Mann-Whitney test. 
Abbreviations: COPD = chronic obstructive pulmonary disease, FEV1= Forced expiratory volume in one second, 
FVC = Forced vital capacity.
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with air derived from the incubator for 10 minutes. After exposure cells were stimulated at the 
apical surface with UV-inactivated NTHi or PBS (negative control).
Bacterial killing assay
The bacterial killing assay was adapted from Pezzulo et al. (21). Instead of golden grids, 
bacteria were linked to glass coverslips. 6 mm round coverslips were rinsed in ethanol, dried 
at room temperature and subsequently silanized with 2% (v/v) 3-Aminopropyltriethoxysilane 
(APTES, H2N(CH2)3Si(OC2H5)3, Sigma-Aldrich) solution in acetone for 10 seconds. After 
rinsing in H2O for 10 minutes and drying at room temperature, coverslips were immersed in 
1 mM 11-mercaptoundecanoic acid (MUA, HS(CH2)10COOH, Sigma-Aldrich) for 30 minutes 
at room temperature. Afterwards, coverslips were incubated in 0.1 M N-hydroxysuccinimide 
(NHS) and 0.1 M 1-ethyl-3-(3-diethylaminopropyl)carbodiimide (EDC) (1:2 molar ratio) 
(both Sigma-Aldrich) for 30 minutes, and subsequently coated for 30 minutes with 10 μg/
mL streptavidin (Sigma Aldrich) in PBS. Next, the coverslips were washed and immersed 
with 1 M glycine for 30 minutes. 1*108 CFU/ml (OD600 ) of log phase growth cultured NTHi 
was incubated in 0.88 mg/ml mg/mL N-hydroxysulfosuccinimide-biotin (sulfo-NHS-biotin, 
Thermo Scientific) for 30 minutes on ice. Next, biotin-labeled NTHi was linked to the surface 
of the streptavidin-coated glass coverslips in PBS for 30 minutes and subsequently washed 
two times in PBS and finally in 0.01M Phosphate buffer pH 7.4, to remove the unbound 
bacteria. Bacterial killing activity was determined of ALI-PBEC that were pre-stimulated with 
UV-inactivated NTHi or PBS (untreated control), which was applied at the apical surface. 
After 6 hours of incubation, cultures were washed with PBS and incubated for 48 hours. 
Afterwards, NTHi coated coverslips were placed on the apical surface of ALI-PBEC for 1 
minute. Coverslips were subsequently stained for 30 seconds with SYTO 9 and propidium 
iodide (both Life Technologies, Darmstadt, Germany), to visualize live and dead bacteria 
respectively. Coverslips were mounted on microscopic slides and covered in Baclight mounting 
oil (Life Technologies). Digital images were made with a Zeiss Axio Scope A1 fluorescent 
microscope and Zeiss Axiocam mRc 5 camera (Carl Zeiss Microscopy, Göttingen, Germany). 
The number of live and dead bacterial was analyzed using Image J software (National Institutes 
of Health, Bethesda, MD, USA). The bacterial killing activity was determined by calculating 
the percentage of dead bacteria.
Microarray gene expression analysis
Primary bronchial epithelial cells from 6 different donors were cultured in submerged 
conditions as previously described (14). Cells were left unstimulated or triggered with UV-
killed NTHi. RNA from these cultures were then isolated at two timepoints: early (6 hour) 
and late (24 hour) and subsequently subject to whole genome profiling of gene expression by 
microarray (Affymetrix GeneTitan platform).
Quantitative real-time PCR (qPCR)
RNA was isolated from ALI-PBEC using the miRNeasy Mini Kit (Qiagen, Venlo, Netherlands) 
according to the manufacturer’s protocol. RNA quantities were determined using the Nanodrop 
ND-1000 UV-visible (UV-Vis) spectrophotometer (Nanodrop Technologies, Wilmington, 
DE) and cDNA was synthesized by reverse transcription polymerase chain reaction (PCR) 
of 1 μg of RNA, using oligo(dT) primers (Qiagen) and Moloney murine leukemia virus 
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(M-MLV) polymerase (Promega, Leiden, The Netherlands). qPCR was done using IQ SYBR 
green supermix (Bio-Rad) and a CFX-384 real-time PCR detection system (Bio-Rad). qPCR 
reactions were performed using the primers shown in Table 3. The housekeeping genes 
RPL13A and ATP5B were selected using the “Genorm method” (Genorm; Primer Design, 
Southampton, United Kingdom). Bio-Rad CFX manager 3.0 software (Bio-Rad) was used to 
calculate arbitrary gene expression by using the standard curve method. 
ELISA
Secretion of innate immune mediators by ALI-PBEC was determined in the apical surface 
liquid, collected by washing the apical surface with 100 µl PBS for 15 minutes, and in the basal 
medium as indicated. The secretion of IL-8 (Sanquin, Amsterdam, The Netherlands) and 
CCL20 (R&D, Minneapolis, MN, USA) was determined by ELISA following the manufacturer’s 
protocol. Reagent for hBD-2 detection was a generous gift of D. Proud (Calgary, Canada), and 
the hBD-2 ELISA was conducted as previously described (22). The optical density values were 
measured with a microplate reader (Bio-Rad). 
Table 3: qPCR primer sequences
























AIRWAY EPITHELIAL ANTIBACTERIAL DEFENSE IN COPD
4
Trans-epithelial electrical resistance 
The epithelial barrier integrity of ALI-PBEC cultures was determined by measuring the trans-
epithelial electrical resistance (TEER) using the MilliCell-ERS (Millipore, Bedford, MA, 
USA).
Western blot 
ALI-PBEC were washed 3 times with cold PBS and cell lysis was done in lysis buffer consisting 
of 150 mM NaCl, 50 mM Tris HCl pH 7.4, 0.1% NP-40 (v/v) and EDTA-free protease inhibitor 
cocktail (Roche, Basel, Switserland) . Samples were subsequently mixed with sample buffer, 
consisting of 0.5 M Tris pH 6.8, 10% SDS (w/v), 20% Glycerol (v/v), 0.02% Bromophenolblue 
and 50 mM DTT. Nuclear fractions were isolated using the NE-PER Nuclear Protein Extraction 
Kit (Thermo Scientific, Rockford, IL) according to the manufactur’s protocol. Protein samples 
were separated by SDS-PAGE gel electrophoresis on 10% glycine-based gels and transferred to 
polyvinylidene difluoride (PVDF) membranes. Membranes were blocked in 5% (w/v) skim-
milk (Sigma-Aldrich) in PBS/0.05% (v/v) Tween-20 and stained with primary antibodies in 
5% (w/v) BSA PBS/0.05% (v/v) Tween-20 overnight at 4°C. Antibodies were used to detect 
p- IKKα/β, IKKβ, IκB-α, p- and t-ERK1/2, p- and t-p38, TBP (all Cell Signaling, Beverly, 
MA, USA), p50, p65 (both Santa Cruz), and β-actin (Leica), Next, membranes were stained 
with secondary HRP-labelled antibody (Sigma-Aldrich) in 5% (w/v) skim-milk (Sigma-
Aldrich) in PBS/0.05% (v/v) Tween-20 for 1 hour. Afterwards, membranes were developed 
with enhanced chemiluminescence substrate (Thermo Scientific). Intensity of bands were 
quantified by densitometry using Image J software (National Institutes of Health, Bethesda, 
MD, USA)
Immunofluorescence confocal microscopy
ALI-PBEC were fixed in 4% paraformaldehyde for 30 minutes, permeabilized in 100% 
methanol for 10 minutes at 4°C, and blocked in blocking solution consisting of 5% (w/v) 
BSA, 0.3% (v/v) Triton X in PBS. In between each step, cells were washed 3 times with PBS. 
Afterwards, the PBEC-containing filters were cut from the Transwell using a razorblade and 
subsequently incubated overnight at 4°C with anti-mouse p50 or anti-rabbit p65 primary 
antibodies (both Santa Cruz Biotechnology, Santa Cruz, CA) diluted in blocking solution. 
Next, filters were washed 3 times in PBS and stained with goat anti-rabbit AlexaFluor 568 or 
goat anti-mouse AlexaFluor 488 (both Life Technologies) respectively, and DAPI as nuclear 
staining. Secondary antibodies and DAPI were diluted in blocking solution and incubated in 
the dark for 30 minutes at room temperature. Afterwards, the filters were washed three times 
with PBS and mounted on coverslips with Vectashield Hard Set Mounting Medium (Vector 
Lab, Burlingame, CA, USA). Images were made using a Leica TCS SP5 confocal inverted 
microscope (Leica Microsystems) and processed using the Leica Application Suite Advanced 
Fluorescence software (LAS AF; Leica Microsystems). 
Data analysis
Statistical analysis was performed in GraphPad PRISM 6.0 (GraphPad Software Inc., La Jolla, 
Ca). Analysis of differences was conducted with a one/two-way repeated measurements 
ANOVA and Bonferroni post-hoc test and (un)paired Student’s t-test as indicated. Differences 




Lower NTHi-induced antibacterial activity by COPD airway epithelial cells 
We first determined the bacterial killing activity of cultured ALI-PBEC from COPD patients 
and non-COPD (ex)smokers. ALI-PBEC were first stimulated at the apical surface with UV-
inactivated NTHi or PBS (negative control) to investigate microbial exposure-induced and 
baseline antibacterial activity. 6 hours after stimulation, the apical surface was washed and 
cells were incubated for an additional 42 hours prior to assessment of the antibacterial activity 
(Figure 1A). A killing assay was used that allows direct assessment of the antibacterial activity 
of the airway surface liquid (ASL) of cultured ALI-PBEC by placing NTHi-coated coverslips 
Figure 1. Impaired bacterial killing by COPD ALI-PBEC. (A) Schematic representation of the bacterial killing assay. 
ALI-PBEC cultures were stimulated with 0.5*109 CFU/ml UV-inactivated NTHi or PBS as negative control for 6 h, 
washed at the apical surface, and incubated for 42 h. Next, streptavidin-coated glass coverslips linked to biotin-bound 
NTHi were placed on the apical surface of ALI-PBEC. Bacterial killing was determined by counting individual live 
and dead bacteria. (B) Bacterial killing was assessed of cultured ALI-PBEC from COPD patients (grey boxplots, n=5 
patients) and non-COPD smokers (white boxplots, n=5 patients), either unstimulated or stimulated with 0.5*109 
CFU/ml UV-inactivated NTHi. Data is shown as % dead bacteria. The killing assay was performed in triplicates. 
COPD and non-COPD comparison results were depicted as boxplot with whiskers from minimum to maximum or 
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on the apical surface. Minimal antibacterial activity was seen in control-treated ALI-PBEC 
from both COPD and non-COPD donors (Figure 1B). Exposure to NTHi significantly 
increased antibacterial activity of non-COPD cultures. In contrast, this increase was not 
observed in COPD epithelia. These findings suggest that cultured airway epithelial cells 
from COPD patients have reduced microbial-induced antibacterial activity compared to cell 
cultures from non-COPD (ex)smokers.
NTHi-induced expression of hBD-2 and S100A7 is altered in COPD ALI-PBEC
To investigate the role of AMPs in the reduced antibacterial activity of COPD airway epithelial 
cells, we examined the expression of microbial-induced AMPs in COPD and non-COPD 
ALI-PBEC exposed to various concentrations of UV-inactivated NTHi for 24 hours. We first 
focused for this analysis on microbial-induced AMPs that were found to be highly expressed 
in submerged cultured and undifferentiated PBEC upon exposure to UV-inactivated NTHi, 
based on a micro-array gene expression analysis (Supplementary Table 1). These genes 
included DEFB4, encoding human β-defensin-2 (hBD-2), the antimicrobial chemokine 
CCL20, lipocalin 2 (LCN2), and S100A7 (23-26). NTHi stimulation induced the expression of 
all examined genes in both COPD and non-COPD cultures (Figure 2A-D) However, COPD 
ALI-PBEC displayed lower NTHi-mediated expression of DEFB4 and S100A7 compared to 
non-COPD cultures (Figure 2A,B), whereas LCN2 and CCL20 did not reveal statistically 
significant differences (Figure 2C,D). We also did not observe differences in the expression 
of other AMPs that were not observed in the micro-array gene expression analysis (LL-37/
CAMP, SLPI, β-defensin 1 and 3 [hBD-1 and hBD-3]) (Supplementary Figure 1). We further 
analyzed the NTHi-induced protein secretion of hBD-2 and CCL20 in apical washes and basal 
medium of COPD and non-COPD ALI-PBEC 24 hours after stimulation. In contrast to the 
mRNA expression, we did not detect a difference in hBD-2 peptide release at the apical surface 
and basal medium between COPD and non-COPD ALI-PBEC (Figure 2E,F). Moreover, 
no differences were observed in secretion of CCL20. To explain this discrepancy between 
hBD-2 mRNA expression and peptide levels, we examined whether the difference in mRNA 
expression was time-dependent. Indeed, in contrast to NTHi-induced mRNA expression at 
24 hours, we did not detect differences between COPD and non-COPD at 3 and 12 hours of 
stimulation (Figure 3A-D). These findings suggest that the attenuated antibacterial defense of 
COPD airway epithelial cells observed 48 h after microbial stimulation was not accompanied 
by differences in the early effects of microbial stimuli on AMP expression, but possibly related 
to lower expression of hBD-2 and S100A7 in COPD cultures only at later time points.
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Figure 2. AMPs expression by COPD ALI-PBEC is lower compared to non-COPD. COPD (grey boxplots, n=12 patients) 
and non-COPD (white boxplots, n=8 patients) ALI-PBEC were stimulated with different concentrations of UV-
inactivated NTHi for 24 hours. mRNA expression of the AMPs: (A) DEFB4/hBD-2, (B) S100A7, (C) LCN2 and (D) 
CCL20 was assessed by qPCR. Stimulations were performed in duplicates. Data is shown as fold change in mRNA 
compared to untreated cells. Assessment of (E) hBD-2 and (F) CCL20 protein secretion in the apical surface liquid 
(ASL) and basal medium (BM) of COPD (grey boxplots, n=9) and non-COPD (white boxplots, n=7-8) ALI-PBEC 
stimulated with 1*109 CFU/ml UV-inactivated NTHi for 24 hours. Stimulations were performed in duplicates. Results 
are shown as boxplot with whiskers from minimum to maximum or bars (means ± SEM). Analysis of differences was 
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Cell differentiation, barrier function and expression of regulatory genes do not differ between 
COPD and non-COPD ALI-PBEC
We further studied the cause of the impaired expression of AMPs in COPD airway epithelial 
cells. Previous research has demonstrated a reduced host defense function of airway epithelial 
cells from severe COPD patients due to impaired cell differentiation (5, 27). In addition, it was 
reported that COPD airway epithelial cells display a reduced barrier function (4). Therefore, 
we examined cell differentiation and the epithelial barrier integrity of COPD and non-COPD 
ALI-PBEC. In contrast to previous findings, we did not observed differences in mRNA 
expression levels of the club cell marker SCGB1A1, ciliated cell marker FOXJ1, goblet cell 
marker MUC5AC, and basal cell marker TP63 (Figure 4A-D). Moreover, we did not observed 
differences in the epithelial barrier function between COPD and non-COPD ALI-PBEC, 
based on trans-epithelial electrical resistance (TEER) measurements (Figure 4E). COPD 
Figure 3. Differences in early- and late-induced transcriptional responses between COPD and non-COPD ALI-PBEC. 
Time course of NTHi-induced mRNA expression in COPD (grey bars, n=12) and non-COPD AL-PBEC (white bars, 
n=9). COPD and non-COPD ALI-PBEC were stimulated with 1*109 CFU/ml UV-inactivated NTHi for 3, 12 and 24 
hours, afterwards mRNA expression of (A) DEFB4/hBD-2, (B) S100A7, (C) LCN2 and (D) CCL20 was examined by 
qPCR. Stimulations were performed in duplicates. Data is shown as fold change compared to unstimulated cells. All 
























































































ALI-PBEC furthermore did not display low TEER values as observed in a previous study (4). 
These findings suggest that the altered NTHi-induced antibacterial defense of COPD airway 
epithelial cells is not caused by impaired cell differentiation or a reduced barrier function. 
Another possible explanation for the persistence of this difference after prolonged culture 
could be the presence of epigenetic modifications in the epithelium from COPD patients. 
These modifications can lead to a variety of changes that may help to explain the observed 
differences. First, this differential expression might be caused by altered expression of pattern 
recognition receptors at later time points. It has been shown that NTHi increases expression of 
TLR2 (28), and impairment of this induction in cells from COPD patients can influence late-
induced innate immune responses. However, we did not observe differences in TLR2 mRNA 
expression between COPD and non-COPD cultures (Supplementary Figure 2). Second, 
alterations in negative-feedback loop mechanism of the NF-κB signaling pathway may also 
result in impaired expression of AMPs, such as differential expression of micro-RNA’s, like 
Figure 4. Expression of epithelial differentiation markers and barrier function in COPD and non-COPD ALI-PBEC. 
Baseline mRNA expression of the cell differentiation markers: (A) SCGB1A1 (club cell), (B) FOXJ1 (ciliated cell), 
(C) MUC5AC (goblet cell), and (D) TP63 (basal cell), was determined in differentiated ALI-PBEC from COPD (grey 
boxplots, n=11 patients) and non-COPD (white boxplots, n=8 patients) ALI-PBEC. Data is shown as normalized 
values. (E) The epithelial barrier integrity of COPD (grey boxplots, n=9 patients) and non-COPD (white boxplots, 
n=7 patients) ALI-PBEC was determined by measuring the trans-epithelial electrical resistance (TEER). TEER values 
are shown as Ω*cm2. ALL results are shown as boxplot with whiskers from minimum to maximum or bars (means ± 
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mir-147b, the deubiquitinating enzyme/ ubiquitin ligase A20, or the transcription factor 
ATF3 (29-31). However, we furthermore did not observe differences in the expression of the 
primary mir-147b transcript, and expression of A20 and ATF3 mRNA ( Supplementary Figure 
2). This suggest that other mechanism underlie the altered microbial-induced expression of 
AMPs in COPD airway epithelial cultures.
Cigarette smoke differentially affects the induction of AMPs and pro-inflammatory mediators 
in ALI-PBEC
We next set out to investigate the effect of cigarette smoke (CS) exposure on the expression 
of AMPs and pro-inflammatory mediators. This was done using a whole CS exposure model 
in which ALI-PBEC are exposed to mainstream smoke derived from one cigarette or room 
air (AIR) as negative control. The exposure is done for a period of 15 minutes, after which 
the cells are stimulated with UV-inactivated NTHi for 3, 12, and 24 hours. After the indicated 
time points mRNA expression was measured by qPCR. Corresponding with earlier reports 
(12-14), CS exposure significantly reduced the NTHi-mediated expression of DEFB4 at 3 and 
12 hours after exposure (Figure 5A). This effect was no longer observed at 24 hours after 
exposure. CS also attenuated the NTHi-induced expression of LCN2, S100A7 and CCL20 after 
3 hours (Figure 5B-D). In accordance with preceding studies (14, 15), we observed a further 
increase in IL-8 and IL-6 mRNA expression upon CS and NTHi co-stimulation (Figure 5E,F). 
We also found decreased NTHi-induced hBD-2 and CCL20 protein secretion in CS exposed 
cultures (Figure 5G,H), whereas IL-8 secretion was not attenuated and further enhanced 
(Figure 5I). Overall, this data demonstrates that CS exposure differentially modulates 
microbial-induced innate immunity, impairing induction of AMPs while increasing pro-
inflammatory mediators. 
Cigarette smoke impairs NTHi-induced expression of AMPs in both COPD and non-COPD 
ALI-PBEC
Next, we determined the effect of CS on COPD and non-COPD ALI-PBEC. As we observed 
an acute effect of CS exposure, which was primarily seen at 3 hours after exposure, we studied 
mRNA expression levels of AMPs at this particular time point. AMP expression was reduced 
by smoke in both COPD and non-COPD cultures, thus suggesting that attenuation of AMP 
expression in our CS exposure model occurs independent of disease status (Figure 6A-D). 
We furthermore did not observe a significant difference in IL-8 mRNA expression between 
CS and NTHi exposed COPD and non-COPD ALI-PBEC (Figure 6E). This suggests that 
modulation of the expression of AMPs and pro-inflammatory mediators by CS occurs in a 
similar extent in COPD and non-COPD ALI-PBEC cultures. 
Cigarette smoke inhibits NTHi-mediated activation of NF-κB but not MAPK signaling in ALI-
PBEC
We subsequently examined the underlying mechanism of the differential regulation of AMPs 
and pro-inflammatory mediators by CS. Microbial- and cytokine-mediated expression 
of AMPs and pro-inflammatory mediators are regulated in particular by the NF-κB and 
mitogen-activated protein kinase (MAPK) signaling pathways (16, 17). Therefore, we 
examined the effect of CS exposure on NF-κB and MAPK signal transduction in ALI-PBEC. 
Epithelial cultures were exposed to CS or air as control and subsequently stimulated with UV-
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Figure 5. Cigarette smoke differentially modulates innate immune gene expression. ALI-PBEC (n=7) were exposure to 
AIR or CS and subsequently stimulated with 1*109 CFU/ml UV-inactivated NTHi for 3, 12, and 24 hours. mRNA 
expression of (A) DEFB4, (B) S100A7, (C) LCN2, (D) CCL20, (E) IL8 and (F) IL6 was measured by qPCR. Stimulations 
were performed in duplicates. Data is shown as fold change in mRNA compared to untreated cells. Assessment of 
(G) hBD-2 secretion in the apical surface liquid and (H) CCL20 and (I) IL-8 secretion in the basal medium of AIR/
CS exposed ALI-PBEC (n=7) stimulated with 1*109 CFU/ml UV-inactivated NTHi. Stimulations were performed in 
duplicates. All results are shown as mean ± SEM. Analysis of differences was conducted with a one-way ANOVA and 
Bonferroni post-hoc test (A-F), and paired t-test (G-I). * p<0.05, ** p<0.01, *** p<0.001.
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Figure 6. Suppression of AMPs by CS in both COPD and non-COPD ALI-PBEC. COPD (grey bars, n=12 patients) and 
non-COPD (white bars, n=8 patients) ALI-PBEC were exposure to AIR or CS and subsequently stimulated with 
1*109 CFU/ml UV-inactivated NTHi for 3 hours. mRNA expression of (A) DEFB4, (B) S100A7, (C) LCN2, (D) 
CCL20, and (E) IL8 was determined by qPCR. Stimulations were performed in duplicates. Data is shown as fold 
change in mRNA compared to untreated cells and depicted as mean ± SEM. Analysis of differences was conducted 
with a paired t-test. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.
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inactivated NTHi at the apical surface for 30 minutes. Activation of NF-κB was determined by 
assessing phosphorylation of the upstream NF-κB signaling kinases IKKα/β and degradation 
of the NF-κB inhibitor IκB-α. MAPK signaling was evaluated by assessing phosphorylation of 
p38 and ERK1/2. NTHi stimulation of air-exposed cultures resulted in enhanced activation of 
NF-κB signal transduction based on phosphorylation of IKKα/β and degradation of the NFκB 
inhibitor IκB-α (Figure 7A-C). In contrast, CS exposure suppressed IKKα/β phosphorylation 
and IκB-α degradation. Both NTHi and CS induced phosphorylation of the MAPKs ERK1/2 
and p38, and CS exposure did not attenuate the NTHi-mediated phosphorylation of ERK1/2 
and p38 (Figure 7A,D,E). These findings demonstrate that CS alters NF-κB and MAPK 
signaling, which corresponds with attenuated expression of AMPs and enhanced expression 
of pro-inflammatory mediators.
Cigarette smoke suppresses NF-κB-mediated transcriptional activity
To further assess whether alterations in NF-κB signaling corresponds with reduced AMPs 
expression we investigated nuclear translocation of NF-κB and transcription of early 
induced target genes. In agreement with impaired IκB-α degradation, CS inhibited nuclear 
translocation of the p50 and p65 NF-κB subunit, as shown by immunofluorescence staining 
and analysis of isolated nuclear fractions (Figure 8A-C). To validate whether this reduced 
nuclear localization impaired NF-κB-mediated transcription, we examined the expression of 
early induced NF-κB-target genes, including the negative feedback regulators NFKBIA and 
ZC3H12A (32), and NFKBIZ, which represent an essential co-transcription factor required 
Figure 7. CS impairs NTHi-induced NF-κB but not MAPK signal transduction in ALI-PBEC. (A) ALI-PBEC (n=4-8) 
were exposed to AIR/CS and stimulated with 1*109 CFU/ml UV-inactivated NTHi for 30 minutes. NF-κB activation 
was assessed by measuring phosphorylation of IKKα/β, and degradation of IκB-α. MAPK signaling was assessed by 
determining phosphorylation of ERK1/2 and p38. (B) Analysis of data by densitometry. Results are shown as mean 










Figure 8. CS impairs NF-κB transcriptional activity by ALI-PBEC. ALI-PBEC were left untreated or exposed to AIR 
or CS and stimulated with UV-inactivated NTHi for 1 h. (A) Cellular localization of the NF-κB subunits p50 and 
p65 was determined by immunofluorescence microscopy. Data shown represent n=3 independent donors. (B) ALI-
PBEC (n=4) were exposed to AIR or CS and stimulated with 1*109 CFU/ml UV-inactivated NTHi for 1 hour. Protein 
expression of p50 and p65 was measured in isolated nuclear extracts. (C) Data was quantified by densitometry. 
ALI-PBEC were unstimulated or exposed to AIR or CS and stimulated with 1*109 CFU/ml UV-inactivated NTHi 
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for AMP expression (33). Moreover, induction of MAPK-regulated early induced target genes 
and AP-1 transcription factors: FOS, JUN and FOSL1 (34) was determined. CS exposure 
attenuated the NTHi-induced expression of NFKBIZ and NFKBIA at 60 and 120 minutes 
after stimulation, whereas induction of ZC3H12A was impaired at 120 minutes (Figure 8D). 
In contrast, CS exposure further increased the induction of FOS at 60 and 120 minutes, 
and JUN and FOSL1 expression after 120 minutes of stimulation (Figure 8E). Overall, these 
observations demonstrate selective attenuation of NF-κB-mediated transcriptional activity by 
CS, which reflects impaired expression of AMPs.
DISCUSSION
In this study we provide evidence that the antibacterial defense of airway epithelial cells from 
COPD patients is decreased compared to non-COPD (ex)smokers. In addition, we show that 
the impairment of microbial-induced expression of AMPs by CS exposure may be related to 
inhibition of NF-κB activation. The persistence of pro-inflammatory responses to microbial 
stimulation in presence of CS may be explained by enhanced MAPK signaling. In contrast 
to the impaired antibacterial activity of cystic fibrosis airway epithelial cells at steady state 
conditions (35, 36), COPD cultures only display an attenuated antibacterial activity upon 
microbial-stimulation, suggesting that the induction of antibacterial factors is impaired. 
Indeed, a previous study reported lower hBD-2 expression in airway epithelial tissues 
from COPD patients compared to non-COPD (ex)smokers (10). In line with this study, we 
detected lowered NTHi-mediated expression of hBD-2/DEFB4 mRNA expression in cultured 
COPD airway epithelia. In addition, we also observed lower NTHi-induced S100A7 mRNA 
by COPD epithelial cultures. In contrast to hBD-2, S100A7 displays antibacterial activity by 
impairing bacterial acquisition of zinc (26), which suggests that expression of AMPs with 
different modes of action is affected in COPD. In contrast to the differential regulation of 
DEFB4 at 24 hours after NTHi stimulation, we did not observe differences in mRNA levels 
at earlier time points and protein secretion at 24 hours. This suggests that COPD and non-
COPD airway epithelial cells differ in late-induced mRNA expression. 
It has been shown that ALI-PBEC cultures from severe COPD patients display impaired 
epithelial differentiation and epithelial barrier integrity, which causes impaired host 
defense (4, 5, 27). However, we did not observed differences in the mRNA expression of 
cell differentiation markers and the epithelial barrier function. It is therefore unlikely that 
altered epithelial differentiation is the underlying cause for the impaired antibacterial activity 
of COPD cultures observed in this study. In contrast to the airway epithelial cell cultures 
from mild-to-moderate COPD patients used in this study, impaired epithelial differentiation 
for 1 hour. ALI-PBEC (n=4) were exposure to AIR or CS and subsequently stimulated with 1*109 CFU/ml UV-
inactivated NTHi for 5, 15, 30, 60 and 120 minutes. mRNA expression of (D) early induced NF-κB-target genes: 
NFKBIA, ZC3H12A and NFKBIZ, and (E) early induced MAPK-target genes FOS, JUN and FOSL1, was determined 
by qPCR. Data is shown as fold change in mRNA compared to air exposed cells. All results are shown as mean ± 
SEM. Analysis of differences was conducted with a paired t-test (C) and two-way ANOVA with Bonferroni post-hoc 
test (D,E). Significant different compared to air: * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. Significant different 
compared to CS+NTHi: ## p<0.01, ### p<0.001.
 85 
AIRWAY EPITHELIAL ANTIBACTERIAL DEFENSE IN COPD
4
in severe COPD may have an additional impact on antibacterial host defense. Impaired 
differentiation may for example lead to a loss of CFTR expression, which in turn may result in 
impaired activity of AMPs in the airway surface liquid (37). 
We further hypothesized that the differences in late-induced mRNA expression between 
COPD and non-COPD airway epithelial cells might be caused by the differential expression 
of second messengers, post-transcriptional and/or post-translational mechanisms influencing 
these late-induced responses. TLR-2, pri-mir-147b, A20, and ATF3, are known regulators 
of microbial-induced innate immune responses that might be affected in COPD cultures 
and thereby explain the impaired antibacterial defense. Despite of this, we did not observe 
differences in the NTHi-induced mRNA expression of these regulators.
Differences in the antibacterial activity between COPD and non-COPD cell cultures were 
determined with an assay previously used to assess the antibacterial activity of cystic fibrosis 
airway epithelial cell cultures (21, 36). Conventional killing assays rely on collection of apical 
washes or inoculation of bacteria to the apical surface that may result respectively in selective 
collection of antimicrobial substances and dilution or modulation of the physiological 
conditions of the apical surface liquid. This may have a major influence on determining the 
antibacterial activity of epithelial cells, and the assay used in the present study is not affected 
by these factors. 
Although it is tempting to speculate that a reduced antibacterial activity of COPD airway 
epithelial cells is due to a reduced expression of DEFB4 and S100A7, a clear link between these 
findings is missing. Indeed, other antibacterial defense mechanisms may also be affected in 
the epithelium of COPD patients, and contribute to the reduced antibacterial activity. In 
addition to various AMPs, also antimicrobial lipids and reactive oxygen species contribute to 
the bacterial killing activity of the airway epithelium (38, 39). Moreover, lower antimicrobial 
activity might also result from other alterations in the airway surface liquid, such as reduced 
pH, and the presence of mucins, F-actin and proteoglycans (21, 40-44). Therefore we cannot 
exclude that changes in the presence or activity of other antibacterial mediators and changes 
in the composition of the airway surface liquid also contributed to the reduced antibacterial 
activity of the COPD airway epithelial cells.
 
In line with previous studies demonstrating reduced antibacterial activity and inhibition 
of hBD-2 expression caused by cigarette smoke (12-14), we showed that the expression of 
S100A7, LCN2 and CCL20 was also inhibited in cigarette smoke-exposed COPD and non-
COPD cultures. In contrast to AMPs, we showed increased NTHi-induced expression of IL-8 
and IL-6 upon CS exposure. This further demonstrates that AMPs and pro-inflammatory 
mediators are differentially regulated in airway epithelial cells. The modulation of innate 
immune responses by CS was primarily observed 3 h after exposure, which is in line with the 
transient effect of the acute exposure (14). 
Our study has several limitations. Our findings are limited to the acute effects of microbial- 
and cigarette smoke on airway epithelial innate immune responses, and chronic exposures of 
airway epithelial cells to both NTHi and CS may cause different effects. Moreover, differences 
in smoking status of both COPD and non-COPD subjects may have an influence on our 
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findings. Current and ex-smokers were both included in the COPD and non-COPD group, 
however we only have limited information about i.e. pack years smoked. Further research 
regarding the influence of smoking status is therefore needed.
To assess whether alterations in AMPs and pro-inflammatory mediator expression are reflected 
by changes in cellular signal transduction pathways, we examined the effect of CS on NF-
κB and MAPK signaling. Whereas CS increased MAPK signaling, it reduced NTHi-induced 
NF-κB signal transduction. NTHi-induced activation of MAPK and NF-κB is mediated by 
the common upstream signaling kinase TAK1, which directly phosphorylates IKKα/β (45). 
Therefore, we speculate that CS causes selective suppression of NF-κB signaling by directly 
modulating IKKα/β phosphorylation, rather than affecting TAK1 or more upstream signaling 
components (Supplementary Figure 3). This appears in contrast to some studies that have 
reported increased NF-κB activation in COPD lung tissue (46-48). However, this is not 
observed in all studies and it has been suggested that NF-κB signaling may not contribute 
to COPD pathogenesis (49). Furthermore, our results are also in line with results of a study 
showing that long-term passive cigarette smoke exposure inhibits UVB-induced NF-κB 
signaling in skin (50), and with earlier reports showing impaired IKKα/β phosphorylation 
and kinase activity caused by post-translational modifications, mediated for instance by 
oxidative stress (51, 52). Previous studies demonstrated the importance of NF-κB in both 
microbial-induced hBD-2 and IL-8 by airway epithelial cells. However, our findings suggest a 
more fundamental role of NF-κB in the antibacterial defense, whereas induction of IL-8 and 
IL-6 persisted independent of NF-κB. Restoration of NF-κB signaling may therefore improve 
the airway epithelial antibacterial defense in smokers. However, further research is required 
to study this. 
As also discussed in the previous section, the role of NF-κB in COPD remains a matter 
of debate since inflammation in COPD may occur independent of NF-κB (49). Based on 
our findings, it can be speculated that MAPK signaling has a more prominent role in CS-
induced airway epithelial inflammatory responses than NF-κB. This is furthermore supported 
by findings from a recent study examining ozone-induced pro-inflammatory responses by 
differentiated airway epithelial cells, revealing MAPK-dependent and NF-κB-independent 
induction of inflammatory mediators (53). 
Our study focused on airway epithelial responses to NTHi, because of the critical role of 
this microbe in COPD pathogenesis (54). However, often multiple respiratory pathogens are 
isolated from the airways of COPD patients and these micro-organisms may affect epithelial 
cell function in a different way than NTHi. In recent years there is an increased awareness of 
the role of the microbiome in COPD development and progression (55). Cigarette smoke-
induced changes in airway epithelial defense may affect the composition of this microbiome, 
and its altered composition may contribute to COPD development and progression. We 
reported in a previous study that cigarette smoke exposure increased expression of the 
antimicrobial protein RNase 7 in ALI-PBEC cultures (14). This raises the possibility that, 
in addition to a selective down-regulation of microbial-induced AMPs, expression of other 
AMPs might be increased by smoke exposure. These and other changes in airway epithelial 
defense may contribute to changes in the microbiome. However, further research is needed to 
study the role of AMPs in regulating the airway microbiome in COPD.
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In summary, our findings demonstrate that cultured airway epithelial cells from COPD 
patients have reduced antibacterial activity. Moreover, we observed an imbalance between 
the protective antibacterial defense and destructive inflammatory innate immune response 
by airway epithelial cells from COPD patients and in response to CS. This imbalance explains 
in part the enhanced bacterial burden and increased lung inflammation observed in COPD 
development and progression. Therefore, application of exogenous AMPs to compensate for 
the loss of AMPs might have therapeutic potential in COPD (56). Furthermore, the differential 
regulation of AMPs and pro-inflammatory mediators at the signal transduction level suggest 
that selective therapeutic targeting of airway inflammation, without affecting the beneficial 
antibacterial defense, might be possible. 
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Supplementary Table 1: Top 25 most differentially expressed genes in NTHi stimulated PBEC






















































Gene expression analysis by microarray of unstimulated (UNST) and UV-inactivated NTHi stimulated PBEC. Fold 
change values are shown for the top 25 most differentially expressed genes at 6 h (left table) and 24 h (right table) 
after stimulation. Selected AMPs that are further analysed are highlighted in bold and grey boxes. PBEC from 6 
independent donors were included in the analysis. The criteria for differential expression was an absolute fold change 
> 2 and p < 0.05, corrected for multiple testing.
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Supplementary Figure 1. Expression of LL-37/CAMP, SLPI, DEFB1 and DEFB3 in COPD and non-COPD ALI-PBEC. 
COPD (grey boxplots, n=11 patients) and non-COPD (white boxplots, n=8 patients) ALI-PBEC were stimulated 
with 1*109 CFU/ml UV-inactivated NTHi for 3 and 24 hours. mRNA expression of (A) LL-37/CAMP, (B) SLPI, 
(C) DEFB1 and (D) DEFB3 was assessed by qPCR. Stimulations were performed in duplicates. Data is shown as 
fold change in mRNA compared to untreated cells. Results are shown as boxplot with whiskers from minimum to 















































































Supplementary Figure 2. Expression of NTHi-induced innate immune regulators by COPD and non-COPD airway 
epithelial cells. COPD (grey boxplots, n=11 patients) and non-COPD (white boxplots, n=8 patients) ALI-PBEC 
were stimulated with 1*109 CFU/ml UV-inactivated NTHi for 3 and 24 hours. Afterwards, mRNA expression of (A) 
TLR2, (B) the primary microRNA 147b (pri-mir-147b) transcript, (C) ATF3 and (D) A20 was assessed by qPCR. 
Stimulations were performed in duplicates. Data is shown as fold change in mRNA compared to untreated cells. 
All results are shown as boxplot with whiskers from minimum to maximum or bars (means ± SEM). Analysis of 
differences was conducted with a two-way ANOVA and Bonferroni post-hoc test.
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Supplementary Figure 3. Hypothetical model of the effect of CS on airway epithelial cell innate immunity. NTHi 
activates both the NF-κB and MAPK signal transduction through the kinase TAK1. Cigarette smoke suppresses 
IKKα/β phosphorylation, which results in impaired NF-κB transcriptional activity reflected by impaired expression 
of early-induced target genes (NFKBIA, ZC3H12A, and NFKBIZ) and AMPs. In contrast, CS further enhances 
activation of the MAP-kinases ERK1/2 and p38, promoting expression of AP-1 transcription factor (FOS, JUN, and 
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Research question: It is currently unknown how cigarette smoke-induced airway remodelling 
affects highly expressed respiratory epithelial defence proteins and thereby mucosal host 
defence.
Methods: Localization of a selected set of highly expressed respiratory epithelial host defence 
proteins was assessed in well-differentiated primary bronchial epithelial cell (PBEC) cultures. 
Next, PBEC were cultured at the air-liquid interface and during differentiation for 2-3 weeks 
daily exposed to whole cigarette smoke. Gene expression, protein levels and epithelial cell 
markers were subsequently assessed. In addition, functional activities and persistence of the 
cigarette smoke-induced effects upon cessation were determined.
Results: Expression of pIgR, SLPI, long and short PLUNC was restricted to luminal cells and 
exposure of differentiating PBEC to cigarette smoke resulted in a selective reduction of the 
expression of these luminal cell-restricted respiratory host defence proteins compared to 
controls. This reduced expression was a consequence of cigarette smoke-impaired end-stage 
differentiation of epithelial cells, and accompanied by a significant decreased trans-epithelial 
transport of IgA and bacterial killing.
Conclusions: These findings shed new light on the importance of airway epithelial cell 
differentiation in respiratory host defence and could provide an additional explanation for 
the increased susceptibility of smokers and patients with COPD to respiratory infections.
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INTRODUCTION
Respiratory infections and microbial colonization are a major health burden in smokers, and 
contribute to exacerbations and to the development and progression of chronic obstructive 
pulmonary disease (COPD) (reviewed by Sethi(1)). The mechanisms underlying this increased 
susceptibility of smokers with or without COPD are incompletely understood, but can be 
attributed in part to epithelial injury and remodelling resulting in a disrupted mucociliary 
clearance(2). In addition to mucociliary clearance, the airway epithelium contributes to host 
defence with a wide variety of additional activities(3) that include secretion of antimicrobial 
peptides that act as endogenous antibiotics or modulate important antimicrobial immune 
responses via a variety of mechanisms(4). Furthermore, the epithelium produces cytokines 
and chemokines that initiate an immune response to act against microbial invaders. Finally, 
transport of polymeric IgA and IgM to the lumen by the polymeric immunoglobulin receptor 
(pIgR) contributes to adaptive immunity in the lung by inhibiting adherence and facilitating 
clearance of pathogens, a process called immune exclusion(5). Several of these respiratory 
host defence proteins (HDPs) in the airways are highly expressed during homeostasis by 
epithelial cells, suggesting their importance for airway epithelial barrier function. Highly 
expressed proteins and peptides include -but are not limited to- antimicrobial peptides such 
as human beta defensin-1 (hBD-1) and lipocalin 2 (LCN2), the secretory leukocyte protease 
inhibitor (SLPI), pIgR and the epithelial sodium channel regulators short and long palate, 
lung and nasal epithelium clone protein (s/lPLUNC or BPIFA1/BPIFB1)(6-8). Expression 
of other peptides involved in airway host defence such as Ribonuclease 7 (RNase 7), LL-
37 and human beta defensin-2 (hBD-2) is low during homeostasis but can be induced by 
e.g. inflammatory mediators, microbial products and upon injury of epithelial cells, and 
thus contribute to clearance of the pathogen and the resulting inflammatory process(4). The 
pseudostratified airway epithelium is composed of several cell-types, including goblet, club 
and ciliated cells that reach out toward the lumen of the airways, while basal cells do not reach 
this lumen in the intact epithelial layer(9). Based on their distinct anatomical positioning, it 
is not surprising that these different cell-types also produce different types of mediators. For 
example, expression of pIgR is restricted to the luminal cells of the pseudostratified airway 
epithelium and is therefore largely regulated by airway epithelial cell differentiation(10), 
similar to e.g. mucin production by goblet cells. In contrast, expression of the antimicrobial 
protein RNase 7 is restricted to basal cells(11). Cigarette smoke is known to induce airway 
epithelial remodelling in smokers and patients with COPD, characterized by an increase in 
goblet cells and a reduction in presence of ciliated cells(2). As a result higher levels of mucus 
are produced by the epithelium, while mucus transport is impaired, thereby compromising 
mucociliary clearance activity of luminal airway epithelial cells. Currently it is unknown if 
the expression of proteins that are important for airway epithelial defence is polarized in the 
epithelium, and if so, how cigarette smoke-induced remodelling of the airway epithelium 
affects their expression. We hypothesized that cigarette smoke-induced alterations in epithelial 
cell differentiation result in a decreased expression of proteins that contribute to respiratory 




Collection of cells and cell culture
Primary bronchial epithelial cells (PBEC) were obtained from tumour-free resected lung 
tissue at the Leiden University Medical Center, Leiden, the Netherlands. For this, bronchial 
epithelial cells were isolated from a bronchial ring by enzymatic digestion for 2 h at 37 
°C with 0.18% (w/v) proteinase type XIV (Sigma-Aldrich, St. Louis, MO, USA) in Ca2+/
Mg2+-free Hank’s Balanced Salt Solution (Life Technologies Europe B.V., Bleiswijk, The 
Netherlands). Next, the obtained cell fraction was expanded in serum-free keratinocyte 
medium (KSFM, Life Technologies Europe B.V.) supplemented with 0.2 ng/ml epidermal 
growth factor (Gibco), 25 μg/ml bovine pituitary extract (Life Technologies Europe B.V.), 
1 μM isoproterenol (Sigma-Aldrich), 100 U/mL Penicillin (Lonza, Verviers, Belgium), 100 
μg/ml Streptomycin (Lonza) and 5 µg/ml Ciproxin. Upon reaching confluence, cells were 
trypsinized in 0.03% (w/v) trypsin (Difco, Detroit, USA), 0.01% (w/v) EDTA (BDH, Poole, 
England), 0.1% glucose (BDH) in PBS and stored in liquid nitrogen until further use. For 
our cultures, cells were thawed in KSFM medium supplemented with the above mentioned 
supplements until near confluence, seeded on semipermeable transwell inserts with 0.4 μm 
pore size (Corning Costar, Cambridge, USA) that were coated with a mixture of bovine serum 
albumin, collagen and fibronectin and cultured as described (11).  PBEC were cultured at the 
air-liquid interface (ALI) for 13 to 19 days (Figure 1A). Apical washes were performed daily; 
medium was refreshed every other day.  
Fractionation of the airway epithelial cultures
Luminal and basal cell-enriched fractions were obtained from 3-4 weeks differentiated 
ALI-PBEC cultures as described previously(11). The luminal cell fraction was spun down 
and either lysed in RNA lysis buffer or fixed with 1% paraformaldehyde (Millipore B.V., 
Amsterdam, the Netherlands) in PBS for 10 minutes on ice and washed afterwards in ice-cold 
PBS. The remaining basal epithelial cell fractions on the transwell inserts were also either 
lysed in RNA lysis buffer (Promega) or fixed with 1% paraformaldehyde (Millipore B.V.) in 
PBS for 10 minutes on ice and washed afterwards with ice-cold PBS. Next, cells were stained 
with antibodies described in Supplementary Table 2.  
Chronic cigarette smoke exposure
When confluent, PBECs were air-exposed (day 0) by removal of medium from the apical side 
of the transwell insert and 4 h later exposed to freshly generated whole cigarette smoke (CS) 
using 3R4F reference cigarettes (University of Kentucky, Lexington, KY). CS exposure was 
repeated daily as described in(11), in the figure legends of Figure 1 and in Supplementary 
Figure 1 and illustrated in Figure 1B and Supplementary Figure 1. Briefly, cells were exposed 
in modified hypoxic chambers for 4-5 minutes to either cigarette smoke from 1 cigarette or 
to room air, after which smoke was removed by ventilation with air during 10 minutes. and 
cells were subsequently placed back in the incubator overnight. Approximately 18-20 h later, 
ALI-PBEC were washed apically with PBS and 4 h hereafter exposed to cigarette smoke. This 
cycle was repeated every day until day 13-19. Cells were harvested for analysis 18-20 h after 
the last cigarette smoke exposure. 
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Figure 1. Cell culture set-up and cigarette smoke exposure of primary bronchial epithelial cells differentiated at the 
air-liquid interface (ALI-PBEC). (A) Primary bronchial epithelial cells (PBEC) were seeded on coated transwells and 
cultured in submerged conditions until confluent. At day 0, cultures were air-exposed and cultured for additional 
13-19 days to allow mucociliary differentiation. (B) Each day, starting at day 0, cultures were exposed to cigarette 
smoke (CS) by placing them in an exposure chamber that was infused with either cigarette smoke or with air for 4-5 
min. Next, residual smoke in the chamber was removed for a period of 10 min. by infusing the chambers with air 
derived from the incubator. Approximately 4 h before each CS exposure the apical surface of the cultures was washed 
to remove mucus. Basal medium was changed every other day. 
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RNA isolation, cDNA synthesis and qPCR
Cells were lysed using lysis buffer from Promega, Leiden, the Netherlands. Next, RNA was 
extracted using the Maxwell tissue RNA extraction kit (Promega) and quantified using the 
Nanodrop ND-1000 Spectrophotometer (Nanodrop technologies, Wilmington, DE). cDNA 
synthesis was performed using oligo dT primers (Qiagen, Venlo, the Netherlands) and M-MLV 
Polymerase (Promega) in the presence of RNAsin (Promega). For qPCR analysis, diluted 
cDNA was mixed with primers (Supplementary Table 1) and iQ™ SYBR® Green Supermix 
(Bio-Rad, Veenendaal, the Netherlands). Reactions were performed in triplicate and results 
were corrected for the geometric mean of expression of 2-3 reference genes selected using 
the Genorm method. Expression values were determined by the relative gene expression of a 
standard curve as determined by CFX manager software (Bio-Rad). 
Confocal microscopy
Following fixation with 1% PFA, cell culture inserts and/or cytospins containing luminal 
epithelial cells were treated with methanol for 10 min at 4 °C, washed with PBS and cells were 
permeabilized with 1% w/v BSA, 0.3% v/v Triton-X100 in PBS (PBT) for 30 min at 4 °C. After 
washing with PBS, cells were pre-treated with SFX-signal enhancer (Life Technologies Europe 
B.V.) followed by incubation with primary antibodies in PBT for 1 h at RT (supplementary 
Table 2). Next inserts were washed in PBS and incubated with an Alexa Fluor 488 or 
568-labeled secondary antibody (Alexa Fluor 488 donkey-anti--mouse IgG; Alexa Fluor 
568 donkey--anti-rabbit IgG, Life Technologies Europe B.V.) together with DAPI in PBT for 
30 min at RT. Images were acquired using a TCS SP5 Confocal Laser Scanning Microscope 
(Leica Microsystems B.V., Eindhoven, The Netherlands) and LAS AF Lite software (Leica 
Microsystems B.V.). 
Transcytosis experiment
Transcytosis capacity of the epithelial cultures was assessed in cultures exposed daily to 
whole cigarette smoke for 13 days, or air as a control. Dimeric IgA was added to the basal 
compartment of the cell cultures and 24 h thereafter, apical washes (PBS) were collected and 
stored at -20°C for further analysis. Apical washes were assessed for secretory (S-)IgA levels 
by sandwich ELISA(10).
Antibacterial activity assay
Direct antimicrobial activity was assessed in cultures of ALI-PBEC that were exposed daily to 
whole cigarette smoke or air controls for 13 days, followed by replacement with antibiotics-
free cell culture medium for an additional 48 h period. Moraxella catarrhalis strain LUH2760 
and Klebsiella pneumoniae strain LUH2754 were cultured in Tryptic Soy broth (TSB) while 
shaking overnight at 37⁰ C. Next, the overnight cultures were transferred into fresh TSB 
medium (1/50 dilution) and incubated for 4 h at 37°C -while shaking- to obtain mid log-
phase-growing bacteria. Bacterial concentrations of log-phase cultures were determined by 
OD600 nm measurements, pre-diluted in PBS and final dilution was made in antibiotics-free 
cell culture medium. Twenty µl of bacterial suspension was added on the apical surface of 
the cells at a concentration of ~6x105/ml CFU/ml for M. catarrhalis and ~1x104 CFU/ml for 
K. pneumoniae and incubated at 37°C, 5% CO2 for 2 h. Hereafter, membranes containing 
the cells with bacteria were dissected from the inserts and placed into tubes containing 
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sterile glass beads and 1% TSB in PBS. Next cells were disrupted by using a minilys personal 
homogenizer (Bertin Instruments, Montigny-le-Bretonneux, France) for 2 times 30 s and kept 
on ice in between. Serial dilutions of both bacterial suspensions were plated on Tryptic Soy 
Sheep blood (TSS) agar plates (Biomerieux, Zaltbommel, The Netherlands), and incubated 
overnight at 37°C to assess surviving bacteria by CFU determination.
ELISA and Trans-epithelial electrical resistance
CXCL8/IL-8 production by ALI-PBEC was determined in the basal medium by use of the 
CXCL8/IL-8 Duoset kit from R&D (MN, U.S.A.). hBD-1 was measured in the apical wash 
and in the basal medium using the hBD-1 kit from Peprotech (London, U.K.) and SLPI was 
measured as described(46). Epithelial barrier integrity of ALI-PBEC cultures was determined 
during cell differentiation by measuring the trans-epithelial electrical resistance (TEER) 
using the MilliCell-ERS (Millipore, Bedford, MA). TEER values were shown as Ω*cm2 and 
calculated as TEER = (measured value – background value) *surface transwell insert in cm2. 
Inhibition of differentiation by DAPT
At day 0, PBEC were air exposed by removal of the medium in the insert and culture medium 
of ALI-PBEC was refreshed with medium supplemented with either 5 µM DAPT (Notch 
signalling inhibitor, Sigma Aldrich, Zwijndrecht, The Netherlands), or solvent control. Every 
other day, basal medium was changed in a similar fashion up to day 13 when the cells were 
harvested.  
Statistics
Statistical analysis was conducted using GraphPad Prism 7 (GraphPad Software Inc., La Jolla, 
CA, U.S.A.). Data are shown as mean ± SEM and significance was tested with use of   a 
paired t-test or two-way ANOVA with a Bonferroni corrected post-hoc test. Differences were 
considered significant at p< 0.05. 
RESULTS
Respiratory host defence proteins display a polarized distribution in airway epithelial cell cultures
In this study we have focussed on a set of proteins and peptides that are important for 
respiratory host defence. These host defence proteins (HDPs) were selected based on their 
constitutive and/or high expression by airway epithelial cells during homeostasis: i.e. SLPI, 
PLUNC (short/long), pIgR, hBD-1 and LCN2. We first investigated whether expression of 
these proteins was polarized in the airway epithelial cultures. To this end, we prepared luminal 
and basal epithelial cell-enriched fractions of well-differentiated primary bronchial epithelial 
cells (PBEC), cultured at the air-liquid interface (ALI, Figure 2A). We confirmed the successful 
enrichment of fractions for luminal and basal cells by determining the gene expression of the 
typical basal cell markers TP63 and KRT5 and luminal epithelial cell markers FOXJ1 (ciliated 
cells), SCGB1A1 (club cells), MUC5AC and MUC5B (both goblet cells) (Figure 2A), and by 
immunofluorescence staining for p63 (basal cells), CC16 (club cells) and acetylated α-tubulin 
(ciliated cells) (supplementary Figure 2). Further analysis of these fractions showed that the 
luminal cell-enriched fraction expressed significantly higher levels of BPIFA1 (sPLUNC), 
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BPIFB1 (lPLUNC) and SLPI (Figure 2A). In contrast, LCN2 and DEFB1 expression did not 
differ between the luminal and basal cell-enriched fraction (Figure 2A). The luminal cell-
specific expression of SLPI and sPLUNC was further confirmed using confocal imaging in 
which the staining of both proteins did not co-localize with p63+ basal cells, but was highly 
present at the apical side of the PBEC culture and in the luminal cell-enriched fraction (Figure 
2B and Supplementary Figure 2). 
Figure 2. Respiratory host defence proteins display a polarized distribution in air-liquid interface cultures of primary 
bronchial epithelial cells (ALI-PBEC). (A) PBEC were seeded on coated transwells and cultured in submerged 
conditions until confluent. At day 0, cultures were air-exposed and cultured at the air-liquid interface. After 3-4 
weeks of differentiation luminal and basal cell-enriched fractions were separated followed by RNA isolation, cDNA 
synthesis and qPCR analysis. Data are shown as target gene expression normalized for the geometric mean expression 
of the reference genes ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), β2-
microglobulin (B2M) and Ribosomal Protein L13a (RPL13A),  n=5-7 different donors. Open bars are basal cell-
enriched fractions; grey bars are luminal cell-enriched fractions. Statistical significance was tested using a paired 
t-test. * p<0.05, ** p<0.01, *** p<0.001. (B) Confocal images to visualize polarized distribution of secretory leukocyte 
protease inhibitor (SLPI) and short palate, lung and nasal epithelium clone protein (sPLUNC) in differentiated ALI-
PBEC cultures cells. After 3 weeks of differentiation, cells were fixed in 1% paraformaldehyde and stained using 
immunofluorescence with primary antibodies against p63 (basal cell marker, red) in combination with primary 
antibodies against SLPI and/or sPLUNC (both green) and DAPI for nuclear staining (blue). Z-stacks and images of 
the apical and basal side of stained cells were made by confocal imaging, scale bars equals 50 µm. Images shown are 
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Chronic cigarette smoke exposure of airway epithelial cell cultures reduces expression of 
respiratory host defence proteins 
We next investigated if cigarette smoke-exposure affected expression of this set of respiratory 
HDPs. To this end, ALI-PBEC cultures were exposed on a daily basis during 2-3 weeks of 
differentiation to whole cigarette smoke (CS) (Figure 1 and Supplementary Figure 1). Gene 
expression analysis showed that DEFB1 (hBD-1) mRNA levels decreased during differentiation, 
but were not affected by CS exposure (Figure 3A). On the other hand, expression of SLPI, 
BPIFA1 (sPLUNC), BPIFB1 (lPLUNC) and PIGR strongly increased during differentiation, 
and this increase was significantly prevented by CS (Figure 3A). In contrast, gene expression 
of LCN2 (lipocalin 2) was increased by CS exposure during differentiation (Figure 3A). These 
findings were further confirmed by assessment of hBD-1 and SLPI protein levels in the apical 
wash and in basal medium from the ALI-PBEC cultures (Figure 3B). Indeed, hBD-1 levels 
reduced over the time of differentiation in the apical wash, but were not significantly affected 
by chronic CS-exposure, whereas SLPI levels were significantly lower in chronic CS-exposed 
cell cultures (Figure 3B). We next performed immunofluorescence staining of the airway 
epithelial cell cultures and found strongly reduced presence of SLPI-, sPLUNC- and pIgR-
positive cells in chronic CS-exposed epithelium compared to air controls (Figure 3C). These 
results confirmed selective impairment of specific respiratory HDPs by chronic CS exposure 
during airway epithelial differentiation.  To exclude that possible toxic effects of the chronic 
CS exposure affected the observations we made, we performed a selection of additional 
experiments. We assessed trans-epithelial electrical resistance (TEER) of ALI-PBEC exposed 
to CS or air as a control: results showed that chronic CS-exposed ALI-PBEC displayed a slight 
but non-significant decrease of TEER in CS-exposed cultures in the first week of exposure, 
and a similar TEER as the air-exposed controls in the second week of exposure up until day 
19  (supplementary Figure 3A).  LDH levels in chronic CS-exposed cell cultures were not 
increased, but rather reduced compared to air-exposed cultures (supplementary Figure. 3B). 
Indirect evidence for absence of marked cytotoxicity was the observation that chronic CS 
exposure significantly increased secretion of the neutrophil-attracting chemokine IL-8 at 13 
days of differentiation in CS-exposed cells compared to air-exposed controls (supplementary 
Figure 3C). The cell size in chronic CS-exposed cell cultures seemed bigger in some donors, 
but not all, compared to air-exposed cultures, but no other morphological changes could be 
detected by microscopic inspection (an example illustrated in supplementary Figure. 3D). 
Together these data show that chronic CS-exposure-mediated loss of specific HDP expression 
by ALI-PBEC is unlikely to be a result of toxicity. This conclusion is further supported by 
measurements on the expression of a selection of inducible HDPs. We previously reported 
induction of RNASE7 mRNA and protein in ALI-PBEC upon acute exposure to one cigarette 
(11), in line with these findings, chronic CS exposure also caused a progressive increase in 
RNASE7 compared to air-exposed controls (supplementary Figure 3E). In addition also 
increased CAMP gene expression (LL-37-coding gene) was detected in chronic CS-exposed 
cultures (supplementary Figure 3E). In contrast, we did not observe a significant difference in 
the expression of DEFB4 (human β-defensin 2) (supplementary Figure 3E). 
106
CHAPTER 5























# # # #
# # # #
****
****
































# # # #
# # # #






























# # # # #

















































# # # #






















# # # #
# # # #



















































Figure 3. Chronic cigarette smoke exposure of air-liquid interface cultures of primary bronchial epithelial cells (ALI-
PBEC) lowers the expression of luminal cell-restricted host defence proteins. (A) ALI-PBEC were daily exposed to 
whole cigarette smoke (CS) or air as a control (AIR) during differentiation for 13-19 consecutive days. Cells were 
lysed at several points during this course of time and RNA was isolated followed by cDNA synthesis to assess gene 
expression of DEFB1 (human beta defensin-1), SLPI (secretory leukocyte protease inhibitor), BPIF1A (short palate, 
lung and nasal epithelium clone protein), BPIF1B (long palate, lung and nasal epithelium clone protein), PIGR 
(polymeric immunoglobulin receptor) and LCN2 (lipocalin 2). Open circles: air-exposed controls, black circles: 
CS-exposed cell cultures; data are shown as target gene expression normalized for the geometric mean expression 
of the reference genes ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), β2-
microglobulin (B2M) and Ribosomal Protein L13a (RPL13A); day 0, 7, 13 n=8 different donors and day 19 n=4 
different donors. Statistical differences were evaluated using a two-way ANOVA and Bonferroni post-hoc test. * 
p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 between AIR and CS.  # p<0.05, ## p<0.01, ### p<0.001, #### p<0.0001 
between AIR at day 7, 13 and 19 and unexposed cultures at day 0. (B) ELISA for hBD-1 and SLPI was performed on 
 107 
DIFFERENTIATION-DEPENDENT AIRWAY EPITHELIAL HOST DEFENCE AND 
THE EFFECT OF CIGARETTE SMOKE
5
Chronic cigarette smoke exposure reduces host defence of the airway epithelial cell cultures by 
decreasing apical release of secretory IgA and bacterial killing of Moraxella catarrhalis and 
Klebsiella pneumoniae  
Next, we assessed if the strong reduction in SLPI, BPIFA1 (sPLUNC), BPIFB1 (lPLUNC) 
and PIGR expression levels in the CS-exposed airway epithelial cultures had functional 
consequences for host defence. We selected pIgR-mediated transfer of dimeric (d)IgA across 
the epithelium as a proof-of-principle for the consequences on immunomodulatory host 
defence functions and found this to be significantly reduced in chronic CS-exposed cultures 
(Figure 4A). We furthermore analysed bacterial killing by chronic CS-exposed cell cultures 
of the Gram-negative bacteria Moraxella catarrhalis and Klebsiella pneumoniae, pathogens 
that are found to be increased in the lungs of patients with stable or acute exacerbations of 
COPD (12). We observed significantly higher bacterial counts (indicating lower antibacterial 
activity) in chronic CS-exposed PBEC cultures when compared to air-exposed cultures for 
both pathogens (Figure 4B). These data indicate that various host defence mechanisms are 
the apical wash (Apical) and basal medium (Basal) of these cultures. Open bars: air controls (AIR), black bars: CS-
exposed cell cultures (CS); day 7 and 13, n=8 different donors and day 19: n=4 different donors. Statistical differences 
on T=7 and T=13 (not T=19) was tested using a paired two-way ANOVA to compare AIR and CS. * p<0.05, ** 
p<0.01. (C) ALI-PBEC were differentiated for 2-3 weeks in which they were daily exposed to CS or air as a control 
(AIR). Subsequently the cells were fixed in 1% paraformaldehyde and stained using primary antibodies against SLPI, 
sPLUNC and pIgR (all green staining) in combination with DAPI to stain the nuclei (blue staining). Scale bars are 






























































Figure 4. Chronic cigarette smoke exposure of air-liquid interface cultures of primary bronchial epithelial cells (ALI-
PBEC) impairs host defence activities. 
(A) ALI-PBEC were daily exposed to whole cigarette smoke (CS) or air as a control (AIR) during differentiation 
for 13 consecutive days. After 13 days of chronic CS exposure, dimeric (d)IgA transcytosis capacity of the epithelial 
cultures was assessed by determining secretory (S)-IgA levels in apical washes by ELISA (no S-IgA could be detected 
in the basal medium, as a control of the assay that does only recognize S-IgA and not d-IgA), n=10 different donors. 
Open bars: air-exposed cell cultures, black bars: CS-exposed cell cultures. (B) After 13 days of chronic CS exposure, 
ALI-PBEC were cultured for 48 h in antibiotics-free cell culture medium after which they were exposed for 2 h to 
Moraxella catarrhalis or Klebsiella pneumoniae at the apical surface of the ALI-PBEC. The surviving bacteria are 
depicted as colony forming units (CFU)/ml,  n=8 different donors. Significance was determined using a paired t-test. 
*p<0.05, **** p<0.0001. 
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functionally impaired in CS-exposed epithelial cell cultures, which corresponds with impaired 
expression of respiratory defence proteins.
Cigarette smoke affects end-stage differentiation of airway epithelial cells
Next we assessed if chronic CS exposure affected differentiation of ALI-PBEC by measuring 
gene expression of epithelial cell-specific markers. Gene expression of the basal cell 
markers cytokeratin-5 (KRT5) and TP63, and of cytokeratin-8 (KRT8) that is expressed by 
intermediate/committed progenitor epithelial cells(13), was not affected by CS (Figure 5A). 
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In contrast, expression of the specialized luminal epithelial cell-specific genes FOXJ1 (ciliated 
cells), SCGB1A1 (club cells) and MUC5B (goblet cells) increased during differentiation, and 
this increase was significantly prevented by CS (Figure 5A). Confocal imaging confirmed the 
aberrant epithelial differentiation in CS-exposed cultures as cells positive for cilia marker 
acetylated α-tubulin, the club cell marker CC16, and the goblet cell marker MUC5AC were 
reduced in chronic CS-exposed cultures, while cytokeratin-8 (CK-8)+ and p63+ cells remained 
unchanged between air and CS-exposed cultures (Figure 5B).
Reversibility of cigarette smoke-induced effects on host defence protein expression
To assess the persistence of the CS-induced reduction in SLPI, BPIFA1 (sPLUNC), BPIFB1 
(lPLUNC) and PIGR expression levels and of its effect on cellular composition, we allowed 
the cultures to recover from 13 days of CS exposure by culturing the cells for an additional 
6 days without CS exposure. Chronic CS-exposed cultures were able to (partly) recover 
from the lack of end-stage differentiation, since all specialized luminal cell markers, except 
for SCGB1A1 (club cells), significantly increased in expression (Figure 6A). Furthermore, 
also SLPI, BPIFA1 (sPLUNC), BPIFB1 (lPLUNC) and PIGR showed enhanced expression 
compared to day 13 (Figure 6A). In addition, KRT5 (basal cell marker), and DEFB1 and LCN2 
increased upon CS cessation, whereas TP63 and KRT8 were unaffected (Supplementary 
Figure 3A). This indicates that the inhibitory effects of cigarette smoke exposure on epithelial 
differentiation and expression of specific respiratory defence proteins are at least in part 
reversible. Furthermore, in an attempt to better mimic the in vivo situation and establish if 
the effects observed after chronic CS exposure also can be obtained when exposing an already 
partly differentiated epithelium to chronic CS, we performed a separate experiment. In this 
experiment, we first allowed the cultures to differentiate for 1 week, after which we started 
chronic CS exposure for an additional 12 days. Here we found similar effects of CS exposure 
on ALI-PBEC cultures regarding cell-type specific markers and HDP expression compared to 
CS exposure starting from day 0 (Figure 6B and Supplementary Figure 3B).
Figure 5. Chronic cigarette smoke exposure of air-liquid interface cultures of primary bronchial epithelial cells (ALI-
PBEC) changes cellular composition. (A) ALI-PBEC were exposed during differentiation for 13-19 consecutive days 
to whole CS. Cells were lysed at several time-points and RNA was isolated followed by cDNA synthesis, to assess gene 
expression of basal cell markers cytokeratin-5 (KRT5) and TP63, of early progenitor cell marker cytokeratin-8 (KRT8) 
and of specialized cell markers FOXJ1 (ciliated cells), SCGB1A1 (club cells) and MUC5B (goblet cells). Open circles: 
air-exposed controls (AIR), black circles: CS-exposed cell cultures (CS); data are shown as target gene expression 
normalized for the geometric mean expression of the reference genes ATP synthase, H+ transporting, mitochondrial 
F1 complex, beta polypeptide (ATP5B), β2-microglobulin (B2M) and Ribosomal Protein L13a (RPL13A); day 0, 
7, 13 n=8 donors and day 19 n=4 donors. Significance was determined using a two-way ANOVA and Bonferroni 
post-hoc test. ** p<0.01, *** p<0.001, **** p<0.0001 between AIR and CS. # p<0.05, ## p<0.01, ### p<0.001, #### 
p<0.0001 between AIR at day 7, 13 and 19 and unexposed cultures at time 0. (B) ALI-PBEC were differentiated for 
2-3 weeks and daily exposed to CS. Subsequently the cells were fixed in 1% paraformaldehyde and stained using 
primary antibodies against basal cells (p63), presented as a red staining, in combination with primary antibodies 
against cytokeratin-8 (CK-8), acetylated α-tubulin (ciliated cells), CC16 (club cells) and MUC5AC (goblet cells), 
which are presented as a green staining; DAPI was used to stain the nuclei (blue staining). Z-stacks and images of the 
apical and basal side of stained cells were obtained by confocal imaging. Scale bars equals 50 µm. Images shown are 












































































































































































































































































































































































































Figure 6. Cigarette smoke-induced impairment of host defence proteins and differentiation markers are partly persistent 
upon cigarette smoke cessation. (A) Air-liquid interface cultures of primary bronchial epithelial cells (ALI-PBEC) 
were exposed during differentiation for 13 consecutive days to whole cigarette smoke (CS) after which cultures were 
continued for another 6 days without CS exposure. Cells were lysed at several points during this course of time and 
RNA was isolated followed by cDNA synthesis, to assess gene expression of the cell specific markers: FOXJ1 (ciliated 
cells), MUC5B (goblet cells) and SCGB1A1 (club cells) and of respiratory defence proteins: SLPI, BPIFA1 (sPLUNC), 
BPIFB1 (lPLUNC) and PIGR. Open bars: air-exposed controls (AIR), black bars: CS-exposed cell cultures (CS), grey 
bars: CS-exposed cultures that were cultured for an additional week without CS exposure (CS cessation). Data are 
shown as target gene expression normalized for the geometric mean expression of the reference genes ATP synthase, 
H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), β2-microglobulin (B2M) and Ribosomal 
Protein L13a (RPL13A). n=8 different donors. Statistical differences were evaluated only for the difference between 
cessation and previous CS expression using a two-way ANOVA and Bonferroni post-hoc test. * p<0.05, ** p<0.01, *** 
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p<0.001, **** p<0.0001. (B) ALI-PBEC were air exposed at day 0 and cultured for 7 days under standard conditions. 
At day 7 cultures were exposed to CS for 12 consecutive days after which the cells were lysed and similar analysed 
as in (A). Grey bars (start point of culture at day 7): unexposed, open bars: air-exposed controls, black bars: CS-
exposed cell cultures. Data are shown as target gene expression normalized for the geometric mean expression of the 
reference genes ATP5B, B2M and RPL13A; n=6 different donors. Statistical differences were evaluated using a two-
way ANOVA and Bonferroni post-hoc test. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001.














































































































































































































































































Figure 7. Chronic cigarette smoke exposure of air-liquid interface cultures of primary bronchial epithelial cells (ALI-
PBEC) results in selective impairment of Notch signalling. (A) After 2 weeks of differentiation and daily cigarette smoke 
exposure, ALI-PBEC were lysed, RNA was isolated and cDNA synthesized. Subsequent qPCR analysis was performed 
on notch signalling ligands DLL1, JAG1 and JAG2, on Notch receptors 1-3 and on the transcriptional co-activators 
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Notch signalling inhibition impairs host defence protein expression during differentiation
Our results so far showed an impaired end-stage differentiation into specialized luminal 
epithelial cells in CS-exposed cultures resulting in reduced levels of SLPI, sPLUNC, 
lPLUNC and pIgR. Previous studies have shown that Notch signalling is involved in airway 
epithelial differentiation and that the airway epithelium of smokers displays reduced Notch 
signalling(14). Therefore, we next examined if Notch signalling was impaired in CS exposed 
cultures, and if Notch signalling inhibition modulates HDP expression during differentiation. 
First, we assessed gene expression of components of the Notch signalling cascade and found 
that chronic CS exposure did not influence gene expression of Notch ligands, receptors or 
transcriptional co-activators in these cultures (Figure 7A). However, the Notch signalling 
target genes, HEY1 and HEY2, were significantly reduced by chronic CS exposure, while 
HES1 was not (Figure 7B), indicating that chronic CS exposure selectively affects target genes 
of the Notch signalling pathway. To further investigate the importance of  Notch signalling in 
the expression of host defence proteins, we examined the effect of the γ–secretase inhibitor 
DAPT, which acts as an inhibitor of Notch signalling (Figure 8A). After 15 days of PBEC 
differentiation in the presence of DAPT, we measured expression of HDPs. DEFB1 (hBD-1) 
and LCN2 were not affected by DAPT, while gene expression of SLPI, BPIFA1 (sPLUNC), 
BPIFB1 (lPLUNC) and PIGR were strongly reduced by DAPT incubation (Figure 8B). 
Furthermore, DAPT-exposed cultures showed a skewing of cell differentiation away from a 
secretory phenotype towards an increase in ciliated cells (Figure 8C) that was also confirmed 
by confocal imaging (Figure 8D).
DISCUSSION
Here we demonstrate that cigarette smoke negatively affects expression of the respiratory 
HDPs: pIgR, SLPI, lPLUNC and sPLUNC. Their expression was significantly reduced in 
epithelial cells daily exposed to CS during differentiation as a result of an impaired end-
stage differentiation of specialized luminal cells. As a consequence, remodelling of the 
airway epithelium by cigarette smoke has a significant impact on respiratory host defence, 
underscored by the severely diminished IgA transport across the CS-exposed epithelium and 
impaired antibacterial defences against M. catarrhalis and K. pneumoniae. Our data suggest 
that increasing expression of specific respiratory HDPs (or preventing their decrease) could be 
of therapeutic interest to improve host defences in the lungs of COPD patients. Furthermore, 
this (selective) loss may also contribute to changes in lung microbiome composition, which 
is increasingly recognized as an important contributor to chronic inflammatory lung 
diseases(15, 16). 
MAML1 and MAML3; data are shown as target gene expression normalized for the geometric mean expression of 
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), β2-microglobulin (B2M) and 
Ribosomal Protein L13a (RPL13A). Open circles: air-exposed controls (AIR), black circles: CS-exposed cell cultures 
(CS); n=8 different donors. (B) Subsequent qPCR analysis was performed on Notch signalling target genes HEY1, 
HEY2 and HES1. Data are shown as target gene expression normalized for the geometric mean expression of the 
reference genes ATP5B, B2M and RPL13A; n=8 different donors. Statistical significance was tested using a two-way 
ANOVA and Bonferroni post-hoc test . ** p<0.01, *** p<0.001 between AIR and CS.
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Figure 8. DAPT inhibits host defence protein expression in air-liquid interface cultures of primary bronchial epithelial 
cells (ALI-PBEC). (A) Mechanism of action of the Notch inhibitor DAPT, a γ-secretase inhibitor that prevents 
proteolytic cleavage of the Notch intracellular domain (NCID). (B) PBEC were seeded on coated transwells and 
cultured in submerged conditions until confluent. At day 0, cells were differentiated for an additional 15 days in the 
presence of 5 µM of the Notch signal transduction inhibitor DAPT in the basal medium or solvent as control. At day 
0, 7, and 15 cells were lysed, RNA was isolated and cDNA synthesized. Subsequent qPCR analysis was performed 
to assess expression of respiratory defence proteins and epithelial cell-specific genes such as: DEFB1 (human beta 
defensin-1), SLPI (secretory leukocyte protease inhibitor), BPIFA1 (short palate, lung and nasal epithelium clone 
protein), BPIFB1 (long palate, lung and nasal epithelium clone protein), polymeric immunoglobulin receptor (PIGR) 
and LCN2 (lipocalin 2). Data are shown as target gene expression normalized for the geometric mean expression 
of the reference genes ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), β2-
microglobulin (B2M) and Ribosomal Protein L13a (RPL13A); n=7 different donors. Statistical significance was tested 
using a two-way ANOVA and Bonferroni post-hoc test . ** p<0.01, *** p<0.001, **** p<0.0001 between CTRL and 
DAPT. (C) qPCR analysis was performed to assess mRNA expression of the epithelial cell markers SCGB1A1 (club 
cells), MUC5B (goblet cells), FOXJ1 (ciliated cells),  TP63 (basal cells), and cytokeratin-8 (KRT8) (intermediate cells) 
after 15 Days of differentiation with DAPT or solvent control, n=6 different donors. Statistical significance was tested 
using a paired t-test * p<0.05, ** p<0.01 between CTRL and DAPT (D) ALI-PBEC were differentiated for 15 Days 
with DAPT or solvent control. Subsequently the cells were fixed in 1% paraformaldehyde and stained using primary 
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The cellular composition of the ALI-PBEC cultures changed drastically upon chronic CS-
exposure. While presence of intermediate CK-8+ cells (or also called early, intermediate 
or committed progenitor epithelial cells(13, 17)) was not affected by chronic CS exposure, 
the specialized luminal cell markers were reduced in chronic CS-exposed cultures. These 
results indicate that specifically end-stage differentiation seems impaired by CS exposure. 
The effects of chronic CS exposure were also observed when the cells were first allowed to 
differentiate for one week in absence of CS. Furthermore, upon cessation of CS exposure, 
gene expression of most luminal cell markers showed a strong recovery. In contrast, 
SCGB1A1 mRNA expression remained absent after almost 1 week of recovery, suggesting an 
exceptional detrimental effect of CS on club cell differentiation or the regulation of SCGB1A1 
gene expression. This is underscored by a recent study showing that expression of the club 
cell-protein CC16 (SCGB1A1) is reduced in COPD patients and in CS-exposed mice. Loss 
of CC16 was correlated with increased severity of the disease and CS-induced pulmonary 
inflammation was lower in mice overexpressing CC16(18). 
Cytotoxicity is unlikely to have a major contribution to the CS-induced effects on the ALI-
PBEC cultures since we detected no difference in trans-epithelial electrical resistance (TEER) 
as a measure of barrier function during the course of differentiation between CS and air-
exposed controls. We previously observed transient decreases in TEER after acute single CS 
exposures, normalizing after 24 h (11). In our chronic CS set-up we measured TEER 18-
20h after the previous CS exposure, which may explain why we did not observe significant 
differences in TEER between air and CS-exposed cultures. Previous studies have shown 
decreases in TEER by CS, but often use cigarette smoke extract (CSE) and not whole CS (19, 
20). CSE has a different composition and concentration than whole CS used in our study. In 
addition, in some studies CSE was added to the basal medium, resulting in stimulation from 
the basal side of the transwells  (19). This may also contribute to differences found in effects on 
TEER. Lastly, LDH release was not increased in our CS-exposed cultures, while cellular size 
appeared larger in the CS-exposed cultures for some donors. Finally, the CS-exposed cultures 
produced higher amounts of IL-8 and displayed increased mRNA expression of the inducible 
antimicrobial peptides RNase7 and LL-37 (but not hBD-2). These results are described in the 
online data supplement and in Supplementary Figure 4
Unexpectedly, we did not observe goblet cell hyperplasia in cultures that were exposed 
to CS, shown previously in smokers (21), guinea pigs (22), rats (23) and in cell lines (23, 
24) or PBEC exposed to cigarette smoke extract (CSE)(19). However, Brekman et al. (25) 
also observed a decline in goblet cells markers in PBEC continuous exposed to CSE. Data 
are therefore conflicting and dependent on the type of cell culture used. Obviously, in our 
primary differentiated cultures,  whole CS exposure alone is insufficient to induce goblet 
cell hyperplasia within 19 days. We strongly consider that the findings in patients are more 
likely explained by a secondary effect of the CS-induced inflammation (which is obviously 
incompletely represented in our in vitro model). For example, neutrophil recruitment as a 
consequence of the CS-induced inflammation and subsequent release of proteases and other 
antibodies against CC16 (club cells), MUC5AC (goblet cells), and acetylated α-tubulin (ciliated cells), which are 
presented as a green staining; DAPI was used to stain the nuclei (blue staining). Scale bars equals 50 µm. Images 
shown are representative for results obtained with cells from 3 different donors. 
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molecules, may help to explain goblet cell formation in patients. In addition, also the presence 
of other cell types besides neutrophils such as macrophages seem important for goblet cell 
hyperplasia. This has also been suggested in literature (26-29). Furthermore, several studies 
suggest that various other factors might have an important role in promoting goblet cell 
hyperplasia that are involved in COPD pathogenesis, including bacterial and viral infections 
(30, 31).
Whereas previous studies have shown that CS reduces the presence of ciliated cells (19, 25, 
32), so far CS-induced airway epithelial remodelling was not yet linked to changes in levels 
of the highly expressed respiratory HDPs, despite the fact that changes in expression in these 
proteins have been reported in smokers or patients with COPD. Aarbiou et al. showed that 
expression of SLPI was significantly reduced in damaged bronchial epithelium of COPD 
patients compared to non-COPD individuals(33), and Gohy et al. showed reduced levels 
of pIgR in the lungs of patients with COPD, however not in smokers with a normal lung 
function compared to healthy controls(10). Finally, reduced levels of PLUNC were detected in 
bronchial brushes performed in current smokers compared to never smokers(34). 
We observed impaired anti-bacterial activity of the CS-exposed airway epithelial cultures 
against M. catarrhalis and K. pneumoniae. We also evaluated direct antibacterial activity 
of the chronic CS-exposed cultures using a grid assay with live/dead staining of bacteria 
(35, 36) and via conventional plating methods against Pseudomonas aeruginosa and non-
typeable Haemophilus influenzae,, but could not detect any differences (data not shown). 
These data suggest that the observed CS-induced impairment of antimicrobial activity may be 
pathogen-specific, since it is not observed with all pathogens studied. In addition to impaired 
antibacterial host defence activities, the loss of HDP expression by the airway epithelium 
can have further negative effects for the host. For example, loss of SLPI expression (highly 
expressed in normal lung tissue) can promote inflammation in the lungs of patients with 
COPD. SLPI acts as an inhibitor of detrimental proteases such as neutrophil elastase, acts as 
an inhibitor of NFκB activation and it modulates macrophage functions(37-39). sPLUNC is 
involved in regulation of the epithelial sodium channel (ENaC), thereby regulating airway 
surface liquid (ASL), and reduced levels could result in lowered ASL volume and impaired 
mucociliary clearance(40). 
Since Notch signalling was previously reported to be impaired in COPD(14), we first analysed 
the effect of chronic CS exposure on components of the Notch signalling pathway and Notch 
target genes, and found that CS decreased the expression of selected Notch target genes. 
When we next used the Notch signalling inhibitor DAPT to inhibit airway epithelial cell 
differentiation, we found similar effects compared to CS exposure on expression of the selected 
set of respiratory HDPs. To our knowledge, this is the first study linking Notch signalling 
to expression of a range of host defence proteins that are increased upon differentiation. 
Whereas chronic CS exposure resulted in a reduction of all luminal-cell markers, DAPT-
exposed cultures showed higher levels of ciliated cells when compared to control-treated cells, 
in line with previous studies(41, 42). These results suggest that expression of the luminal 
cell-restricted HDPs is confined to mature secretory epithelial cells, rather that the ciliated 
epithelium. Further studies using single cell RNA sequencing, may reveal whether the 
expression is restricted to a certain secretory cell phenotype. The partial similarity between 
the DAPT-incubated cultures and the CS-exposed cultures suggests involvement of altered 
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Notch signalling in the CS-induced effects. However, alterations in other signalling pathways 
might also be involved in the observed effects of CS, such as those involving EGFR(32), 
TGF-β(25) Wnt(43) and BMP(44). Most likely a more systems/-omics approach has the 
potential to elucidate in detail all effects of chronic CS exposure on Notch and other signalling 
pathways(45).
In summary, these findings shed new light on the role of dysregulated host defence in smokers 
and patients with COPD by highlighting the importance of airway epithelial cell differentiation 
in the expression of respiratory HDPs. Further investigations into how suppression of epithelial 
cell differentiation by cigarette smoke contributes to microbial colonization and infections of 
the airways are warranted in order to develop new therapeutics that restore airway epithelial 
host defence in patients with COPD.
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Supplementary Table 1. Primer sequences.
































DIFFERENTIATION-DEPENDENT AIRWAY EPITHELIAL HOST DEFENCE AND 
THE EFFECT OF CIGARETTE SMOKE
5
Supplementary Table 2. Antibodies used for confocal imaging
Antibody Supplier Catalog# species Antibody dilution
CK-8 Novus Biologicals NBP2-34266 mouse 1/100
pIgR R&D Systems MAB27171 mouse 1/100
p63 Abcam ab124762 rabbit 1/100
sPLUNC Hycult Biotech HM2314 mouse 1/100
SLPI Hycult Biotech HM2037 mouse 1/100
Mucin 5AC Labvision Neomarkers MS-145-P1 mouse 1/1000
CC16 Hycult Biotech HM2178 mouse 1/50
Acetylated 
α-Tubulin
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Supplementary Figure 1. Details of the cigarette smoke exposure design and procedure. Approximately 4 h before the 
cigarette smoke exposure, the apical surface of the cell cultures were washed with PBS and every other day the basal 
medium was replaced. Next, the cells were placed in the exposure chamber and the lid was removed. The closed 
exposure chamber was then infused with cigarette smoke from 1 cigarette for 4-5 min, or normal air in the control 
chamber. Hereafter, the tubing from the cigarette is clamped and vents on the exposure chamber connecting to the 
space in the incubator are opened and the air is refreshed with air from the incubator for an additional 10 min. The 
smoke-containing air is removed via separate tubing outside the incubator into a fume hood. After the exposure and 
refreshing, the chamber is opened, the lid placed back on the cells and the cells are placed back in a separate incubator 
for 20 h when the procedure is repeated. 
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Supplementary Figure 2. Expression of respiratory host defence proteins in the luminal cell fraction of air-liquid 
interface-differentiated primary bronchial epithelial cells (PBEC). PBEC were seeded on coated transwells and 
cultured in submerged conditions until confluent. At day 0, cultures were air-exposed and cultured at the air-liquid 
interface (ALI). After 3 weeks of differentiation, luminal and basal cell fractions were separated. Cells were fixed in 
1% paraformaldehyde and cytospins were prepared of the luminal cell enriched fraction. Luminal cell cytospins and 
the basal cell enriched fraction located on the transwell inserts were subsequently stained using immunofluorescence 
with primary antibodies against p63 (basal cell marker, red) in combination with primary antibodies against SLPI, 
sPLUNC, CC16 and acetylated α-tubulin (all green) and DAPI for nuclear staining (blue). Scale bars equal 50 µm. 
Images shown are representative for results obtained with cells from 3 different donors.
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Supplementary Figure 3. Chronic cigarette smoke exposure of airway epithelial cell cultures does not lead to cell 
toxicity. Air-liquid interface cultures of primary bronchial epithelial cells (ALI-PBEC) were daily exposed to whole 
cigarette smoke (CS) or air as a control (AIR) during differentiation for 13-19 consecutive days. (A) Each day trans-
epithelial electrical resistance (TEER) measurements were performed ~18 h after the previous CS exposure. Data 
are expressed as Ω*cm2. Open circles: air-exposed controls, black circles: CS-exposed cell cultures;  n=8 different 
donors. Significance was determined using a two-way ANOVA and Bonferroni post-hoc test. (B) At several time-
points during differentiation apical washes were collected and assessed for LDH content. Open circles: air-exposed 
controls, black circles: CS-exposed cell cultures;  n=6 different donors. Statistical differences were evaluated using 
a two-way ANOVA and Bonferroni post-hoc test. * p<0.05, ** p<0.01 between AIR and CS. (C) At day 7 and Day 
13 (~18 h after the last CS exposure), IL-8 protein levels were assessed by ELISA in the basal medium of the ALI-
PBEC cultures. Open bars are air-exposed controls, grey bars are chronic CS-exposed cultures; n=8 different donors. 
Statistical differences were tested using a paired t-test. * p<0.05. (D) Illustrating phase contrast light microscopy 
images showing the increasing effects of 13 days of CS exposure (CS) or air as a control (AIR) on cell morphology 
in some donors. (E) At several time-points during differentiation, cells were lysed and RNA was isolated followed by 
cDNA synthesis, to assess gene expression of RNASE7, CAMP (LL-37) and DEFB4 (human beta defensin-2). Data are 
shown as target gene expression normalized for the geometric mean expression of the reference genes ATP synthase, 
H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B), β2-microglobulin (B2M) and Ribosomal 
Protein L13a (RPL13A), n=8 different donors. Statistical differences were evaluated using a two-way ANOVA and 
Bonferroni post-hoc test. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 between AIR and CS.
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Supplementary Figure 4. Persistence of cigarette smoke-induced changes in airway epithelial HDP expression and 
cellular composition. (A) Primary bronchial epithelial cells (PBEC) were cultured at the air-liquid interface (ALI) 
and exposed during differentiation for 13 consecutive days to whole CS after which cultures were continued for 
another 6 days without CS exposure. Cells were lysed at several points during this course of time and RNA was 
isolated followed by cDNA synthesis, to assess gene expression of the cell specific markers: TP63, KRT5 (basal cells) 
and KRT8 (intermediate cells), the HDPs: DEFB1 (human beta-defensin 1) and LCN2 (lipocalin 2). Open bars: air-
exposed controls (AIR), black bars: CS-exposed cell cultures (CS), grey bars: CS-exposed cultures that were cultured 
for an additional week without CS exposure (CS cessation). Data are shown as target gene expression normalized for 
the geometric mean expression of the reference genes ATP synthase, H+ transporting, mitochondrial F1 complex, 
beta polypeptide (ATP5B), β2-microglobulin (B2M) and Ribosomal Protein L13a (RPL13A); n=8 different donors. 
Statistical differences were evaluated using a two-way ANOVA and Bonferroni post-hoc test. * p<0.05, **** p<0.0001. 
(B) ALI-PBEC were air exposed at day 0 and cultured for 7 days under standard conditions. At day 7 cultures were 
exposed to CS for 12 consecutive days after which the cells were lysed and similar analyzed as in (A). Grey bars: T=0 
(day 7), open bars: air-exposed controls (AIR), black bars: CS-exposed cell cultures (CS). Data are shown as target 
gene expression normalized for the geometric mean expression of the reference genes ATP5B, B2M and RPL13A. 
n=6 different donors. Statistical differences were evaluated using a two-way ANOVA and Bonferroni post-hoc test. * 
p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. 

CHAPTER 6
Cigarette smoke modulates repair and innate 
immunity following injury to airway epithelial cells.
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Cigarette smoking is the main risk factor associated with chronic obstructive pulmonary 
disease (COPD), and contributes to COPD development and progression by causing 
epithelial injury and inflammation. Whereas it is known that cigarette smoke (CS) may affect 
the innate immune function of airway epithelial cells and epithelial repair, this has so far 
not been explored in an integrated design using mucociliary differentiated airway epithelial 
cells. In this study, we examined the effect of whole CS exposure on wound repair and the 
innate immune activity of mucociliary differentiated primary bronchial epithelial cells, upon 
injury induced by disruption of epithelial barrier integrity or by mechanical wounding. Upon 
mechanical injury CS caused a delayed recovery in the epithelial barrier integrity and wound 
closure. Furthermore CS enhanced innate immune responses, as demonstrated by increased 
expression of the antimicrobial protein RNase 7. These differential effects on epithelial repair 
and innate immunity were both mediated by CS-induced oxidative stress. Overall, our 
findings demonstrate modulation of wound repair and innate immune responses of injured 
airway epithelial cells that may contribute to COPD development and progression.
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Smoking has been shown to increase epithelial inflammation and injury, and has been 
suggested to disrupt the host defense function of the airway epithelium (1, 2). These effects 
may be highly relevant for our understanding of the development of smoking-induced lung 
diseases (3), including chronic obstructive pulmonary disease (COPD), an inflammatory 
lung disorder that is characterized by a progressive and irreversible obstruction of airflow 
(4). Changes in the airway epithelium resulting from exposure to smoke are early and key 
events in the development and progression of COPD (5, 6). Airway epithelial cells, which 
line the surface of the respiratory tract, normally function as the first host defense barrier 
against respiratory pathogens (2). However, extensive epithelial injury, for instance caused 
by cigarette smoking, respiratory pathogens and inflammation, may lead to disruption of the 
epithelial barrier integrity and cell death (7-9). Upon injury, a rapid wound repair process is 
initiated during which airway epithelial cells produce innate immune mediators to enhance 
host defenses at the wounded area (10). These repair responses are essential for restoration 
of the barrier function of the epithelium, and subsequent regeneration of a pseudostratified 
layer of epithelial cells. However, the repair process might be altered directly by CS exposure 
or indirectly by CS-induced inflammation, and this modulation of repair might contribute 
to COPD development and progression by promoting epithelial remodeling and persistent 
airway inflammation. 
The direct effects of CS on wound repair of airway epithelial cells have been primarily studied 
by applying an aqueous extract of CS on undifferentiated submerged cultures of airway or 
alveolar epithelial cell lines or primary airway epithelial cells (7, 11, 12). However, to gain 
more insight in the effect of smoking on airway epithelial repair, further research is required 
using conditions that better reflect the local conditions in lungs of smokers. Air-liquid 
interface cultures of mucociliary differentiated primary bronchial epithelial (ALI-PBEC) 
represent a widely accepted model to investigate airway epithelial cell functioning in lung 
diseases (2, 5). These cultures are highly similar to the airway epithelium of the small and 
large conducting airways, and display a pseudostratified morphology including ciliated, 
secretory, intermediate columnar and basal cells (BCs) (13, 14). We have used exposure of 
ALI-PBEC cultures to whole CS to better mimic smoke exposure in vivo (9, 15). Using this 
model, we have previously shown epithelial injury and transient disruption of the epithelial 
barrier integrity upon acute exposure to whole CS (9). This response was accompanied by 
epidermal growth factor receptor (EGFR)-mediated expression of innate immune mediators, 
including expression of the neutrophil chemoattractant C-X-C Ligand 8 (CXCL8, or IL-8) 
and selective expression of the antimicrobial protein Ribonuclease 7 (RNase 7) by BCs present 
in ALI-PBEC cultures. These findings provided important evidence for a dual function of 
airway BCs in epithelial repair and innate immunity that requires further investigation (16). 
Especially, the influence of CS on the dual function of airway epithelial BCs in mediating 
wound repair and innate immunity is of interest in view of the development of smoking 
related diseases such as COPD. 
In the present study we examined the effect of epithelial exposure to whole CS on repair 
and induction of innate immune responses by wounded ALI-PBEC cultures. Epithelial injury 
was induced by disrupting the epithelial barrier integrity, via disruption of cell junctions 
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or via mechanical wounding of epithelial layers. EGFR-induced innate immune responses 
were examined by determining the expression of the BC-specific mediator RNase 7 and the 
luminal airway epithelial cell- and BC-expressed chemokine IL-8. In addition, the role of BCs 
in wound repair after mechanical injury was determined by assessment of the number of BCs 
at the wound edge. Moreover, we studied the contribution of oxidative stress and EGFR signal 
transduction to wound repair and innate immune responses.
MATERIALS AND METHODS
ALI-PBEC and whole CS exposure model
Primary bronchial epithelial cells (PBEC) were isolated from macroscopically normal lung 
tissue obtained from patients undergoing resection surgery for lung cancer at the Leiden 
University Medical Center. Use of such lung tissue that became available for research within the 
framework of patient care was in line with the “Human Tissue and Medical Research: Code of 
conduct for responsible use” (2011) (www.federa.org), that describes the no-objection system 
for coded anonymous further use of such tissue. PBEC were cultured and differentiated at the 
air-liquid interface as previously described (9, 17). In short, cells at passage 2 were seeded at 
a density of 40.000 cells/0.9 cm2 on 0.4 µm pore sized semi-permeable transwell membranes 
(Corning Costar, Cambridge, MA, USA) that were coated with a mixture of 30 µg/ml PureCol 
(Advanced BioMatrix, San Diego, CA, USA), 10 µg/ml bovine serum albumin (BSA) (Sigma-
Aldrich, St. Louis, MO, USA) and 10 µg/ml fibronectin (isolated from human plasma) in PBS. 
Cells were cultured in Bronchial epithelial growth medium (BEGM) (Lonza, Verviers, Belgium) 
and Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Bleiswijk, The Netherlands) (1:1 
mixture) containing 1 mM Hepes (Lonza) and supplemented with SingleQuot supplements 
and growth factors according to the manufacturer’s instructions (bovine pituitary extract 
[BPE], hydrocortisone, human epidermal growth factor [hEGF], epinephrine, transferrin, 
insulin, T3 and retinoic acid; all from Lonza), and additional 15 ng/ml retinoic acid (Sigma-
Aldrich), 1 mg/ml BSA (Sigma-Aldrich), 100 U/mL penicillin and 100 µg/ml streptomycin 
(Lonza). Cells were first cultured in submerged conditions until confluence, followed by air-
exposed culturing during 2-3 weeks to allow mucociliary differentiation. Exposure of ALI-
PBEC to whole cigarette smoke (CS) was done according to a previously described model (9). 
In this model, ALI-PBEC were placed in exposure chambers and exposed to air (control) or 
whole cigarette smoke (CS) derived from one cigarette (3R4F reference cigarettes, University 
of Kentucky, Lexington, KY, USA) during a period of 15 minutes. Following exposure, the 
culture medium was refreshed. 
Calcium switch assay
The effect of disruption of the epithelial barrier integrity was examined using the calcium 
switch assay (18). In brief, ALI-PBEC were incubated for 15-30 minutes with 700 µL of 
calcium-free minimum essential medium (Gibco) that was added at the apical side and 1000 
µL in the basolateral compartment to deprive cells of calcium to disrupt cell-cell contacts. 
Epithelial barrier disruption was determined by measuring the trans-epithelial electrical 
resistance (TEER) using MilliCell-ERS (Millipore, Bedford, MA, USA). After a complete 
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loss of the barrier integrity, the apical medium was removed and cells were exposed to air 
or CS. Following exposure, the basal medium was replaced with calcium-containing culture 
medium with growth factors to allow reformation of junctions. 
Wound healing assay 
Wound healing assays were performed according to a previously described protocol (7), 
adapted for use in ALI-PBEC. In brief, the apical side of ALI-PBEC cultures was washed 
with PBS, and cells were starved for growth factors overnight in starvation medium 
(supplemented BEGM:DMEM without BPE and hEGF). 500 µL PBS was added to the apical 
surface of ALI-PBEC to facilitate mechanical injury, which was induced by scraping the 
cell layer with a sterile Pasteur pipette with a soft tip, creating a wound with a diameter of 
3 mm. After wounding, the apical surface of the cultures was washed with 200 µL PBS to 
remove cellular debris. In designated experiments, 10 mM of N-acetylcysteine (NAC) (Sigma 
Aldrich) was used to determine the role of oxidative stress. To investigate EGFR and ERK 
signaling, cells were incubated with AG1478 (EGFR tyrosine kinase inhibitor) or U0126 
(MEK1/2 inhibitor) (both Calbiochem, Darmstadt, Germany). After wounding, ALI-PBEC 
cultures were exposed to whole CS, and culture medium was replaced by fresh starvation 
medium, including additional inhibitors as indicated. For live imaging experiments, images of 
wounded ALI-PBEC were acquired using a Leica DM16000 phase-contrast light microscope 
(Leica Microsystems, Wetzlar, Germany), collecting digital images of the wound every 15 
minutes up to 48 hours. During this period, cells were placed inside a micro cell incubator at 
37°C in a 7.5% CO2 humidified atmosphere. The acquired images were used to create a time-
lapse movie. For other wound healing experiments, digital images were collected on a digital 
camera connected to an inverted phase-contrast light microscope using Cell Sense Entry 
imaging software (both Olympus, Tokyo, Japan), at time 0, 6, 24 and 48 h after wounding. The 
surface of the wound area was measured using Photoshop CS6 (Adobe, San Jose, California, 
USA) in order to assess remaining wound size and wound closure rates.
Immunofluorescence confocal imaging
Immunofluorescence staining of wounded ALI-PBEC was conducted as previously described 
(9). Cells were stained with a monoclonal anti-rabbit p63 antibody (ab124762, Abcam, Cam-
bridge, UK) (1:100) to detect BCs, and DAPI to stain all nuclei. Z-stack images of the wound 
edge were made using a Leica TCS SP5 confocal inverted microscope (Leica Microsystems, 
Wetzlar, Germany) and processed using the Leica Application Suite Advanced Fluorescence 
software (LAS AF; Leica Microsystems). Five random images of air and CS-exposed wound-
ed ALI-PBEC were used from independent donors to determine the number of p63+ cells. 
The percentage of p63+ nuclei was determined at the leading wound edge and at a randomly 
selected unwounded area. Moreover, the average number of p63+ cells at the wound edge was 
calculated per 400 µm, and the internuclear distance between a p63+ cell at the leading wound 
edge and its first adjacent p63+ cell was quantified in approximately 20-30 nuclei per image. 
Further explanation of this method is provided in Supplementary Figure 2.
Quantitative real-time PCR
RNA extraction, cDNA synthesis and quantitative real-time PCR (qPCR) was conducted as 
described previously (9). mRNA expression was examined for the genes described in Table 
132
CHAPTER 6
S1. Relative gene expression compared to reference genes ATP5B and RPL13A was calculated 
according to the standard curve method. Reference genes were selected using the “Genorm” 
software (19). 
Western blot
Western blot analysis of EGFR and ERK1/2 phosphorylation was done as previously described 
(9). The following primary antibodies were used: rabbit monoclonal Ab EGFR #D38B1 
(1:1000), rabbit polyclonal phospho-EGFR #2234 , rabbit polyclonal ERK1/2 #9102 (1:1000), 
and rabbit polyclonal phospho-ERK1/2 #9101 (all Cell Signalling, Leiden, The Netherlands). 
Protein bands were quantified by densitometry using ImageJ software (National Institutes of 
Health, Bethesda, MD, USA). 
ELISA
Secretion of IL-8 (R&D, Minneapolis, MN, USA) was determined according to the 
manufacturer’s protocol. 
Statistics
Data were analyzed using GraphPad Prism 6.0 (GraphPad Inc., La Jolla, CA, USA). Statistical 
tests used for data analysis were 2-way ANOVA, with post-hoc Bonferroni correction for 
multiple analyses. Differences with a p-value < 0.05 were considered as statistically significant
RESULTS
Cigarette smoke delays barrier recovery and enhances innate immune responses by ALI-PBEC
We first used a calcium switch assay to determine the effect of CS on recovery of the airway 
epithelial barrier, and to explore the importance of the loss of barrier integrity for the induction 
of RNase 7 and IL-8. In this assay, calcium-depleted culture medium was applied at the apical 
surface and basal compartment of ALI-PBEC, resulting in a complete impairment of the 
airway epithelial barrier integrity as determined by measuring the trans- epithelial electrical 
resistance (TEER). Subsequently, cells were exposed to CS or air as negative control. The effect 
of CS on barrier recovery was determined at different time points, and induction of innate 
immune responses was assessed at 24 h. Both air- and CS-exposed ALI-PBEC displayed 
complete recovery of the airway epithelial barrier integrity 24 h after barrier disruption 
(Figure 1A). However, CS exposure caused a delay in this recovery at 6 h after exposure, 
which was significantly different compared to air-exposed cells. Assessment of RNase 7 
mRNA expression demonstrated a significantly higher expression in CS-exposed ALI-PBEC 
incubated with calcium-depleted medium (Figure 1B). In control cultures, we did not detect 
CS-induced expression of RNase 7 at 24 h; in a previous study we also no longer detected 
CS-induced expression of RNase 7 at this time point (9). Similar to RNase 7, we observed 
enhanced secretion of IL-8 in the basal medium upon barrier disruption and CS exposure 
(Figure 1C). Overall, these findings suggest that CS delays restoration of epithelial barrier 
function following calcium deprivation, while further increasing innate immune responses.
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Cigarette smoke delays repair and further increases RNase 7 expression in ALI-PBEC
To further examine epithelial repair and induction of innate immune responses in wounded 
airway epithelial cells, we used a wound healing model in which ALI-PBEC cultures were 
mechanically injured by applying circular wounds. In this model, ALI-PBEC displayed 
intrinsic wound healing, and full wound closure was observed within approximately 48 h, as 
measured by live imaging (Supplementary Figure 1). Whole CS exposure directly following 
epithelial injury impaired wound healing of ALI-PBEC during the first 24 h after exposure 
(Figure 2A,B), with significantly decreased wound closure rates during the first 6 h after 
CS exposure, but not at later time intervals (Figure 2C). Live imaging experiments further 
demonstrated impaired wound repair at early time points, with recovery of wound closure 
rates approximately 6 h after CS exposure (Figure 2D). Next, we determined the effect of CS 
exposure following mechanical injury on mRNA expression of RNase 7 and protein secretion 
of IL-8. Comparison between intact and wounded cultures demonstrated significant higher 
CS-induced mRNA expression of RNase 7 in wounded ALI-PBEC at 6 h after exposure 
(Figure 2E). In contrast, we did not observe such an effect on IL-8 protein secretion (Figure 
2F). Taken together, these findings further demonstrate impairment of epithelial repair upon 
CS exposure, which was accompanied by induction of RNase 7, but not of IL-8.
p63+ cells at the wound edge are increased in CS exposed ALI-PBEC
Previously, we reported cell-type specific expression of RNase 7 by BCs in response to CS, 
whereas expression of IL-8 was observed in both luminal cells and BCs (9). The selective 
increase in RNase 7 expression in CS-exposed wounded cells suggests that CS in particular 
affects the activity of BCs in wounded ALI-PBEC. Therefore, we next examined the 
contribution of BCs to wound repair of ALI-PBEC. This was determined by assessing the 
Figure 1. Effects of CS on airway epithelial barrier recovery and innate immunity. Barrier integrity in ALI-PBEC 
was disrupted using calcium depletion, and cells were subsequently exposed to air or CS. (A) The trans-epithelial 
electrical resistance (TEER) was subsequently measured at 0, 3, 6, and 24 h after exposure to assess loss and recovery 
of barrier integrity in air- and CS-exposed cultures. TEER values in ohm (Ω). n = 7 independent donors. (B) At 24 h, 
mRNA expression of RNASE7 was assessed in ALI-PBEC that were incubated with calcium-depleted medium (w/o 
Ca2+) versus control medium (ctrl), and subsequently exposed to either air or CS and further incubated in calcium 
containing medium. Normalized mRNA expression compared to RPL13A and ATP5B is depicted in the graph. n = 
4 independent donors. (C) Secretion of IL-8 in the basal culture medium was assessed by ELISA. n = 5 independent 
donors. Data are shown as mean; error bars represent SEM; experiments were conducted using duplicate exposures 
in all donors, * p < 0.05.
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Figure 2. Effect of CS on airway epithelial wound healing and innate immunity. ALI-PBEC were mechanically injured 
and subsequently exposed to air (control) or whole cigarette smoke (CS). (A) Phase-contrast light microscopy images 
were made of air- and CS-exposed ALI-PBEC at 0, 6, 24 and 48 h after exposure. (B) Wound closure is shown 
in percentage in air- versus CS-exposed cells and (C) wound closure rate in percentage per hour at different time 
intervals was calculated. n = 8 independent donors. (D) Wound closure rates per hour in air- and CS-exposed ALI-
PBEC up to 12 h after exposure were determined using live imaging. n = 7 independent donors. (E) RNASE7 mRNA 
expression was determined in intact or wounded ALI-PBEC exposed to air or CS, at 6 h after exposure. Values 
shown represent normalized mRNA expression compared to RPL13A and ATP5B. n = 7 independent donors. (F) 
IL-8 secretion was determined in the basal culture medium. n = 9 independent donors. Data are shown as mean; 
error bars represent SEM; experiments were conducted in duplicate i, * p < 0.05.
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number of cells at the wound edge that stained positive for the nuclear BC-marker p63 (Figure 
3A and Supplementary Figure 2). The majority of cells (approximately 80%) directly located 
at the wound edge stained p63+, which was a significantly higher proportion compared to 
intact areas of the same culture (appr. 35%) (Figure 3B). In CS-exposed cultures, p63+ cells 
appeared to accumulate in higher numbers at the wound edge (Figure 3C). Moreover, we 
observed in CS-exposed cells significant smaller internuclear distances between p63+ cells 
located at the leading wound edge and located directly adjacent to the wound edge (Figure 
3D and Supplementary Figure 2 for explanation of the method). These observations suggest 
that CS impairs spreading and migration of BCs, a process that is important especially in the 
initial phase of wound repair. Collectively, these findings suggest that CS not only affects the 
innate immune function of BCs during repair, as shown by increased expression of RNase 7, 






































































Figure 3. p63+ cells at the wound edge of ALI-PBEC. (A) Immunofluorescence staining for p63 (green) and nuclei 
(blue (DAPI)) of mechanically injured ALI-PBEC. (B) Percentage of p63+ cells at the first line of cells directly at the 
wound edge or in intact areas, in air- versus CS-exposed cells. (C) Number of p63+ cells and p63- cells at the wound 
edge per 400 μm length of wound edge, in air- versus CS-exposed cells. (D) Internuclear distance in μm between p63+ 
cells located directly at the leading wound edge and the first adjacent p63+ cell. All graphs: data are shown as mean; 
error bars represent SEM, experiments were conducted in duplicate, n = 3 independent donors, * p < 0.05.
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Cigarette smoke differentially affects wound repair and innate immune responses through 
oxidative stress
To understand the mechanism of CS-mediated modulation of wound repair and innate 
immune responses we next examined the role of oxidative stress. The presence of oxidative 
stress upon CS exposure was demonstrated indirectly by showing CS-induced mRNA 
expression in wounded ALI-PBEC of heme oxygenase (decycling) 1 (HMOX1) and smoke 
and cancer-associated IncRNA-1 (SCAL1), both target genes of the oxidative stress-dependent 
Nrf2 pathway (20, 21). This induction by CS was blunted by treatment with the antioxidant 
N-acetylcysteine (NAC), suggesting involvement of oxidative stress (Figure 4A,B). Treatment 
with NAC in CS-exposed cultures partially restored wound repair (Figure 4C). In contrast, 
CS-induction of RNase 7 in wounded ALI-PBEC was completely inhibited by NAC (Figure 
4D), and also CS-induced IL-8 mRNA expression was significantly inhibited (Figure 4E). 
These findings demonstrate a differential effect of CS-induced oxidative stress on wound 



















































































































Figure 4. Role of CS-induced oxidative stress in modulating airway epithelial repair and innate immunity. Wounded 
ALI-PBEC were pre-incubated with NAC (10 mM) and subsequently exposed to air or CS. mRNA expression of 
the oxidative stress-induced genes (A) HMOX1 and (B) SCAL1 was determined 6 h after exposure. Values shown 
represent normalized mRNA expression compared to RPL13A and ATP5B. n = 3 independent donors, * p < 0.05. (C) 
Wound closure in presence or absence of NAC (10 mM) 6 h after wounding, in air- versus CS-exposed cells. Data 
are shown as percentage wound closure compared to t = 0 h. n = 7 independent donors. (D) mRNA expression of 
RNASE7 and (E) CXCL8 was assessed in wounded ALI-PBEC incubated with NAC (10 mM), at 6 h after exposure 
to air or CS. Data are shown as normalized mRNA expression compared to RPL13A and ATP5B. n = 3 independent 
donors. In all graphs data are shown as mean; error bars represent SEM; experiments were conducted in duplicate; 
* p < 0.05.
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EGFR- and ERK1/2-dependent signaling are required for wound repair and innate immune 
responses
The epidermal growth factor receptor (EGFR) and downstream MAP-kinase/extracellular 
signal-regulated kinase (ERK)1/2 signaling pathway are important in both wound repair and 
induction of innate immune responses (10). Therefore, we examined the role of EGFR and 
ERK1/2 in the repair and induction of innate immune responses in wounded ALI-PBEC. First, 
the contribution to the intrinsic wound repair of ALI-PBEC was demonstrated by inhibitor 
experiments, showing impaired wound healing in the presence of AG1478 (EGFR tyrosine 
kinase inhibitor) and U0126 (Mitogen activated protein kinase/ERK kinase (MEK)1/2 
inhibitor) (Figure 5A). As CS completely impaired wound healing at 6 h, we did not observe 
an additional effect of EGFR or MEK1/2 inhibition. In agreement with our previous study (9), 
CS-induced mRNA expression of RNase 7 in wounded ALI-PBEC cultures was significantly 
inhibited upon EGFR and ERK1/2 inhibition (Figure 5B). We subsequently determined EGFR 
and ERK1/2 phosphorylation in wounded ALI-PBEC. Phosphorylation of both proteins was 
observed in CS-induced wounded ALI-PBEC (Figure 5C-E). EGFR inhibition completely 
suppressed ERK1/2 phosphorylation in air-exposed cells, whereas in CS-exposed cells only 
a partial inhibition was observed. In contrast, inhibition of ERK1/2 phosphorylation did not 
Figure 5. EGFR and ERK1/2 signaling in wounded ALI-PBEC. (A) Intrinsic wound healing of ALI-PBEC was 
determined in the presence of the EGFR tyrosine kinase inhibitor AG1478 (1 µM) or the MEK1/2 inhibitor U0126 
(25 µM) at 6 h after exposure with either air or CS. Data are shown as percentage wound closure compared to t = 
0 h. (B) mRNA expression of RNASE7 was determined by qPCR. Data are shown as normalized mRNA expression 
compared to RPL13A and ATP5B. (C) Western blot analysis of EGFR and ERK1/2 phosphorylation of wounded 
ALI-PBEC exposed to air or CS in the presence of AG1478, U0126, and NAC, at 6 h after exposure. (D) Bands were 
quantified by densitometry for analysis of EGFR and (E) ERK1/2 phosphorylation and corrected for total-EGFR 
and total-ERK1/2, respectively. For all graphs data are shown as mean; error bars represent SEM; experiments were 

































































































































































affect EGFR phosphorylation. The contribution of CS-induced oxidative stress to EGFR and 
ERK1/2 phosphorylation was determined by examining the effect of antioxidant treatment. 
CS-induced EGFR phosphorylation in wounded ALI-PBEC was not altered by NAC (Figure 
5C-E), whereas NAC did decrease CS-induced ERK1/2 phosphorylation. This suggests an 
EGFR-independent activation of ERK1/2 mediated by oxidative stress. In summary, these 
findings indicate involvement of EGFR- and ERK1/2 signaling in intrinsic wound healing, 
and in CS-induced innate immune responses during repair. Moreover, CS increases ERK1/2 
phosphorylation in both an EGFR-dependent and -independent pathway mediated in part by 
oxidative stress (Figure 6).
DISCUSSION
In this study we examined the effect of whole CS exposure on wound repair and innate 
immune responses of injured ALI-PBEC cultures. We observed a detrimental effect of acute 
CS exposure on the restoration of the epithelial barrier integrity and wound closure after 
mechanical wounding. In contrast, induction of innate immune responses, in particular 
expression of RNase 7, was further enhanced in CS-exposed injured ALI-PBEC. The 
impairment of epithelial repair in the mechanical injury model was accompanied by an 
accumulation of BCs at the wound edge. Moreover, oxidative stress contributed to the CS-
induced attenuation of wound repair and the induction of innate immune responses. Both 
intrinsic wound repair and CS-induced innate immune responses required EGFR- and 
ERK1/2 mediated signal transduction.
Whole CS exposure of ALI-PBEC attenuated airway epithelial repair, in particular during 
the first 6 h following CS exposure. Such a transient effect of CS is in line with our previous 
study, in which CS was shown to transiently affect the epithelial barrier integrity followed 
by restoration within 24 h (9). Oxidative stress contributed to the observed effects of whole 
CS exposure on epithelial wound repair, as NAC partly reversed the observed induction of 
an anti-oxidant response and impairment of epithelial wound repair. This is in line with our 
previous findings in undifferentiated (submerged cultured) PBEC, using an aqueous extract 
of cigarette smoke (7), and suggest that findings made in these less physiological conditions 
remain relevant. 
In contrast to the suppressive effect of CS on epithelial repair, CS-exposure resulted in 
increased innate immune responses in injured airway epithelial cell layers. Following CS 
exposure, increased IL-8 secretion was observed in the calcium switch model, whereas 
increased expression of RNase 7 was detected in the calcium switch as well as the mechanical 
wound model. Previously, we reported cell type-specific expression of RNase 7 by BCs present 
in ALI-PBEC cultures (9). The current observation further suggests that BCs are particularly 
affected upon injury of ALI-PBEC. Indeed, BCs are regarded as a heterogenic population 
including epithelial progenitor cell of the pseudostratified airway epithelium (22, 23), and it 
is assumed that BCs repopulate denuded wound areas through cell spreading and migration 
after injury (24). In agreement with this, the majority of cells at the leading wound edge of 
injured ALI-PBEC stained positive for the BC marker p63. In line with earlier reports (7, 25), 
this could not be explained by increased proliferation, as only limited numbers of proliferating 
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cells were observed at the wound edge as assessed by BrdU incorporation (data not shown). 
However, p63+ cells displayed smaller internuclear distances upon CS exposure, suggesting 
that spreading and migration of BCs is impaired. Further studies are needed to determine 
whether cigarette smoke specifically targets subpopulations of BCs.
We speculate that the transient effect of CS in our model reflects the acute effects of smoking 
on the airway epithelium that is in a process of repair. Normally, BCs of the airway epithelium 
will close denuded wound areas through cell spreading before starting cell proliferation (26). 
However, primarily under the influence of oxidative stress caused by smoke exposure, the cells 
shift towards a different function, displaying reduced repair-promoting migratory activity but 
increased innate immune and cytoprotective anti-oxidant responses. The transient effect of 
CS on wound repair suggests recover of airway epithelial cells from mild damage that do not 
cause extensive cell injury and promote cell death. Indeed, CS exposure induced the expression 
of genes involved in the Nrf2-mediated antioxidant and survival response, which suggests 
that this response is involved in the restoration of wound repair following CS exposure. This 
mechanism may be impaired in COPD, since previous studies have reported attenuated Nrf2-
dependent antioxidant responses in the bronchial tissues from COPD patients compared 
to non-COPD smokers (27, 28). Moreover, it has been shown that COPD airway epithelial 
cells display reduced wound repair and epithelial barrier properties (29, 30). Therefore, it can 
be speculated that an impaired oxidative stress response is related to epithelial dysfunction 
during COPD disease progression. It needs to be noted that our experimental design was 
adapted to mimic the effects acute cigarette smoke exposure, and not that of the repeated 
exposures that are typical form smoker’s lungs. Further studies are needed to explore such 
effects during repeated CS exposure. Although the airway epithelial cells start to recover from 
the effects of CS in both the calcium switch and wound repair model at 6 h after exposure, 
induction of RNase 7 in BCs persisted at later time points. In particular, in the calcium switch 
assay enhanced expression of RNase 7 was observed at 24 h after smoke exposure, when 
the epithelial barrier integrity had recovered. This suggests that BCs display innate immune 
responses after the epithelium has recovered from injury. Epithelial injury results in activation 
of the EGFR signalling pathways in BCs, which is important for both wound closure and 
RNase 7 expression.
We propose that the reduced wound repair activity of the airway epithelium upon CS exposure 
increases the susceptibility of the epithelium and underlying tissues to microbial colonization 
and infections. The increased expression of the antimicrobial RNase 7 by BCs that occurs in 
parallel with impaired wound repair might be a compensatory mechanism to provide a last-
resort antibacterial defense against invading microbes. We did not study the host defence 
activity of CS-exposed and injured airway epithelial cells using functional assays. Therefore, 
further research is required to determine the additional effects of adding live microbes in our 
wound healing model, and the putative modulating effect of increased RNase 7 expression. 
Antimicrobial proteins and peptides such as RNase 7 display immunomodulatory and wound 
repair enhancing properties (31, 32). These responses might contribute to the wound repair 
process but might also contribute to cell injury when these mediators are produced in high 
amounts and/or during prolonged periods. There is however currently no evidence for other 
activities of RNase 7, and therefore further research is required to demonstrate this. We used 
mechanical wounding of the epithelial layer by scraping, which is widely used in studies on 
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repair but is obviously a less physiological relevant model of injury than e.g. bacterial or viral 
infection or repeated smoke exposure. An important advantage of the model is, however, that 
it allows creation of a defined wound and quantification of its repair. Another advantage is 
that it allows an analysis of the interaction between microbial infection or smoke exposure 
and wound repair.
Previously, we reported the importance of EGFR signaling in induction of innate immune 
responses by CS, which was mediated by downstream ERK1/2 activation (9). Antioxidant 
treatment did not reduce EGFR signaling, but did decrease ERK1/2 phosphorylation, 
suggesting an EGFR-independent activation of ERK1/2 by oxidative stress (Figure 6). Thus, 
although EGFR-signal transduction is critical in airway epithelial wound repair and innate 
immunity (33), these findings demonstrate that other signaling transduction pathways 
contribute to repair and might be affected by CS exposure. Further research on CS effects 
on other repair pathways is required, and might also elucidate the differential regulation of 















Figure 6. Proposed model. EGFR signaling is activated by CS and injury, and this leads to MEK1/2-mediated 
phosphorylation of downstream ERK1/2. CS furthermore directly causes phosphorylation and activation of ERK1/2 
via oxidative stress, which is independent of EGFR signaling. EGFR/ERK1/2-mediated wound repair is suppressed 
by CS via oxidative stress. In contrast, activation of ERK1/2 due to a combined effect of CS-induced oxidative stress 
and injury, results in an enhanced innate immune response. Solid lines represent the effect of CS, dashed lines the 
effect of injury. NAC, AG1478 and U0126 were used to inhibit oxidative stress, EGFR phosphorylation, and ERK/12 
phosphorylation respectively.
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In summary, our findings demonstrate disturbances in the repair of injured airway epithelium 
and epithelial innate immunity upon cigarette smoke exposure. Oxidative stress caused by 
smoking is a key mechanism in modulating these responses, and in particular affects the 
activity of basal cells. These findings contribute to our understanding of how the repair and 
innate immune activity of wounded airway epithelial cells can be affected by cigarette smoking 
and might contribute to the development and progression of COPD. 
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Supplementary Figure 1. Live imaging of intrinsic airway epithelial wound repair. (A) Primary bronchial epithelial 
cells (PBEC) were cultured and differentiated in an air-liquid interface (ALI) model, and subsequently mechanically 
wounded to assess wound repair. (B) The wound closure of ALI-PBEC was followed by live imaging at 0, 6, 12, 24, 36 
and 48 h after wounding. (C) Wound closure was determined each hour, up to 48 h, by live imaging. Data are shown 
as the percentage wound closure compared to t = 0. Data are shown as mean; error bars represent SEM; experiments 
were conducted in duplicate. N = 3 independent donors.
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Supplementary Figure 2. Quantification methods of p63+ cells in wounded ALI-PBEC. (A) Analysis of p63+ and 
p63- DAPI-stained nuclei at the leading wound edge. (B) Graphic example of how the internuclear distances were 
determined between p63+ cells located at the leading wound edge and p63+ cells that were perpendicular to the 
wound. p63+ cells at the leading wound edge were defined by the absence of other p63+ cells in the 45°-135° angle 
in its front perpendicularly to the wound edge. The most proximate p63+ cell that did not fulfill this definition 
was considered the reference cell to be selected for the measurement of the internuclear distance between adjacent 
p63+ cells. The distance between the outside edges of these two cells was regarded the internuclear distance. To 
prevent underestimation of distances in p63+ denser areas, each non-wound edge cell could be used only once for 
internuclear distance assessment, targeting overall at the lowest mean distance. The measurements were done in 5 
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Maintaining airway epithelial integrity is critical for lung defense. However, exposure to 
inhaled micro-organisms and toxicants constitutes a continuous threat to this defense. 
The integrated stress response (ISR) is a cellular mechanism that may contribute to the 
protection and recovery of airway epithelial cells upon injury. However, especially following 
chronic activation, the ISR may also mediate cell death. It has been proposed that the ISR 
contributes to the development and/or progression of the lung disorder chronic obstructive 
pulmonary disease (COPD). Moreover, it has been shown that prolonged exposure of 
cultured airway epithelial cells to cigarette smoke, which is the main risk factor of COPD, 
causes ISR-mediated cell death. This suggests a role of the ISR in smoke-induced effects on 
the airway epithelium that may contribute to COPD development. However, activation of the 
ISR has been investigated mainly in cell lines, while activation in primary airway epithelial 
cell cultures from COPD patients has not been studied. In the present study, we therefore 
further examined the influence of acute exposure to whole cigarette smoke or cigarette 
smoke extract on activation of the ISR in differentiated and undifferentiated airway epithelial 
cells respectively. We demonstrate that the ISR is activated in both smoke exposure models. 
Moreover, we observed higher expression of ISR-related target genes in whole smoke-exposed 
COPD cell cultures compared to controls, and provide data to propose a mechanism by which 
smoke-induced oxidative stress modulates the ISR. Taken together, our findings provide 
evidence for the involvement of activation of the ISR in the airway epithelial response to 
cigarette smoking and the importance of oxidative stress in modulating this response. More 
pronounced activation of the ISR in smoke-exposed epithelial cells from COPD patients, 
suggests involvement of the ISR in COPD pathogenesis. 
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INTRODUCTION
The airway epithelium is the first cellular defense lining of the respiratory tract and provides 
protection through its barrier function, mucociliary clearance, and innate immune defense 
mechanisms (1-4). Environmental stressors, including inhaled pathogens and cytotoxic 
particles and gases, may have detrimental effects on the airway epithelium, causing injury and 
promoting cell death (5). Adaptation of airway epithelial cells to stressors is therefore critical, 
and various intrinsic mechanisms provide protection from inhaled toxicants, including the 
detoxification by metabolic enzymes and antioxidants (6). 
The main risk factor for the development and progression of the inflammatory lung disorder 
chronic obstructive pulmonary disease (COPD) in Westernized societies is cigarette smoking 
(7). Various studies have provided evidence that cigarette smoke exposure results in activation 
of the unfolded protein response (UPR) to endoplasmic reticulum (ER) stress (8-11). It was 
shown that cigarette smoke extract may selectively activate the PERK arm of the UPR in 
the bronchial epithelial cell line BEAS-2B and that this could be inhibited by anti-oxidants 
(12). PERK is an ER stress-sensing kinase that phosphorylates the eukaryotic translation 
initiation factor 2 (eIF2) subunit, eIF2α (13). Since eIF2α can also be phosphorylated by other 
stress-sensing kinases (GCN2, HRI and PKR), the pathway starting with phosphorylation 
of eIF2α is also referred to as the integrated stress response (ISR) (14). Phosphorylation and 
inactivation of eIF2α leads to the protection of the cell by inducing a broad inhibition of protein 
translation. This inhibition may provide protection against e.g. the accumulation of misfolded 
proteins in the ER. Phosphorylation of eIF2α also results in activation of gene expression 
through selective translation of the transcription factor ATF4, resulting in production of the 
transcription factor C/EBP homologous protein (CHOP), that regulates expression of a range 
of genes including growth arrest and DNA damage-inducible protein 34 (GADD34) (15). 
Interestingly, the gene expression signature present in bronchial tissue from COPD patients 
is enriched for genes regulated by ATF4 (16). By dephosphorylating eIF2α, GADD34 enables 
the recovery of protein synthesis and thus controls the duration of ISR. In contrast, during 
sustained stress, recovery of protein translation by GADD34 may promote cell death (15). 
GADD34 is therefore a critical regulator of cell viability, which depends on the resolution or 
persistence of cellular stress. 
Although evidence suggests that the UPR and ISR can be activated by cigarette smoke (CS), 
many studies were performed in cell lines or undifferentiated primary cells using CS extract. 
Consequently, relatively little is known about activation of the UPR and ISR in differentiated 
primary airway epithelial cells by whole CS, or whether these responses are affected by the 
COPD status of the tissue donor. This is important, since we and others have shown that 
biochemical features of COPD may persist in epithelial cell cultures ex vivo (17). Moreover, 
the mechanistic relationship between CS and activation of the ISR remains obscure. 
In a previous study we showed that short-term exposure of airway epithelial cells to whole 
CS had a mild cytotoxic effect, while cells displayed transient inflammatory responses and a 
temporary impairment in the epithelial barrier integrity (18).  Activation of the ISR might 
contribute to this recovery of epithelial cells after acute CS exposure. Therefore, in the present 
study we examined ISR activation in airway epithelial cells during short-term exposures 
150
CHAPTER 7
to whole CS, and compared the activation of the ISR between cell cultures derived from 
individuals with COPD and non-COPD controls. We provide evidence that CS increases 
expression of GADD34 both via the classical ISR and via a non-ISR oxidative stress-dependent 
pathway. These findings suggest a new mechanism by which oxidative stress can modulate 
activation of the ISR. 
MATERIALS AND METHODS 
Cell culture
Primary bronchial epithelial cells (PBEC) were isolated from tumour-free resected lung 
tissue obtained during surgery for lung cancer, and cultured at the air-liquid interface (ALI-
) or submerged conditions (S-). Culturing of ALI-PBEC and S-PBEC was performed as 
previously reported (18). In ALI-PBEC cultures, cells were seeded on 0.4 µm pore sized semi-
permeable transwell membranes (Corning Costar, Cambridge, MA, USA) and first cultured 
in submerged conditions in a 1:1 mixture of bronchial epithelial growth medium (BEGM) 
(Lonza, Verviers, Belgium) and Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, 
Bleiswijk, The Netherlands) containing 1 mM HEPES (Lonza), 100 U/mL penicillin and 100 
µg/ml streptomycin (Lonza) (hereafter referred to as B/D culture medium), supplemented 
with singleQuot BEGM supplements (except Gentamycin) (Lonza), 15 ng/ml retinoic acid 
(Sigma-Aldrich) and 1 mg/ml BSA (Sigma-Aldrich). When monolayers were confluent, the 
apical medium was removed and cells were cultured in air-exposed conditions for at least 2 
weeks to allow mucociliary differentiation. In western blot experiments, cells were cultured 
overnight and during the experiment with starvation medium, consisting of B/D medium 
without BSA and the SingleQuot supplements BPE and EGF. ALI-PBEC cultures were used 
from COPD patients and non-COPD (ex)smokers, for whom the disease status was determined 
based on pre-surgery lung function data according to the Global Initiative for Chronic 
Obstructive Lung Disease classification (7) (Table 1). S-PBEC were cultured in regular tissue 
culture plates with B/D culture medium as earlier described, but without the additional 15 
ng/ml retinoic acid supplementation. Cells were used when approximately 80-90% confluent. 
In all experiments, S-PBEC were cultured overnight prior to the experiment and during the 
experiment with starvation medium, which was similar to ALI-PBEC starvation medium, 
but lacked the additional 15 ng/ml retinoic acid supplementation. eIF2αAA and eIF2αSS mouse 
embryonic fibroblasts (MEFs) were cultured as previously described (19). 
Cigarette smoke exposure models and other stimuli
ALI-PBEC cultures were exposed to whole cigarette smoke (CS) using an exposure model 
previously described (18). In short, cells were exposed to whole smoke derived from one 
standard research cigarette (3R4F), after which cells were incubated for the indicated periods 
of time. S-PBEC and MEF cultures were treated with cigarette smoke condensate (CSC), 
which was prepared as previously reported (20). Cells were treated with CSC via a “pulse” 
method described in Figure 4 and corresponding text in the Results section, similar to the 
whole CS exposure protocol. In indicated experiments, cells were pre-treated for 1 hour and 
treated during the experiment with the anti-oxidant N-acetylcysteine (NAC) (Sigma). As 
indicated, in some experiments cells were treated with thapsigargin (Tg) or tunicamycin (Tm) 
(both Sigma) as positive controls for ER stress
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Western blot
Cell lysates were prepared in Harvest Buffer (Buffer H), consisting of 10 mM HEPES pH 7.9, 
50 mM NaCl, 0.5 mM sucrose, 0.1 mM EDTA, 0.5% (v/v) Triton X-100, 1 mM DTT, Protease 
inhibitor cocktail (Roche Applied Science, Mannheim, Germany), phosphatase inhibitors (10 
mM tetrasodium pyrophosphate, 17.5 mM β-glycerophosphate, and 100 mM NaF), and 1 
mM PMSF. Nuclear extraction was performed using the NE-PER Nuclear Protein Extraction 
Kit (Thermo Scientific, Rockford, IL) according to the manufacturer’s protocol. Cell lysates 
were diluted in 4x sample buffer consisting of 0.2 M Tris-HCl pH 6.8, 16% [v/v] glycerol, 
4% [w/v] SDS, 4% [v/v] 2-mercaptoethanol and 0.003% [w/v] bromophenol blue. Samples 
were separated using a 10% SDS-PAGE gel and proteins were transferred onto nitrocellulose 
membrane. Primary antibodies were used against: eIF2α, phospho-eIF2α, ATF4, TBP (Cell 
Signaling Technology), GADD34 (ProteinTech) and puromycin (Millipore) (all 1:1000 
diluted). After secondary antibody incubation, proteins detection was visualized using ECL 
(ThermoScientific) or the LI-COR Odyssey Infrared Imaging System (LI-COR Biosciences). 
Quantification of protein bands was done by densitometry using ImageJ software (National 
Institutes of Health, Bethesda, MD, USA).
qPCR
RNA was isolated with the Maxwell tissue RNA extraction kit (Promega) or Qiagen RNeasy 
mini kit (Qiagen). cDNA synthesis and qPCR was performed as previously described (see 
Table 2 for qPCR primer pairs) (18, 19). Relative gene expression was calculated according to 
the standard curve method. ATP5B and RPL13A were selected using the “Genorm method” 
(Genorm; Primer Design, Southampton, UK) as reference genes for PBEC. β-actin was used 
as reference gene for MEFs.
ELISA & LDH release assay
Protein secretion of IL-8/CXCL8 (R&D systems), and LDH release (Roche) was determined 
in the cell culture medium according to the manufacturer’s protocol.
Statistics
Results were analyzed using GraphPad Prism 6.0 (GraphPad Inc). As indicated in the figures, 
statistical tests used for data analysis were (un)paired t-test or 2-way ANOVA, with post-hoc 
Bonferroni correction for multiple analyses. Differences with a p-value < 0.05 were considered 
statistically significant.
Table 1: Characteristics of COPD and non-COPD patients. 
COPD non-COPD p-value
Number of donors 7 6
Gender (females/males) 2/5 2/4
Age, years 58±7 67±9
FEV1, % predicted 64±11 96±20 < 0.002
FEV1/FVC % 53±8 76±4 < 0.0001
Patient characteristics: Age and lung function are shown as means ± SD. The mean differences in FEV1 (% predicted) 




Whole cigarette smoke exposure increases the ISR in ALI-PBEC 
We first examined the effect of whole cigarette smoke (CS) on activation of the integrated 
stress response (ISR) in mucociliary differentiated primary bronchial epithelial cells (ALI-
PBEC). Cell cultures were exposed to whole CS from a single cigarette (Figure 1A), which in 
previous studies was shown to cause an acute and transient disruption of the epithelial barrier, 
impairment of wound repair and induction of innate immune responses with minimal 
cytotoxic effects (17, 18, 21). An acute activation of the ISR upon CS exposure was detected 
based on the increased phosphorylation of eIF2α and nuclear accumulation of ATF4 within 
the first 2 hours after exposure (Figure 1B,C). In addition, a time-dependent expression of 
GADD34 and CHOP mRNA was observed, which continued to increase up to 2 hours after 
exposure (Figure 1D). In previous studies it has been shown that smoke-induced activation of 
the ISR pathway is induced by the unfolded protein response (UPR) to endoplasmic reticulum 
(ER) stress (12). Therefore, we further examined activation of the UPR by determining the 
expression of the UPR target gene BIP/GPR78 and splicing of XBP1 mRNA. We did not 
observe an increased expression of BIP nor increased splicing of XBP1 mRNA within the 2 
h timeframe that was examined (Figure 1E). Similar results were obtained when expression 
levels of BIP and spliced XBP1 were determined at 6 h after CS exposure, by which time the 
ER stress inducer tunicamycin was able to increase the expression of both markers in ALI-
PBEC (Figure 1F). In contrast, both the levels of CHOP and GADD34 mRNA expression were 
induced by both CS and tunicamyin at 6 hours. 
The persistence of CS-induced ISR activation was subsequently determined at time points 
ranging from 0-24 h post-CS exposure (Figure 2A) by determining GADD34 protein 
Table 2 qPCR primers




Bip/GRP78 CGAGGAGGAGGACAAGAAGG CACCTTGAACGGCAAGAACT 
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Figure 1. Effect of whole cigarette smoke (CS) exposure on ISR-activation in ALI-PBEC cultures. (A) Schematic of 
the whole CS exposure experiment, in which ALI-PBEC were exposed to CS from a single cigarette, followed by 
incubation for different time periods ranging from 15-120 min. (B) eIF2α phosphorylation was determined 15-
120 min after whole CS exposure. The ER stress inducing agent tunicamycin (TM) was used as positive control. 
Results were quantified by densitometry using total eIF2α as loading control. (C) Nuclear localization of ATF4 was 
determined 2 h after CS exposure. Results were quantified by densitometry using TATA binding protein (TBP) as 
loading control. (D) Analysis of GADD34 and CHOP, (E) BiP/GRP78 and sXBP1 mRNA expression 15-120 min 
after CS exposure. (F) mRNA expression of  GADD34, CHOP, BiP/GRP78 and sXBP1 after Air/CS exposure or TM 
after 6 h incubation period. Results are shown as mean ± SD of at least 3 different donors. Analysis of differences was 
conducted using (B,D,E) a one-way ANOVA with a Bonferroni post-hoc test and (C,F) a paired t-test. * p < 0.05, ** 
p < 0.01, *** p < 0.001, **** p <0.0005.
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expression, eIF2α phosphorylation, and puromycin incorporation as measurement of protein 
synthesis. Increased GADD34 protein expression was observed at 3 h and peaked at 6 h after 
CS exposure (Figure 2B,C). This was preceded by an earlier increase in CS-induced eIF2α 
phosphorylation (Figure 1B), which fell below baseline levels at 6-12 h before returning 
to baseline by 24 h (Figure 2B,C). CS exposure impaired protein synthesis, as reported by 
puromycin incorporation, and this inhibition was most prominent at 3 h after CS exposure 
but protein synthesis progressively recovered at 6, 12 and 24 h after exposure. Taken together, 
these findings suggest that acute exposure to whole CS causes a transient activation of the ISR.
COPD airway epithelial cells display higher CS-induced expression of CHOP and GADD34 
Next, we examined the induction of the ISR in ALI-PBEC from COPD patients and non-
COPD (ex)smokers by comparing expression of CHOP and GADD34 mRNA. ALI-PBEC were 
exposed to whole CS and mRNA expression levels were determined at 3, 12 and 24 h after 
exposure. In line with earlier observations, CS-induced CHOP and GADD34 expression was 
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Figure 2. Effect of whole CS exposure on protein translation in ALI-PBEC cultures. (A) Schematic of the experiment, in 
which ALI-PBEC were exposed to CS from a single cigarette, followed by incubation for different time periods ranging 
from 0-24 h. (B) Analysis of GADD34 protein expression, eIF2α phosphorylation, and puromycin incorporation as 
marker of protein translation. (C) Results were quantified by densitometry using total eIF2α as loading control. 
Experiments were conducted in 2 independent donors showing similar results.
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3A). A comparison between COPD and non-COPD airway epithelial responses demonstrated 
a significantly higher expression of GADD34 and CHOP in COPD airway epithelial cultures. 
In addition, and in line with this observation, we observed a negative correlation between CS-
induced GADD34 and CHOP expression and FEV1 (Figure 3B) and FEV1/FVC (Figure 3C). 
In addition to GADD34 and CHOP, we also determined the expression of PTGS2, DUSP5 
and cFOS, which have previously been found to be enhanced in airway epithelial tissue from 





































































































































































Figure 3. CS-induced expression of GADD34 and CHOP in COPD and non-COPD ALI-PBEC. (A) ALI-PBEC from 
COPD and non-COPD donors were exposed to whole CS and incubated for 3,12, and 24 h after which GADD34 and 
CHOP mRNA expression was determined. (B) Correlation between fold change in mRNA expression compared to 
air controls of GADD34 and CHOP mRNA, with FEV1 (% pred), and (C) FEV1/FVC (% pred). n=7 COPD and n=6 
non-COPD donors were used in the analysis. Analysis of differences was conducted using a one-way ANOVA with a 
Bonferroni post-hoc test. ** p < 0.01. Correlations were assessed by determining the linear regression.
156
CHAPTER 7
whereas expression of these genes was also transiently increased at 3 hours post-CS exposure, 
we did not observe differences in the expression of these genes between COPD patients and 
non-COPD controls (Supplementary Figure 1).
Cigarette smoke extract increases the ISR in submerged cultured PBEC
Although whole CS exposure of ALI-cultured PBEC may adequately mimic in vivo smoke 
exposure of epithelial cells in lung tissue, this model does not readily allow exploration of the 
mechanisms regulating ISR activation. Therefore we also determined the effect of short-term 
cigarette smoke exposure on ISR activation using cigarette smoke condensate (CSC), which 
can be used in conventional submerged cell cultures. First, we examined the effect of CSC 
on submerged cultured primary bronchial epithelial cells (S-PBEC), to determine whether 
activation of the ISR could be reproduced in this model. Similar to ALI-PBEC exposed to whole 
CS, S-PBEC were stimulated using a pulse exposure method in which cells were incubated with 
CSC for 15 minutes, after which the culture medium was refreshed and cells were incubated 
for different time periods (Figure 4A). This was done using CSC concentrations that in a 
previous study were shown to be cytotoxic to epithelial cells upon prolonged exposure (20). 
In contrast to prolonged exposures, pulse exposure only caused a mild cytotoxic effect based 
on the release of LDH in the culture medium (Figure 4B). However, CSC exposure of S-PBEC 
did cause a dose-dependent protein secretion of the neutrophil chemoattractant IL-8/CXCL8 
(Figure 4C). This was accompanied by an early and dose-dependent mRNA expression of 
IL8 (Figure 4D,E). These findings suggest that, similar to our studies using the whole CS 
exposure model (18), pulsed CSC stimulation also induces pro-inflammatory responses with 
minimal cytotoxic effects. We next determined ISR activation in S-PBEC stimulated with 
CSC by determining mRNA expression of CHOP and GADD34. Similar to IL8, GADD34 and 
CHOP mRNA expression was rapidly but transiently induced, reaching maximal levels at 3 
h after exposure (Figure 4D). Moreover, a dose dependent increase of GADD34 and CHOP 
mRNA expression was observed at 3 h after exposure (Figure 4E). Interestingly, in contrast to 
our observations with differentiated ALI-PBEC, CSC also increased mRNA expression of BIP 
and spliced XBP1, peaking at 6 h after exposure (Figure 4F). 
CSC –induced GADD34 expression occurs independent of the ISR 
Next, to gain insight into the mechanism by which CS induced expression of GADD34 and 
CHOP, we repeated the exposure to CSC experiments in MEFs, comparing wild type eIF2αSS 
cells with MEFs lacking the ability to phosphorylate eIF2α owing to mutation of serine-51, 
eIF2αAA (22). As expected, CSC induced expression of both CHOP and GADD34 in eIF2αSS 
MEFs, however, in eIF2αAA MEFs CSC remained able to induce GADD34 expression, but the 
induction of CHOP was lost (Figure 5A). Indeed, in eIF2αAA MEFs CSC induced GADD34 
at a concentration below that required to induce GADD34 in wild type cells. In line with 
this observation, increased levels of GADD34 protein was also observed in both eIF2αAA 
and eIF2αSS MEFs following (Figure 5B), suggesting that an ISR-independent mechanism 
contributes to CSC-induced GADD34 expression. 
ISR-deficient cells are known to be impaired in their response to oxidative stress (23).  It is also 
known that altered redox plays an important role in the cytotoxic effects of cigarette smoke 
(20). We therefore determined whether the ISR-independent expression of GADD34 might 
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Figure 4. Effect of CSC on ISR activation in undifferentiated S-PBEC. (A) Schematic of experiments with CSC pulse 
exposure of S-PBEC cultures. (B) Assessment of the cytotoxic effect of 1-10 AU/ml CSC on S-PBEC after 24 h 
incubation. Percentage LDH release was used as measurement of cytotoxicity. (C) Assessment of IL-8 protein release 
in the cell culture supernatant of S-PBEC stimulated with 1, 5 and, 10 AU/ml CSC and incubated for 24 h. (D) 
Assessment of IL8, GADD34 and CHOP mRNA expression at different time points (3-24 h) after 10 AU/ml CSC 
exposure of S-PBEC. mRNA expression is shown as fold chance compared to control-treated cells. (E) Assessment of 
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be mediated by oxidative stress. eIF2αAA and eIF2αSS MEFs were treated with the anti-oxidant 
N-acetylcysteine (NAC) and CSC in combination. CSC-induced expression of GADD34 was 
inhibited by NAC in both eIF2αAA and eIF2αSS MEFs (Figure 5C). In contrast, the ER stress 
activator thapsigargin induced GADD34 expression only in ISR-competent eIF2αSS and this 
induction was insensitive to NAC (Figure 5C). This finding suggests that CSC can modulate 
the ISR via oxidative stress-induced GADD34 expression.
DISCUSSION
In the present study, we have used two complementary cigarette smoke exposure models to 
show that that short-term exposures of airway epithelial cells to cigarette smoke results in 
activation of the ISR. Whole cigarette smoke rapidly caused ISR activation in ALI-PBEC, 
which declined at later time points. Moreover, during the recovery period we observed that 
the kinetics of eIF2α dephosphorylation and recovery of protein synthesis corresponded with 
that of GADD34 protein expression. This suggests that the transient activation of the ISR by 
smoke is attenuated by GADD34. 
We have previously shown that acute exposure to cigarette smoke caused a transient 
disruption of the epithelial barrier integrity in ALI-PBEC (18). Furthermore, we have shown 
that cigarette smoke transiently impaired epithelial wound repair by reducing cell migration 
(21). Interestingly, we found that recovery of epithelial barrier and wound repair functions 
were occurred 6 hours after exposure, which corresponds with the kinetics of GADD34 
protein expression and the recovery of protein translation it mediates. It is therefore tempting 
to speculate that GADD34-dependent recovery of protein translation might be responsible, 
at least in part, for the recovery of ALI-PBEC cultures following smoke exposure. However, 
we currently lack conclusive evidence that proves that GADD34 expression is cytoprotective 
in this context. 
We observed more pronounced expression of CHOP and GADD34 mRNA in ALI-PBEC 
cultures from COPD patients when compared to non-COPD controls, and a correlation 
between gene expression and lung function parameters. This finding is in line with our earlier 
study that detected an ATF4 gene signature within the airway of individuals with COPD, 
although GADD34 and CHOP were not part of the transcriptome data (16). Other genes, such 
as PTGS2, DUSP5 and cFOS, that were found to be increased in COPD airways (16), were not 
different between COPD and non-COPD cultures exposed to CS in the current study. This 
is likely reflects the existence of additionally signaling pathways acting upon epithelial cells 
in vivo that do no persist ex vivo. More pronounced activation of ISR in COPD cultures may 
report and innate increased susceptibility to cigarette smoke of some individuals, although 
IL8, GADD34 and CHOP mRNA expression in S-PBEC after stimulation with 1, 5, and 10 AU/ml CSC exposure and 
3 h incubation. mRNA expression is shown as fold chance compared to control-treated cells. (F) mRNA expression of 
BiP/GRP78 and sXBP1 at different time points (3-24 h) after 10 AU/ml CSC exposure of S-PBEC. mRNA expression 
is shown as fold chance compared to controls. Results are shown as mean ± SD using cells of at least 3 independent 
donors. Analysis of differences was conducted using a one-way ANOVA with a Bonferroni post-hoc test . * p < 0.05 
and ** p < 0.01.
 159 
ACTIVATION OF THE INTEGRATED STRESS RESPONSE CIGARETTE SMOKE 
7

















































































































Figure 5. ISR-independent expression of GADD34 in cigarette smoke condensate (CSC) exposure of MEFs. (A) 
Assessment of GADD34 and CHOP mRNA expression in eIF2αAA and eIF2αSS MEFs stimulated with 1,5 or 10 AU/ml 
CSC after pulse stimulation and followed by 24 h incubation. Results are shown as fold change in mRNA compared 
to control-treated cells. (B) Assessment of GADD34 protein expression in eIF2αAA and eIF2αSS MEFs stimulated with 
10 AU/ml CSC after pulse stimulation and followed by incubation at different time points. Results were quantified by 
densitometry using total eIF2α as loading control. (C) Assessment of the effect of N-acetyl cysteine (NAC) on CSC 
and thapsigargin (Tg)-induced expression of GADD34 in eIF2αAA and eIF2αSS MEFs after 8 h incubation. Results 
were quantified by densitometry using total eIF2α as loading control. Results are shown as mean ± SD of at least 3 
different experiments. Analysis of differences was conducted using a one-way ANOVA with a Bonferroni post-hoc 
test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p <0.0005.
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this might be considered out of keeping with a proposed protective role for the ISR during 
exposure to smoke. However, the chronicity stress has major effects both on the output of 
the ISR and on the pathological consequences of smoke, which may account for some of 
these apparent disparities (24).  For example, it is plausible that ISR-independent expression 
of GADD34 caused by oxidative stress may enhance the recovery of protein synthesis that 
would otherwise by inhibited by CS. Alternatively, a cytoprotective effect of the ISR during 
acute cigarette smoke exposure might support the persistence of other airway epithelial 
cells functions that contribute to COPD pathogenesis. It has been shown, for instance, that 
CHOP can regulate airway epithelial expression of CXCL8/IL-8 in airway epithelial cells (25, 
26). Moreover, the recovery of protein translation mediated by GADD34 has been shown 
to enable for the synthesis of innate immune mediators including IL-6, interferon-α and -β 
(27, 28). In addition, it has been shown that GADD34 knockout mice display reduced lung 
inflammation upon exposure to the cigarette smoke component acrolein (29). Overall, these 
studies suggest that both CHOP and GADD34 may contribute to inflammatory responses, 
and therefore increased expression in COPD airway epithelial cells may further enhance 
airway inflammation in response to cigarette smoke.
Similar to airway epithelial cells, CSC also increased expression of CHOP and GADD34 
in MEFs. This is in line with the non-cell type specific activation of the ISR by cigarette 
smoke, which has been shown in other cell types besides airway epithelial cells (8, 30). 
When examining the role of ISR activation in this response, using cells expressing a non-
phosphorylatable mutant of eIF2α, we demonstrated that GADD34 expression occurred 
independent of the ISR. This alternative pathway is dependent upon oxidative stress and can 
be inhibited by antioxidants. This effect could be reproduced in the airway epithelial cell line 
16HBE (Supplementary Figure 2A), suggesting conservation of this mechanism in airway 
epithelial cells. Previous reports have shown that activation of the p38 MAPK pathway led 
to increased expression of GADD34 (31). Indeed, CSC-induced activation of p38 in airway 
epithelial cells was shown to be oxidative stress-dependent (20), and therefore it is possible 
that this signaling axis is involved in the ISR-independent expression of GADD34. In 
experiments using the airway epithelial cell line 16HBE, we observed reduced CS extract-
induced GADD34 protein expression upon inhibition of p38 (Supplementary Figure 2B). 
However, further research is required to demonstrate this in primary airway epithelial cells. 
As oxidative stress has an important role in the induction of inflammatory responses in airway 
epithelial cells, it can be further speculated that the oxidative stress-mediated expression of 
GADD34 may contribute to this response. Moreover, persistent GADD34 expression induced 
by oxidative stress resulting from prolonged exposure to cigarette smoke may contribute to 
cell death by completely inhibiting activation of the ISR.
In summary, we have shown that ISR activation is part of the response of airway epithelial cells 
to cigarette smoke. This response is more pronounced in COPD airway epithelial cells and 
correlates with disease severity, suggesting a role of the ISR in COPD. Moreover, an oxidative 
stress-dependent and ISR-independent expression of GADD34 suggests the involvement of 
alternative mechanisms initiated by cigarette smoke exposure that may affect airway epithelial 
cell functions. 
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Supplementary Figure 1. CS-induced expression of ATF4-related and COPD enhanced target 
genes in COPD and non-COPD ALI-PBEC. ALI-PBEC from COPD and non-COPD donors 
were exposed to whole CS and incubated for 3, 12, and 24 h after which PTGS2, DUSP5 
and cFOS mRNA expression was determined. n=7 COPD and n=6 non-COPD donors were 
used in the analysis. Analysis of differences was conducted using a one-way ANOVA with a 
Bonferroni post-hoc test.
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Supplementary Figure 2. Effect of N-acetyl cysteine and p38 inhibition on cigarette smoke 
condensate-induced GADD34 expression in 16HBE. (A) Assessment of the effect of N-acetyl 
cysteine (NAC) on CSC and thapsigargin (Tg)-induced expression of GADD34 in the airway 
epithelial cell line 16HBE after 8 h incubation. (B) Assessment of the effect of the p38 inhibitor 
BIRB 796 on CSC and thapsigargin (Tg)-induced expression of GADD34 in the airway 
epithelial cell line 16HBE after 8 h incubation. Results were quantified by densitometry using 
total eIF2α as loading control. Results are shown as mean ± SD of 3 independent experiments. 
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Aberrant activity of a disintegrin and metalloprotease 17 (ADAM17), also known as 
TACE, and epidermal growth factor receptor (EGFR) has been suggested to contribute to 
chronic obstructive pulmonary disease (COPD) development and progression. The aim of 
this study was to investigate the role of these proteins in activation of primary bronchial 
epithelial cells differentiated at the air–liquid interface (ALI‐PBEC) by whole cigarette smoke 
(CS), comparing cells from COPD patients with non‐COPD. CS exposure of ALI‐PBEC 
enhanced ADAM17‐mediated shedding of the IL‐6 receptor (IL6R) and the EGFR agonist 
amphiregulin (AREG) toward the basolateral compartment, which was more pronounced 
in cells from COPD patients than in non‐COPD controls. CS transiently increased IL6R and 
AREG mRNA in ALI‐PBEC to a similar extent in cultures from both groups, suggesting that 
posttranslational events determine differential shedding between COPD and non‐COPD 
cultures. We show for the first time by in situ proximity ligation (PLA) that CS strongly 
enhances interactions of phosphorylated ADAM17 with AREG and IL‐6R in an intracellular 
compartment, suggesting that CS‐induced intracellular trafficking events precede shedding to 
the extracellular compartment. Both EGFR and ADAM17 activity contribute to CS‐induced 
IL‐6R and AREG protein shedding and to mRNA expression, as demonstrated using selective 
inhibitors (AG1478 and TMI‐2). Our data are consistent with an autocrine‐positive feedback 
mechanism in which CS triggers shedding of EGFR agonists evoking EGFR activation, in 
ADAM17‐dependent manner, and subsequently transduce paracrine signaling toward 
myeloid cells and connective tissue. Reducing ADAM17 and EGFR activity could therefore 
be a therapeutic approach for the tissue remodeling and inflammation observed in COPD.
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder characterized by 
irreversible airflow obstruction due to airway inflammation, infection, and tissue remodeling 
(1). Airway epithelial cells play a central role in the pathogenesis of COPD through a variety 
of mechanisms, including production of inflammatory mediators, antimicrobial peptides, and 
growth factors (2). Exposure of the lung tissue to triggers like cytotoxic particles and gasses, 
including cigarette smoke, microbes, and innate immune mediators (3-7) activate various 
matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs) 
expressed by airway epithelial cells (8, 9). The activity of MMPs and ADAMs contributes 
not only to proteolytic degradation of lung tissue, but also to regulation and processing of 
numerous receptor activating proteins (10-13). Through these various activities, MMPs 
and ADAMs are implicated in a broad spectrum of processes ranging from inflammatory 
responses to airway epithelial repair. It has been proposed that their aberrant activity might 
lead to chronic inflammation and abnormal tissue remodeling in the lungs of COPD patients 
(9).
One of the ADAMs, a ubiquitously expressed Zn2+‐dependent disintegrin and metalloprotease 
17 (ADAM17), formerly known as TNFα converting enzyme (TACE), is recognized as an 
important regulator of pulmonary inflammation, cell proliferation, and epithelial barrier 
function (5, 14). In bronchial epithelial cells, ADAM17 modulates these processes by cleaving 
membrane‐bound cytokines (TNFα), several EGF receptor (EGFR) agonists (TGF‐α, 
amphiregulin, epiregulin, HB‐EGF), cytokine receptors (IL6R, TNF‐R), growth factor 
receptors (NOTCH receptors), and adhesion proteins (L‐selectin, ICAM‐1, E‐cadherin) (11-
13, 15). Moreover, ADAM17 phosphorylation and activity is enhanced in airway epithelial 
cell lines and in undifferentiated primary cells upon exposure to cigarette smoke extract (5, 
6, 16).
Our studies focus on two ADAM17 substrates implicated in COPD pathogenesis: the IL‐6 
cytokine receptor (IL6R) and the growth factor amphiregulin (AREG), one of the EGFR 
agonists produced by bronchial epithelial cells (10). Elevated levels of IL6R have been 
observed in peripheral blood leukocytes of COPD patients (17), and recently genetic variants 
of IL6R have been linked with COPD severity (18). However, the regulation of shedding of 
IL6R and AREG from COPD airway epithelium has not been studied. Upon shedding from 
epithelial cells, IL6R and AREG activate the shared interleukin receptor gp130 and EGFR, 
respectively, on epithelial cells (autocrine), as well as on underlying myofibroblasts and 
myeloid cells (paracrine) (19-22). Both IL6/IL6R/gp130 and AREG/EGFR/ERK pathways are 
involved in the resolution of lung inflammation and repair of injury, but also in progression 
of subepithelial fibrosis and collagen deposition (7). These signaling pathways involve the 
JAK kinase and/or MAP kinase pathway, which are druggable targets in COPD pathology 
(23). Excessive ligand‐mediated EGFR activation results in epithelial hyperproliferation and 
increased production of the inducible mucin MUC5AC, processes observed in smokers with 
or without COPD (5, 6, 16, 21, 24-26). Moreover, EGFR activation results in subsequent 
transcriptional regulation of inflammatory mediators such as IL‐8 (10), a chemokine that has 
been implicated in COPD development.
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So far, studies on the effect of cigarette smoke on epithelial ADAMs activity has largely relied 
on the use of airway epithelial cell lines or undifferentiated primary cell cultures, stimulated 
with an aqueous extract of cigarette smoke. However, whole cigarette smoke exposure and 
primary differentiated airway cell cultures represent more relevant physiological conditions. 
Firstly, fresh whole cigarette smoke (CS) contains unstable active components and particulate 
matter that are largely absent from extracts. Furthermore, immortalized epithelial cells 
are poor models of bronchial epithelium in situ, since they are frequently karyotypically 
unstable and heterogeneous, do not show characteristic features of differentiation and 
inherently carry multiple mutations in pathways essential for growth, differentiation, cell‐
cell interaction, and polarization. Furthermore, submerged cultures of primary airway 
epithelial cells fail to differentiate. Finally, using cell lines does not allow a comparison of 
patient populations. Therefore, we examined the effect of whole CS exposure on shedding 
of the soluble interleukin‐6 receptor (sIL6R) and the EGFR‐ligand amphiregulin (AREG) 
by well‐differentiated, air–liquid interface cultured human primary bronchial epithelial cells 
(ALI‐PBEC).
This allowed us to compare CS‐induced ADAM17‐mediated protein shedding and mRNA 
expression of sIL6R and AREG in well‐differentiated ALI‐PBEC from COPD and non‐COPD 
(ex)smokers. Moreover, we established in this model the involvement of both EGFR and 
ADAM17 not only in shedding of ADAM17 substrates, but also in the regulation of mRNA 
levels of ADAM17 substrates and IL‐8. Finally, for the first time, we observed intracellular 
CS‐induced phosphorylated ADAM17‐substrate interaction via an in situ proximity ligation 
assay. Overall, our results provide novel insights into the activation of airway epithelial cells 
by cigarette smoke in COPD, and highlight a possible role of ADAMs and EGFR in COPD 
pathology.
MATERIALS AND METHODS
Air–liquid interface cell culture of human primary bronchial epithelial cells
Human airway epithelial cells were obtained from macroscopically normal, anonymous 
bronchial tissue obtained from lung cancer patients undergoing resection surgery for lung 
cancer at LUMC. This material was be used for research according to the “Code of Conduct 
for Responsible Use” (FEDERA code) based on the condition that the patient has no objection 
against such use. Primary bronchial epithelial cells (PBEC) were isolated from tumor‐free 
lung resection material (27), and passage 2 expanded cells were cultured at the air–liquid 
interface (ALI) to achieve mucociliary differentiation as previously described (28). Briefly, 
40,000 cells were seeded on 0.65 cm Transwell inserts (Corning Costar, Cambridge, MA) 
with a 0.4 µm pore size, which were coated with 30 µg/mL PureCol (Advanced BioMatrix, 
San Diego, CA), 10 µg/mL Bovine serum albumin (Sigma‐Aldrich, St. Louis, MO), and 10 
µg/mL Fibronectin (isolated from plasma). Cells were cultured in Bronchial epithelial growth 
medium (BEGM) (Lonza, Verviers, Belgium) and Dulbecco’s modified Eagle’s medium 
(DMEM) (Gibco, Bleiswijk, The Netherlands) (1:1 mixture) containing 1 mmol/L Hepes 
(Lonza) and supplemented with SingleQuot supplements and growth factors according to 
the manufacturer’s instructions (bovine pituitary extract, hydrocortisone, human epidermal 
growth factor, epinephrine, transferrin, insulin, T3 and retinoic acid; all from Lonza), 
 171 
EFFECT OF CIGARETTE SMOKE  ON ADAM17 INDUCED SHEDDING 
8
additional 15 ng/mL retinoic acid (Sigma–Aldrich), 1 mg/mL BSA (Sigma–Aldrich), 100 U/
mL penicillin, and 100 µg/mL streptomycin (Lonza). PBEC were initially cultured on inserts 
in submerged conditions until cell layers were confluent. Next, apical medium was removed 
and cells were cultured at air‐exposed conditions for at least 2 weeks to allow mucociliary 
differentiation. Clinical history and lung function data were obtained from anonymized 
patients (Table 1), and COPD disease status was based on lung function data according to the 
Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification (1). Donor cells 
were randomly allocated to experimental groups.
Cigarette smoke exposure
Air–liquid interface cultured human primary bronchial epithelial cells were exposed to whole 
cigarette smoke (CS) in an exposure model, adapted from (29) and previously described in 
more detail (28). In this model, ALI‐PBEC cultures were placed in either a CS‐ or air (negative 
control) exposure chamber located in a tissue incubator at 37°C and 5% CO2. Smoke derived 
from one cigarette (3R4F reference cigarettes [University of Kentucky, Lexington, KY]) was 
infused into the exposure chamber by a mechanical pump with a constant flow of 1 L/min, 
and equally distributed by a ventilator inside the chamber. After infusion (approximately 4–5 
min), residual smoke was removed by infusion of air from the tissue incubator for 10 min. 
Directly after CS exposure, the basal medium of the cell cultures was refreshed and cells were 
incubated for the indicated periods of time. Untreated cells used as controls were subjected to 
the same procedure omitting the smoke (AIR).
Inhibitors
TMI‐2 (1 µmol/L; PF‐5480090), a highly selective inhibitor of ADAM17 activity (30), was 
obtained from Wyeth inc. (Philadelphia, Pennsylvania) and the selective EGFR inhibitor 
AG1478 (1 µmol/L) was from Sigma Aldrich. Cells were preincubated for 1 h with inhibitors 
before CS exposure, and directly after CS exposure media were replaced and inhibitors were 
freshly added.
ELISA
ALI‐PBEC conditioned culture media were collected from the basolateral side of the inserts 
(1 mL), and apical washes were obtained by washing the apical surface with 100 µL PBS at 
Table 1: COPD and non‐COPD patient characteristics
COPD non‐COPD P‐value
Number of donors 15 11
Gender (females/males) 4/11 2/9
Age, years 70 ± 8 66 ± 6 0.1667
FEV1, % predicted 65 ± 16 81 ± 16 <0.01
FEV1/FVC % 55 ± 9 79 ± 9 <0.0001
Characteristics of PBEC donors. Age in years, and lung function as FEV1 (% predicted) and FEV1/FVC are shown 
as means ± SD. The mean differences were compared using the nonparametric Mann–Whitney test. COPD, chronic 
obstructive pulmonary disease, FEV1, Forced expiratory volume in one‐second, FVC, forced vital capacity.
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different time points, dependent on the experiment. Collected samples were diluted 1:1 with 
BEGM media and analyzed for IL6R and AREG by human IL6R or AREG ELISA kit, R&D. 
Further steps were performed according to the manufacturer’s protocol. Data were corrected 
for the dilution factor and insert size, and the amount of the shed IL6R and AREG was 
expressed as pg/mL per cm2.
RNA isolation and quantitative real‐time PCR
RNA was isolated using the miRNeasy Mini Kit (Qiagen) according to the manufacturer’s 
instructions, and cDNA was synthesized by reverse‐transcription PCR using oligo(dT) 
primers (Qiagen) and Moloney murine leukemia virus (M‐MLV) polymerase (Promega, 
Leiden, The Netherlands). mRNA expression was determined by quantitative real‐time PCR 
as described previously (28) with primer pairs presented in Table 2. mRNA expression was 
quantified using the standard curve method (31), in which arbitrary expression levels were 
normalized to the housekeeping genes RPL13A and ATP5B. The housekeeping genes were 
selected based on stable expression using the “Genorm method” (32).
Proximity ligation assay
Chronic obstructive pulmonary disease ALI‐PBEC were fixed with 4% paraformaldehyde and 
permeabilized with 0.5% Triton‐X100 in PBS twice for 15 min, blocked with 1% BSA and 
0.15% glycine. Next, they were incubated overnight in 4°C with two different first antibodies 
simultaneously: against ADAM17 (rabbit polyclonal, C‐terminal ADAM17, 25 µg/mL, 
ab78162, Abcam) or ADAM17PT735 (rabbit polyclonal, phospho‐ADAM17 in position T735, 
25 µg/mL, ab60996, Abcam) and IL6R (goat anti‐human IL6R recognizing extracellular 
domain, 20 µg/mL, AF‐227‐NA, R&D) or AREG (polyclonal goat anti‐human Areg, 25 µg/
mL, AF‐262, R&D). All washing steps were repeated three times with 0.5% Triton‐X100 in 
PBS (Sigma‐Aldrich). Further steps were performed according to the DuoLink manufacturer’s 
protocol. Briefly, Proximity ligation assay (PLA) probes for anti‐goat PLUS and anti‐rabbit 
MINUS were incubated at 37°C for 1 h. Ligation and amplification steps were performed 
with Detection Red Reagent. Finally, inserts with ALI‐PBEC were cut out and mounted on 
the slides with DAPI (Vectashield mounting medium for fluorescence with DAPI, H‐1200). 
Z-stacks were acquired using confocal microscopy (Leica604).
Table 2 Primer sequences
Gene Forward primer Reverse primer
IL8 5’-CAGCCTTCCTGATTTCTG-3’ 5’-CACTTCTCCACAACCCTCTGC-3’
AREG 5’-GTGGTGCTGTCGCTCTTGATA-3’ 5’- ACTCACAGGGGAAATCTCACT-3’
full‐IL6R 5’-GCTGTGCTCTTGGTGAGGAAGTTT-3’ 5’-CTGAGCTCAAACCGTAGTCTGTAGAAA-3’
s p l i c e d 
IL6R
5’-GCGACAAGCCTCCCAGGTT-3’ 5’-CCGCAGCTTCCACGTCTTCTT-3’
RPL13A 5’-AAGGTGGTGGTCGTACGCTGTG-3’ 5’- CGGGAAGGGTTGGTGTTCATCC-3’
ATP5B 5’-TCACCCAGGCTGGTTCAGA-3’ 5’-AGTGGCCAGGGTAGGCTGAT-3’
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PLA image analysis
The number of dots was counted in the whole Z-Stack with Image J software. The threshold 
values were adjusted with the Intermodes algorithm (the filter size set between 10 and 437 
microns to exclude the small and large dots, which were in the range of 10% of the total dot 
count). The objects on the edges of the culture inserts were excluded from the analysis. The 
number of nuclei was counted in each Z-stacks by hand to express the number of dots per 
nucleus.
Statistical analysis
Data were analyzed with GraphPad Prism Software, using the appropriate statistical test, as 
indicated underneath each figure. Cells from various donors (number indicated by n in the 
legends of figures) were used for each experiment, samples were collected from two or three 
wells from a single donor, averaged and represented as a single dot in the figure. Statistical 
analysis was performed on the averaged data. Values are presented as mean with SEM values. 
Differences at values *P < 0.05 were considered to be statistically significant. ns > 0.05, *P < 
0.05, **P < 0.01, ** P < 0.001, **** P < 0.0001.
RESULTS
CS induces shedding of IL6R and AREG by ALI‐PBEC into basolateral medium, but not apical
We first examined the effect of cigarette smoke (CS) exposure on the release of sIL6R and AREG 
by ALI‐PBEC at the apical surface and in the basal medium, which contains a maintenance 
level of EGF, associated with a basal level of EGFR activity. This was done, using a previously 
described whole CS exposure model (28), in which CS caused a transient disruption in the 
airway epithelial barrier integrity, accompanied by minor cytotoxic effects measured at the 
apical surface. Both sIL6R and AREG were barely detectible in the apical washes collected 
from ALI‐PBEC of 17 COPD donors at different stages of disease, following exposure to 
either CS or air (Figure 1A,B). In contrast, sIL6R and AREG were markedly released into the 
basal medium in both conditions. CS significantly increased release of sIL6R into the basal 
medium at 12 h post exposure, while AREG levels were increased at 12 and 24 h after CS 
exposure. These results demonstrate that shedding of sIL6R and AREG by ALI‐PBEC occurs 
mainly to the basolateral compartment, and is enhanced by CS exposure.
CS significantly induces shedding of IL6R and AREG in COPD ALI‐PBEC but not in non‐COPD 
ALI‐PBEC
Next, we explored whether shedding of sIL6R and AREG differs between ALI‐PBEC isolated 
from COPD patients and non‐COPD (ex)‐smokers upon CS and air exposure. Based on the 
previous result, the release was only determined in the basal medium 24 h after exposure. 
Shedding of sIL6R and AREG did not differ between COPD and non‐COPD ALI‐PBEC 
exposed to air (Figure 2A,B), indicating no differences at baseline conditions. In contrast, 
shedding of sIL6R (Figure 2A) and AREG (Figure 2B) was significantly higher after CS 
exposure only in COPD ALI‐PBEC, and not in non‐COPD ALI‐PBEC. These data show that 
CS‐induced release of sIL6R and AREG was more pronounced in airway epithelial cells from 




Figure 2. Cigarette smoke significantly induces shedding of IL6R and AREG into basolateral medium by COPD ALI‐
PBEC. Soluble forms of IL6R (A) and AREG (B) shed into the basolateral compartment were detected 24 h after CS or 
air exposure in ALI‐PBEC derived from non‐COPD and COPD donors (Table 1). (A) IL6R levels were significantly 
increased 24 h after CS treatment in COPD‐ALI‐PBEC (n = 15), but this increase was not significant in the non‐
COPD group (n = 11 donors). (B) Similarly, CS exposure significantly increased AREG levels in ALI‐PBEC cells 
derived from COPD donors (n = 10), but not in non‐COPD ALI‐PBEC (n = 8 donors). Statistical analysis: paired 
t‐test. n refers to the number of donors, duplicate or triplicate data were averaged per donor. Statistical analysis was 
performed on the averaged data from each donor.
A B
Figure 1. Cigarette smoke induces shedding of IL6R and AREG by ALI‐PBEC into basolateral medium. IL6R (A) and 
AREG (B) were mainly shed to the basolateral compartment in ALI‐PBEC (COPD donors at different stages, n = 12 
for IL6R and n = 5 for AREG). Basolateral media (basolateral) were collected and apical PBS washes (apical) were 
performed 12 h and 24 h after CS or air exposure. Both IL6R and AREG were readily detectable in the basolateral 
compartment, and barely present in the apical washes. The response of cells from each donor was analyzed within one 
experiment using duplicate or triplicate inserts. Statistical analysis was performed by two‐way ANOVA (Bonferroni) 
on the averaged data from each donor, comparing apical versus basolateral shedding at air and CS exposure, and 
basolateral shedding at air versus CS exposure.
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CS‐induced IL6R and AREG mRNA expression is lower in COPD ALI‐PBEC compared to non‐
COPD cultures
We further determined mRNA expression of IL6R and AREG in CS and air exposed ALI‐
PBEC cultures from COPD and non‐COPD patients. The soluble form of IL6R can be 
generated either by shedding of the membrane anchored form or by de novo synthesis of the 
alternatively spliced isoform that differs at the C‐terminus (22). Therefore, we determined 
mRNA expression levels of both IL6R variants: the membrane‐anchored (full‐IL6R mRNA) 
and the alternatively spliced (spliced‐IL6R mRNA) variant.
Time‐course analysis revealed that CS increased full‐IL6R mRNA 3 h after exposure, but not 
at later time points (Figure 3A). In contrast, baseline expression of spliced‐IL6R mRNA did 
not differ from the expression after CS treatment (Figure 3B), suggesting that the increase in 
Figure 3. CS exposure transiently enhances IL6R and AREG mRNA expression in COPD and non‐COPD ALI‐PBEC. 
mRNA levels of the IL6R full‐length variant (full‐IL6R) (A), the IL6R splice variant (spliced‐IL6R) (B) and AREG 
(C) were determined by qPCR 3, 12, and 24 h after CS (black bars) or air exposure (open bars) (n = 14 unspecified 
donors). A transient induction of full‐IL6R (A) and AREG (C), but not spliced‐IL6R (B) was observed at 3 h after CS 
exposure. In COPD (n = 7) and non‐COPD (n = 8) ALI‐PBEC, mRNA of full‐IL6R (D), spliced‐IL6R (E), and AREG 
(F) were determined 3 h after CS exposure. mRNA expression of full‐IL6R and AREG, was lower on average but 
not statistically significant in COPD compared to non‐COPD donors. Data were normalized for expression against 
two reference genes (ATP5B and RPL13A). n refers to the number of donors. The response of cells from each donor 
was analyzed within one experiment using duplicate inserts and data were averaged per donor. Statistical analysis 






sIL6R protein levels in culture supernatants did not result from alternative splicing. Similar to 
full‐IL6R mRNA, CS significantly induced AREG mRNA expression 3 h after exposure, but 
not at later time points (Figure 3C). These findings suggest that the CS‐induced increase in 
IL6R and AREG shedding is mediated at least in part via regulation of their mRNA expression 
levels.
Baseline expression of full‐IL6R and AREG mRNA did not differ between COPD and non‐
COPD ALI‐PBEC (Figure 3D,F). After CS exposure, full‐IL6R and AREG mRNA were 
expressed at higher levels in both non‐COPD and COPD ALI‐PBEC. Interestingly, after 
CS induction, COPD cells expressed full‐ILR and AREG at lower levels on average but this 
did not reach statistical significance (Figure 3D,F). Spliced‐IL6R mRNA expression did not 
differ between investigated groups either after CS or air exposure (Figure 3E). These findings 
suggest that COPD patients may have impaired transcriptional or posttranscriptional 
responses to inflammatory and tissue regenerative triggers. The apparent contrast with the 
more pronounced shedding from COPD cells after CS challenge (Figure 2) suggests that 
posttranslational mechanisms determine shedding rate, rather than substrate mRNA levels.
ADAM17 is required for CS‐induced release of IL6R and AREG in ALI‐PBEC
To confirm the previously established involvement of ADAM17 in the shedding process of 
IL6R and AREG in our model, we used the selective ADAM17 inhibitor TMI‐2 (Wyeth) 
(30). TMI‐2 only partially decreased baseline IL6R release at all investigated time points 
(Figure 4A), plausibly because release of the product of spliced‐IL6R mRNA, which cannot 
A B
Figure 4. ADAM17 is involved in the release of soluble IL6R and AREG in ALI‐PBEC. The selective ADAM17 inhibitor, 
TMI‐2 (Zhang et al. 2004) decreases basal and CS‐induced IL6R (A,B) and AREG (C,D) shedding in ALI‐PBEC cells 
(n = 3 COPD donors) at 3, 6 (A,C), 12, and 24 h time points (B,D). n refers to the number of donors. The response 
of cells from each donor was analyzed within one experiment using duplicate or triplicate inserts and data were 
averaged per donor. Statistical analysis was performed on the averaged data from each donor, by two‐way ANOVA 
(Bonferroni), confirming first the effect of CS on IL6R and AREG shedding at different time points, and second the 
effect of TMI‐2 on shedding during air and CS exposure.
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be distinguished from shed IL‐6R with the available antibodies, is not sensitive to inhibitors of 
ADAMs (33). In contrast, TMI‐2 significantly decreased baseline AREG shedding at all time 
points (Figure 4B). Importantly, CS‐induced shedding of IL6R and AREG was significantly 
inhibited by TMI‐2 at all timepoints after CS exposure, indicating that ADAM17 activity is 
involved in CS‐induced ADAM17 substrate release (Figure 4).
ADAM17‐ and ADAM17P‐substrate interactions are increased after CS exposure in an 
intracellular compartment of ALI‐PBEC
Next, we explored the interactions of IL6R or AREG with ADAM17 3 h after CS treatment 
in ALI‐PBEC with an in situ proximity ligation assay (PLA) (34), using antibodies against 
ADAM17 phosphorylated at Thr735 (ADAM17‐PT735) or total ADAM17. Protein IL6R/
AREG‐ADAM17 and IL6R/AREG‐ADAM17‐PT735 interactions were visualized as fluorescent 





Figure 5. CS increases substrate‐ADAM17 and substrate‐ADAM17‐PT735 interactions in pseudostratified COPD ALI‐
PBEC cells. The proximity ligation assay (PLA) signal in COPD‐ ALI‐PBEC exposed to CS or air was performed 
for the following interactions: IL6R‐ADAM17, IL6R‐ADAM17PT735, AREG‐ADAM17, and AREG‐ADAM17‐PT735. 
Relevant control data are shown in Figure S1. Here, we show a representative figure of IL6R‐ADAM17PT735 3 h after 
air (A) and CS exposure (B). Left panels show merged signals of nuclei (blue) and PLA (red) in the x–y sections of the 
confocal z‐stack and right panel presents PLA signal in the apical region (red dots). The number of PLA interactions 
was counted for all interactions as described in the methods section and expressed per nucleus 3 h after CS or air 
exposure in the whole z‐stack of the ALI‐PBEC (C–F). The red lines on the graphs indicate the maximal dot count 
in the PLA assay controls, in which one of the antibodies for the interaction was omitted (background staining not 
shown). For each interaction, cells from one donor were analyzed. Different filters (n = 4) were used to show distinct 
interactions. Statistical analysis: unpaired t‐test.
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In air‐exposed cells, PLA signals were largely confined to the basal region, as in the control 
incubations, and not significantly higher than background (data not shown), as indicated 
by red lines in Figure 5C–F (relevant control data are shown in Supplementary Figure 1). 
Interestingly, CS exposure significantly increased the total number of PLA signals for 
interactions of IL6R or AREG with ADAM17 (Figure 5C,E). We observed that CS strongly 
enhanced interactions of IL6R or AREG with ADAM17‐PT735 (Figure 5D,F), which further 
extends previous findings showing that ADAM17 is phosphorylated after smoke extract 
(CSE) exposure in submerged immortalized NCI‐H292 cells (5). CS‐induced PLA signals 
of substrate‐ADAM17 and substrate‐ADAM17‐PT735 were primarily detected in the apical 
region of the cells and were not confined to a lateral membrane pattern suggesting an 
intracellular vesicular localization of protein complexes in ALI‐PBEC. These data for the 
first time demonstrate that CS exposure strongly increases the interaction of ADAM17 and 
ADAM17‐PT735 with IL6R or AREG in an intracellular vesicular compartment of ALI‐PBEC, 
suggesting a CS induced effect on protein trafficking.
EGFR is required for basal and induced AREG shedding in ALI‐PBEC
ADAM17‐dependent shedding of EGFR ligands such as AREG results in activation of 
EGFR through an autocrine feedback loop, which modulates basal EGFR activity (35). This 
mechanism was shown to be activated by CS extract in submerged cultured PBEC and in cell 
lines (16). In our experimental set‐up, we have previously shown that CS enhances basal EGFR 
activity by increasing its phosphorylation (28). To illustrate the involvement of EGFR in CS‐
induced ADAM17‐related shedding in ALI‐PBEC, we assessed sIL6R and AREG shedding 
after starvation for growth factors, using medium devoid of EGF and bovine pituitary extract 
(BPE). Removing these factors from the medium substantially reduced baseline shedding of 
IL6R and AREG (Figure 6), when compared to standard culture conditions including EGF 
and BPE (Figure 4A,C). Both sIL6R and AREG release were significantly increased at 3 h after 
CS exposure. The selective ADAM17 inhibitor TMI‐2 and the EGFR tyrosine kinase inhibitor 
(AG1478) added prior to CS exposure, partially inhibited sIL6R shedding, consistent with 
a substantial contribution of the ADAM‐insensitive splice variant sIL‐6R levels in the basal 
A B
Figure 6. IL6R and AREG shedding depends on ADAM17 
and EGFR activity in COPD‐ALI‐PBEC. COPD ALI‐
PBEC (n = 3 donors) were starved for growth factors 
for 48 h prior to CS or air exposure. Three hours after 
CS exposure, IL6R (A) and AREG (B) shedding were 
significantly increased compared to air. The ADAM17 
inhibitor (1 μmol/L TMI‐2) and the EGFR inhibitor (1 
μmol/L AG1478) significantly reduced AREG, but IL6R 
shedding to a lesser extent. The response of cells from 
each donor was analyzed within one experiment using 
triplicate inserts and data were averaged per donor. 
Statistical analysis was performed on the averaged data 
from each donor by one way ANOVA (Tukey multiple 
comparison test), only relevant comparisons are shown, 
air versus CS‐treated cells and the effect of inhibitors in 
CS‐treated cells.
 179 
EFFECT OF CIGARETTE SMOKE  ON ADAM17 INDUCED SHEDDING 
8
medium (Figure 6A). AG1478 strongly impaired AREG shedding, to a similar extent as 
TMI‐2 (Figure 6B). These findings together demonstrate a critical role of EGFR activation in 
ADAM17‐mediated basal and CS‐induced shedding activity.
EGFR and ADAM17 are required for CS‐induced IL6R and AREG mRNA expression
We previously observed that EGFR activation is involved in CS‐induced expression of several 
genes in ALI‐PBEC (28). The molecular mechanism by which CS activates EGFR are not 
known. Here, we explored the effect of ADAM17 and EGFR inhibition on CS‐induced IL6R 
and AREG mRNA levels in ALI‐PBEC. At 3 hours after CS exposure in the absence of EGF 
in the medium, both TMI‐2 and AG1478 significantly impaired CS‐induced expression of 
full‐L6R mRNA (Figure 7A), but not the splice variant (Figure 7B). Both inhibitors strongly 
diminished CS‐induced AREG mRNA levels (Figure 7C) as well as IL‐8 mRNA expression 
(Figure 7D). Overall, these findings for the first time demonstrate that ADAM17, next to 
EGFR, is essential in the CS‐induced mechanism regulating not only the mRNA of ADAM17 
substrates (IL6R and AREG), but also IL‐8 in ALI‐PBEC.
A B
C D
Figure 7. IL6R and AREG mRNA expression are 
regulated by ADAM17 and EGFR activity in ALI‐
PBEC. ALI‐PBEC (n = 3 donors) were starved for 
growth factors for 48 h prior to CS exposure. At 3 
h, CS‐induced mRNA levels of full‐length IL6R 
(A), AREG (C), and IL8 (D) were diminished 
upon ADAM17 (1 μmol/L TMI‐2) and EGFR (1 
μmol/L AG1478) inhibition, whereas that of the 
alternatively spliced form of IL6R was not affected 
(B). n refers to the number of donors. The response 
of cells from each donor was analyzed within 
one experiment using triplicate inserts and data 
were averaged per donor. Statistical analysis was 
performed on the averaged data from each donor, 
by one‐way ANOVA (Tukey multiple comparison 
test), only relevant comparisons are shown, air 





Many studies have demonstrated that airway epithelial cells are activated by exposure to 
environmental triggers like cigarette smoke, which contributes to COPD pathology (28, 
36-38). In contrast to most studies, we used fresh whole cigarette smoke instead of (aged) 
cigarette smoke extract, and ALI‐differentiated PBEC from COPD and non‐COPD donors 
instead of submerged cultures of non-differentiated primary cells or cell lines.
While the obvious advantage of this approach is that we can study well‐differentiated primary 
cells from different patient populations, a limitation is that confirmation of data obtained with 
experimental pharmaceutics by, for example, gene editing or RNAi technology is not feasible 
in this context. Aside from efficiency issues and off‐target effects in primary cells, knocking 
down EGFR or ADAM17 likely affects the growth and differentiation of primary bronchial 
epithelial cells, which essentially defeats our purpose. However, the two inhibitors that we 
apply here to inhibit EGFR (AG1478) and ADAM17 (TMI‐2), respectively are widely used 
and are known to be highly selective.
Importantly, our data demonstrate for the first time that CS triggered increase of basal 
shedding of IL6R and AREG into the basal medium, in the presence of EGF in the growth 
medium providing basal EGFR activity, was more pronounced in ALI‐PBEC derived from 
COPD patients compared to non‐COPD controls. We further report the ability of CS to 
increase mRNA expression of these genes in an EGFR‐ and ADAM17‐dependent way in 
ALI‐PBEC cells, under these conditions, with a lower tendency to induction in the COPD 
group. These results extend previous studies showing dysregulated responses of COPD airway 
epithelial cells to cellular stress, and provide novel evidence for the mechanism of CS‐induced 
and COPD‐related proinflammatory and profibrotic responses (Figure 8).
The differential effect of CS on sIL6R and AREG release between COPD and non‐COPD ALI‐
PBEC might be related to differences in epithelial barrier function as previously described 
(39). Using the current CS exposure system, we have previously shown that CS causes a 
transient decrease in epithelial barrier function (28). However, in contrast to Heijink et al., we 
did not observe differences between COPD and non‐COPD cultures at baseline conditions 
and upon CS exposure (40), which may be explained by the fact that Heijink et al. focused on 
severe (GOLD stage IV) COPD. Another explanation might be differences in epithelial cell 
differentiation, as it has been shown that COPD epithelial cells display a more mesenchymal 
phenotype due to enhanced autocrine expression of TGF‐β1 (41).
As previously shown, the EGFR‐ADAM17 pathway is essential for IL‐8 release from a 
bronchial epithelial cell line exposed to particulate air pollution (42) and implicated in CS 
extract‐induced expression of the mucin MUC5AC (6). Further, autocrine production of 
EGFR ligands is involved in CS‐induced IL‐8 release from airway epithelial cells (10). Our 
studies extend these observations by showing the involvement of the ADAM17‐EGFR 
pathway in the release of IL6R and AREG upon CS exposure of differentiated PBEC, both in 
the presence (Figure 4), and absence (Figure 6) of EGFR ligand (EGF) in the basal medium 
respectively. Notably, the basal shedding rates are considerably lower in cells pre-incubated in 
medium lacking EGF, resulting in a much larger ADAM17‐ and EGFR‐dependent stimulation 
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effect of CS (compare Figures 4 and 6). Which of these extreme conditions of basal EGFR 
activation apply in normal and COPD lungs in situ, and to what extent autocrine feedback 
signaling through ADAM‐dependent EGFR ligand shedding determines EGFR activity 
(Figure 8) remains to be established.
Additionally, EGFR and ADAM17 were both essential for CS‐induced IL6R and AREG 
mRNA expression (Figure 7). These results provide novel insights into the mechanisms of 
airway epithelial cell activation by cigarette smoke in COPD, and highlight a role of ADAMs 
and EGFR in this process (Figure 8).
We further found that CS increases shedding of IL6R and AREG to the basal medium, but 
not to the apical side (Figure 1). This is in line with report in polarized Madin‐Darby canine 
kidney cells (MDCK cells) showing that newly synthetized AREG is directly delivered to the 
basolateral surface with >95% efficiency (43). However, this is in contrast to the secretion 
of the innate immune mediators IL‐8 and ribonuclease 7, which were also detected at the 
apical surface (28). A polarized ADAM17‐mediated secretion toward underlying tissue may 
be relevant for lung tissue remodeling through autocrine, paracrine, extracrine (exosomal 
targeted receptor activation) pathways in COPD (7, 44). Further examination of this 
phenomenon in epithelial–mesenchymal co‐culture systems is in progress.
Amphiregulin release and phosphorylation of ADAM17 after CS extract treatment in ALI‐
PBEC has been previously detected by ELISA or western Blotting (5). Our proximity ligation 
assay (PLA) data show for the first time that CS‐induced shedding involves an intracellular 
interaction between phosphorylated ADAM17 and its substrates (Figures 5 and 8), whereas 
the majority of the literature suggests that shedding occurs mainly at the plasma membrane 
surface. This interaction likely takes place in intracellular membranes that sequester active 
phosphorylated ADAM17 and its transmembrane substrates upon activation. This process 
may relate to the transient change in barrier function upon CS treatment in our system 
and the subsequent activation of EGFR (28). Our observation is supported by other reports 
showing the presence ADAM17 or its substrates in a vesicular compartment in lysosomes (45), 
endosomes (46, 47), and exosomes negative for the ER marker calreticulin (48). Moreover, 
Gutwein et al. demonstrated that ADAM10‐mediated L1 migration factor cleavage occurs 
in Golgi‐derived vesicles in tumor cells (49). This was further supported by a recent paper 
suggesting that also ADAM10/ADAM17‐mediated release of soluble FasL occurs from an 
intracellular vesicular pool of secretory lysosomes in stimulated T lymphocytes (45). 
Moreover, after ligand binding, EGFR traffics in endosomes from the plasma membrane to an 
intracellular compartment to continue its signaling (50, 51). EGF‐dependent MAPK signaling 
occurs from late endosomes and lysosomes (52). Interestingly, the MAPK/ERK pathway 
regulates trafficking of ADAM17 phosphorylated at Thr735 from the endoplasmic reticulum 
toward the plasma membrane (53, 54), which can be also activated through ligand binding to 
EGFR. Higginbotham et al. showed that AREG containing exosomes are rapidly internalized 
by recipient cells in an EGFR‐dependent manner (48), enhancing invasion of LM2‐4175 cells 
through Matrigel and wound healing. In our ALI‐PBEC system, we observed a predominantly 
lateral localization of EGFR under basal culture conditions. After exposure to CS, we observed 
a more cytoplasmic localization, consistent with EGFR activation (Supplementary Figure 2). 
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Therefore, in line with these and published observations, our findings suggest that in HBEC‐
ALI, CS triggers EGFR‐mediated trafficking of ADAM17 and its substrates to a common 
subcellular compartment to allow proteolysis and subsequent secretion of soluble products 
(Figure 8). At this time, we cannot establish to what extent autocrine signaling through 
shed ADAM substrates determine this response, or whether alternative mechanisms such as 
transactivation by intracellular kinases or oxidation or the extracellular receptor domain plays 
Figure 8. Cigarette smoke exposure activates EGFR‐ADAM17 axis in airway epithelial cells. Under basal conditions, 
there is ADAM17 related AREG and IL6R shedding activity, depending on the level of EGFR activity (compare 
Figure 4 and 6). Cigarette smoke exposure (CS) initiates an interaction of the phosphorylated form of ADAM17 
(ADAM17‐P) with the full‐length transmembrane forms of IL6R and AREG in an intracellular compartment of the 
airway epithelial cell (Figure. 5), resulting in proteolysis and subsequent secretion (shedding) of the soluble active 
domains of IL6R and AREG toward the basolateral compartment. This involves both ADAM17 and EGFR activity 
(Figures 4 and 6). CS exposure also affects IL6R and AREG gene expression or mRNA stabilization in airway epithelial 
cells through ADAM17 and EGFR activation. sAREG and sIL6R secreted towards the basolateral compartment 
may change the level of activity of EGFR and the interleukin receptor IL6st/gp130 on the airway epithelial cells 
(autocrine). This may contribute to the activity of the EGFR/ADAM17 axis (positive feedback), which is likely kept in 
check by inactivation of internalized EGFR. Paracrine activity of sAREG and sIL6R may further transactivate EGFR 
and the interleukin receptor IL6st/gp130 on the underlying myofibroblasts, and myeloid cells, activating downstream 
pathways, including STAT3, involved in inflammation, collagen deposition, and myofibroblast proliferation.
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a role. Additional studies of triggered trafficking of EGFR, ADAM17‐P, and its substrates in 
polarized airway cells are required to further establish this mechanism.
In addition to CS‐enhanced release through ADAM17 enzymatic activity, we observed 
transiently enhanced mRNA expression of both AREG and full‐IL6R in ALI‐PBEC upon CS 
exposure (Figure 3). CS did not affect the level of the alternatively spliced form of IL6R, so 
we conclude that alternative splicing unlikely contributes to CS‐enhanced release of IL6R. 
Previously, we observed upregulated IL‐8 mRNA expression in ALI‐PBEC exposed to CS as a 
result of enhanced EGFR phosphorylation and activation of the downstream MAPK/ERK1/2 
signaling pathway (28). Here, we report that CS‐induced IL6R and AREG mRNA expression 
was also reduced upon EGFR inhibition. In addition, we show here for the first time that 
inhibition of ADAM17 has the same effect on these mRNA levels (Figure 7). Therefore, 
our data suggest that CS enhances factors common for activation of IL6R, AREG, and IL‐8 
mRNA expression likely via an autocrine ADAM17‐EGFR axis (Figure 8). The transcriptional 
and posttranscriptional regulation of these genes upon inhaled toxic substances has not been 
fully elucidated. Induced EGFR signaling is able to activate transcription of target genes. In 
addition, it has been shown that CS extract enhances HuR‐mediated IL‐8 mRNA stability in 
airway epithelial cells (55). Moreover, UV‐exposure of keratinocytes enhances mRNA HuR‐
mediated stability of AREG, in an EGFR‐dependent manner (56). These observations suggest 
that CS‐induced activation of EGFR enhances sIL6R, AREG, and IL8 mRNA stability in ALI‐
PBEC. Furthermore, mRNA regulation may be altered in cultured airway epithelial cells from 
COPD patients (57). CS‐treated COPD ALI‐PBEC expressed lower AREG and IL6R mRNA 
levels on average compared to non‐COPD controls, but this difference was not statistically 
different (Figure 3). Further studies on mRNA stability in this system are required to establish 
this. Nevertheless, this observation contrasts with the shedding data (Figure 2) and suggests 
that ADAM17‐dependent AREG and sIL6R output is not primarily regulated on the mRNA 
level, but involves posttranslational regulation.
Our data support the relevance of the ADAM17/EGFR pathway in COPD development and 
progression. Selective inhibitors of ADAM17, EGFR, and other components of this signaling 
pathway such as JAK and MAPK potentially expand therapeutic possibilities. The development 
of ADAM inhibitors for clinical use has been studied intensively (58-60). In cellular and animal 
tumor models, positive results were recorded (61). An ADAM17 inhibitor, TAPI‐0, reduced 
bleomycin‐induced lung inflammation (62). The selective inhibitor TMI‐2 used in this study, 
reduced LPS‐induced inflammation in vivo (30). However, due to a lack of target specificity of 
available compounds, and side effects associated with the various other biological functions of 
ADAMs, chronic and systemic application of these compounds in humans is so far prohibited 
(63). Clearly, more advanced intervention tools are required. Our data offer new insights in 
the regulation of mRNA expression, secretion, and release of ADAM17 substrates in airway 
epithelial cells upon triggering, which in combination with state of the art molecular design 
and advanced organotypic cellular modeling of airways could allow development of more 
selective inhibitors, targeted to specific cells and subcellular domains.
In summary, this study provides evidence that ADAM17‐mediated release and shedding of 
IL‐6R and AREG is highly enhanced in airway epithelial cells in response to CS‐induced 
injury. Next to ADAM17, we highlight the importance of EGFR in the regulation of IL6R and 
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AREG release and mRNA expression. Moreover, CS‐induced ADAM17‐mediated shedding 
of IL6R and AREG is especially high in COPD ALI‐PBEC, suggesting that reducing ADAM17 
activity in COPD might be a potential therapeutic approach.
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Supplementary Figure 1. The proximity ligation assay (PLA) background signal. PLA recognizes two proteins that are 
in close proximity by using a combination of two specific antibodies and two complementary secondary antibodies 
carrying the ligation probes (Frederiksson et al., 2002). To check the specificity of the PLA signal, the filters 
with ALI-PBEC used for the assay of Figure 5 (COPD n=1) were incubated with only one of the first antibodies: 
IL6R, AREF, ADAM17, ADAM17PT735, or no first antibodies (2nd antibodies control). (A) The representative 
immunofluoresence pictures are shown. Left panel shows PLA signal of the apical region (red dots) and right panel 
presents merged signals of nuclei (blue) and PLA (red) in the x-uy sections of the confocal z-stack. (B) The number 
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Supplementary Figure 2. Lateral EGFR in ALI-PBEC, internalized after CS treatment. ALI-PBEC cultured under basal 
conditions, including (EGF and BPE) were treated with air or CS as described in the methods section (A) Lateral 
EGFR immunofluoresence signal (green) becomes more diffuse three hours after CS treatment. (B) Lateral E-cadherin 
(red) illustrates the partial cytoplasmic localisation of EGFR. (C) This is confirmed in a seperate experiment, after 10 
minutes exposure to air or CS, with three seperate filters each.
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Whey acidic protein four-disulfide-core 12 (WFDC12) is an anti-inflammatory mediator 
that is expressed during airway inflammation. Airway epithelial cells are centrally involved 
in regulating airway inflammation, however the expression of WFDC12 in these cells, and its 
role in the chronic inflammatory lung disease COPD, has not been investigated. Therefore, we 
examined the expression of WFDC12 in (un)differentiated primary bronchial epithelial cells 
(PBEC) that were exposed to inflammatory stimuli, and compared the expression in COPD 
and control cell cultures. Exposure to the COPD-related pathogen non-typeable Haemophilus 
influenzae increased mRNA of WFDC12 in undifferentiated PBEC, whereas it only affected 
WFDC12 secretion in differentiated PBEC. TNFα/IL-1β stimulation increased WFDC12 
mRNA in differentiated PBEC, whereas supplemented and endogenously produced TGF-β1 
suppressed the expression. Baseline WFDC12 mRNA levels were increased upon differentiation 
and were mainly observed in luminal cell of differentiated PBEC. This constitutive expression 
of WFDC12 was furthermore lower in cell cultures from COPD patients when compared to 
controls. Overall, these findings demonstrate a dynamic regulation of WFDC12 in airway 
epithelial cells during differentiation. Decreased production as observed in COPD epithelial 
cell cultures might favor the persistence of inflammation in this disease.
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INTRODUCTION 
The whey acidic protein four-disulfide-core (WFDC) domain-containing protein family 
comprises an evolutionary conserved group of proteins, including secretory leukocyte 
protease inhibitor (SLPI) and elafin (protease inhibitor 3; PI3) (1). These proteins are 
important regulators of innate immune responses in the lung that display a range of functions 
including antiprotease and antimicrobial activity, anti-inflammatory effects, and wound 
healing properties.
Recently, the expression and function of another, previously uncharacterized WFDC domain 
protein, WFDC12, was described  (2). In contrast to the mouse orthologue (3), human 
WFDC12 did not display antibacterial properties. However, functional studies showed 
antiprotease activity against neutrophil-derived cathepsin G and reduced IL-8 and MCP-1 
secretion by in vitro cultured monocytes stimulated with LPS (2). Moreover, LPS increased 
the expression of WFDC12 in the lungs in vivo, and increased expression levels were detected 
in secretions and tissues derived from the lungs of patients with acute respiratory distress 
syndrome. Together, these findings suggest a role of WFDC12 in regulating inflammatory 
responses in the airways.
In addition to immune cells, the airway epithelium plays a central role in regulating airway 
innate immunity and inflammation (4, 5). Airway epithelial cells are a major source of WFDC 
proteins in the lung and express several protein family members either constitutively or upon 
exposure to pro-inflammatory stimuli (6, 7). It remains however unknown if WFDC12 is also 
expressed by human airway epithelial cells, which mechanisms are involved in its expression, 
and furthermore whether its expression is affected in chronic inflammatory lung diseases.
Chronic obstructive pulmonary disease (COPD) is a smoking-related lung disorder that is 
characterized by irreversible, chronic and progressive airflow limitation, bacterial colonization 
and infection, a persistent inflammatory response in the lung, and remodeling of lung tissue 
(8-10). It is postulated that alterations in airway epithelial innate immunity contribute to the 
onset and progression of COPD (5), but the mechanisms that are affected remain incompletely 
understood. Indeed it has been shown in previous studies that airway epithelial cells in COPD 
display reduced anti-inflammatory activity, for instance due to reduced expression of club cell 
secretory protein-16 (11). In addition to this, reduced expression of other anti-inflammatory 
proteins, such as WFDC12, may also contribute to the reduced anti-inflammatory activity of 
airway epithelial cells in COPD.
In the present study we examined the expression of WFDC12 in primary bronchial epithelial 
cells (PBEC) in response to microbial and inflammatory stimuli related to COPD. To this end 
we examined the effect of the COPD-related respiratory pathogen non-typeable Haemophilus 
influenzae (NTHi), cigarette smoke, the pro-inflammatory cytokines TNFα/IL-1β and the 
growth factor TGF-β1 on WFDC12 expression. Moreover, expression of WFDC12 was 
compared between air-liquid interface cultured and mucociliary differentiated PBEC (ALI-




Cell culture and stimuli
Primary bronchial epithelial cells (PBEC) were isolated from macroscopically normal lung 
tissue obtained from patients undergoing resection surgery for lung cancer at the Leiden 
University Medical Center. Use of such lung tissue that became available for research within 
the framework of patient care was in line with the “Human Tissue and Medical Research: 
Code of conduct for responsible use” (2011) (www.federa.org), that describes the no-
objection system for coded anonymous further use of such tissue. Therefore, individual 
written or verbal consent is not applicable. Cells were cultured as previously described (12, 
13) either in transwells at the air-liquid interface (ALI) to allow mucociliary differentiation 
(ALI-PBEC), or cultured in undifferentiated submerged conditions in regular tissue culture 
plates (referred to as S-PBEC). In Figure 5 ALI-PBEC cultures were derived from COPD 
patients or non-COPD controls with a smoking history. The disease status of anonymized 
donors was determined based on lung function data according to the Global Initiative for 
Chronic Obstructive Lung Disease classification (14) (Table 1). PBEC were stimulated with 
UV-inactivated non-typeable Haemophilus influenzae (NTHi) and exposed to whole cigarette 
smoke (CS) essentially as previously described (13). The pro-inflammatory cytokines TNFα, 
IL-1β and the growth factor TGF-β1 (all at 20 ng/ml; PeproTech, Rocky Hill, NJ) were added 
to the basal culture medium. Neutralization of endogenous TGF-β1 was performed by adding 
10 µg/ml anti-TGF-β1 neutralizing antibody to the culture medium, and equal amounts of a 
monoclonal mouse IgG1 was used as isotype control (both R&D, Minneapolis, MN, USA). 
In indicated experiments, basal and luminal cell-enriched fractions were isolated from ALI-
PBEC cultures based on differential disassociation upon treatment with Ca2+ free medium, 
essentially as previously described (13, 15).
RNA isolation and qPCR
RNA isolation, cDNA synthesis and qPCR analysis was performed as previously described 
(13) using the primers shown in Table 2. mRNA expression levels were normalized against 
the reference genes RPL13A and ATP5B, which were selected using the “Genorm method” 
(Genorm; Primer Design, Southampton, United Kingdom) .
Table 1: Characteristics of COPD and non-COPD patients.
COPD non-COPD p-value
N= 10 8
Gender (Females/Males) 2/8 2/6
Age, years 67±7 66±8
FEV1 , % predicted 64±14 92±22 < 0.02
FEV1/FVC % 57±9 80±9 < 0.0001
Patient characteristics of airway epithelial cell donors. Age and lung function are shown as means ± SD. The mean 
differences in FEV1 (% predicted) and FEV1/FVC (%) were compared using the non-parametric Mann-Whitney test. 
Abbreviations: COPD = chronic obstructive pulmonary disease, FEV1= Forced expiratory volume in one second, 
FVC = Forced vital capacity.
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ELISA
The secretion of IL-8/CXCL8 (R&D, Minneapolis, MN, USA) was assessed following the 
manufacturer’s protocol. Secretion of WFDC12 by ALI-PBEC was determined using a 
previously described ELISA (2). To this end, conditioned medium was collected from the 
basal compartment, and the apical surface samples were collected by washing the cell cultures 
with 100 µl PBS. Collected samples were directly incubated in a high-binding 96 well plate to 
allow optimal detection of WFDC12.
Data analysis
GraphPad PRISM 6.0 (GraphPad Software Inc., La Jolla, Ca) was used for statistical analysis. 
Analysis of differences was conducted by using a (un)paired Student’s t-test, Mann-Witney 
U test, or one/two-way repeated measurements ANOVA and Bonferroni post-hoc test. 
Differences between groups were considered significant at p-values < 0.05.
RESULTS
NTHi increases WFDC12 protein secretion but not mRNA expression in ALI-PBEC
As monocytes express WFDC12 in response to the microbial component LPS (2), we first 
studied the effect of microbial stimuli on WFDC12 expression by airway epithelial cells. This 
was done by stimulating differentiated ALI-PBEC to the COPD-related respiratory pathogen 
non-typeable Haemophilus influenzae (NTHi). Various concentrations of UV-inactivated 
NTHi were added to the apical surface of ALI-PBEC cultures and after 3 h incubation mRNA 
expression of WFDC12 was determined by qPCR. We did not observe an increase in WFDC12 
expression in NTHi stimulated cells (Figure 1A), and therefore assessed whether WFDC12 
expression was induced in a time-dependent manner by NTHi. This was done by exposing 
ALI-PBEC cultures to NTHi and determining mRNA expression levels after 3, 12, and 24 h 
of incubation. However, similar to the NTHi-dose response experiments, we did not observe 
a NTHi-induced expression of WFDC12 at other time points (Figure 1B). We subsequently 
Table 2 Primer sequences
Gene Forward primer Reverse primer




TGFB1 5’-CTAATGGTGGAAACCCACAACG-3’ 5’- TATCGCCAGGAATTGTTGCTG-3’
TP63 5’-CCACCTGGACGTATTCCACTG-3’ 5’-TCGAATCAAATGACTAGGAGGGG-3’
KRT5 5’-CCAAGGTTGATGCACTGATGG-3’ 5’-TGTCAGACATGCGTCTGC-3’
FOXJ1 5’-GGAGGGGACGTAAATCCCTA-3’ 5’-TTGGTCCCAGTAGTTCCAGC -3’
SCGB1A1 5’- ACATGAGGGAGGCAGGGGCTC-3’ 5’- ACTCAAAGCATGGCAGCGGCA-3’




determined whether the inability of ALI-PBEC to increase WFDC12 gene expression 
after NTHi stimulation was accompanied by unchanged protein secretion levels. First, we 
compared the baseline WFDC12 protein release in the basal culture medium and apical 
surface washes from ALI-PBEC cultures, and observed that the protein was more abundantly 
secreted in the basal culture medium (Figure 1C). Next, we assessed WFDC12 secretion in 
the basal medium of ALI-PBEC exposed at the apical surface with NTHi. In contrast to the 
unchanged WFDC12 mRNA levels, NTHi increased protein secretion in ALI-PBEC cultures 
after 24 h stimulation (Figure 1D). SLPI secretion was not affected in NTHi-stimulated ALI-
PBEC (Figure 1E), suggesting a distinct regulation of WFDC12 protein secretions in response 
to microbial stimuli. In summary, these findings suggest that NTHi increases the secretion, 

































































































Figure 1. Effect of NTHi on WFDC12 mRNA expression and protein secretion in ALI-PBEC. ALI-PBEC were stimulated 
with 0.25, 0.5, and 1*109 CFU/ml UV-inactivated NTHi and incubated for 3 h (A) or stimulated with 1*109 CFU/
ml UV-inactivated NTHi, for 3, 12 and 24 h incubation (B), followed by analysis of WFDC12 expression by qPCR. 
mRNA expression is shown as normalized values corrected for the reference genes RPL13A and ATP5B. n=10 
independent donors. (C) Baseline WFDC12 protein secretion was assessed in basal culture medium or washings 
of the apical surface of ALI-PBEC. n=9 independent donors. ALI-PBEC were stimulated with 1*109 CFU/ml UV-
inactivated NTHi for 24 h. (D) WFDC12 and E) SLPI protein secretion was determined in the basal medium. n=4 
independent donors. Results are shown as mean ± SEM. Analysis of differences was conducted with a (A,B) two-way 
ANOVA with a Bonferroni post-hoc test and (C-E) paired t-test. * p < 0.05, *** p < 0.001. 
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NTHi induces mRNA expression of WFDC12 in undifferentiated airway epithelial cells 
In a previous study, we observed NTHi-induced expression of the antimicrobial protein 
RNase 7, which was dependent on the differentiation status of the airway epithelial cells (13). 
Therefore, we further examined the induction of WFDC12 in undifferentiated submerged 
PBEC (S-PBEC) and differentiated ALI-PBEC following exposure for 24 hours to UV-
inactivated NTHi. Similar to RNase 7, WFDC12 was induced in S-PBEC but not in ALI-PBEC 
cultures (Figure 2A). To compare this response with the expression of other WFDC-family 
members, we also examined SLPI and PI3 mRNA expression levels. SLPI was not significantly 
induced in both S- and ALI-PBEC (Figure 2B). In contrast, PI3 expression was induced by 
NTHi in both types of PBEC cultures, although its induction in submerged cultures did 
not reach statistical significance (p=0.06; Figure 2C). We have recently shown that cigarette 
smoke exposure, in contrast to NTHi, increases RNase 7 expression in ALI-PBEC (13, 16). 













































































































































Figure 2. NTHi-induced expression of WFDC12 in S-PBEC and ALI-PBEC and effect of cigarette smoke. S-PBEC and 
ALI-PBEC were stimulated with 0.5*109 CFU/ml UV-inactivated NTHi, and mRNA expression was determined 
of (A) WFDC12, (B) SLPI, and (C) elafin (PI3), at 24 h after stimulation. mRNA expression was corrected for 
the reference genes RPL13A and ATP5B, and shown as fold change compared to air exposed ALI-PBEC. n=4 
independent donors. Results are shown as mean ± SEM. ALI-PBEC were exposed to air or CS and subsequently 
stimulated with 1*109 CFU/ml UV-inactivated NTHi. mRNA expression of (D) WFDC12, (E) SLPI, and (F) elafin 
(PI3) was determined by qPCR after 3 h incubation. mRNA expression is shown as normalized values corrected for 
the reference genes RPL13A and ATP5B. n=4 independent donors. Results are shown as mean ± SEM. Analysis of 




Therefore, we questioned if cigarette smoke (CS) exposure, and the combined effect of CS 
and NTHi, could affect the expression of WFDC12 in ALI-PBEC as well. Cell cultures were 
first exposed to air or CS during a period of 15 minutes, which in a previous report was 
shown to cause a transient impairment of the epithelial barrier integrity and induction of 
innate immune responses (13). Subsequently, cells were stimulated at the apical surface with 
UV-inactivated NTHi. 3 h after exposure the WFDC12 expression was determined by qPCR. 
This post-exposure incubation time was used, because in previous studies we observed that 
the main effects of CS on mRNA expression of innate immune genes were observed at early 
time points due to a transient effect (13). Similar to earlier observations, NTHi did not affect 
WFDC12 expression, but also CS exposure and the combined exposure of NTHi and CS did 
not influence the expression (Figure 2D). SLPI expression was also not affected by NTHi and 
CS (Figure 2E). Although not significant, PI3 induced by NTHi was inhibited by CS (Figure 
2F). In summary, these findings suggest that NTHi-induced WFDC12 expression depends on 
cell differentiation, but in contrast to RNase 7, is not expressed upon cigarette smoke-induced 
injury. Moreover, the expression of WFDC12 is distinct from SLPI and PI3.
TNFα/IL-1β and TGF-β1 modulate the expression of WFDC12 by ALI-PBEC
Secreted cytokines and growth factors produced by airway epithelial cells or underlying 
immune and stromal cells, can influence activity of the epithelium (4)(Whitsett and Alenghat, 
2014). Therefore, we determined the effect of the pro-inflammatory cytokines TNFα and IL-
1β on the expression of WFDC12 by ALI-PBEC. Combined stimulation with TNFα and IL-1β 
significantly increased WFDC12 expression in ALI-PBEC (Figure 3A). As positive control, 
TNFα and IL-1β also promoted mRNA expression of the pro-inflammatory chemokine IL-8/
CXCL8 (Figure 3B). Previous reports have shown that the growth factor TGF-β1 is increased 
in COPD (17, 18) and that TGF-β1 can inhibit the expression of SLPI in airway epithelial cells. 
Therefore, we explored the influence of TGF-β1 on WFDC12 production by determining the 
effect of recombinant TGF-β1 on ALI-PBEC. TGF-β1 stimulation attenuated the expression 
of WFDC12 mRNA in ALI-PBEC (Figure 3C). However, we did not observe a significant 
suppression of WFDC12 protein secretion into the basal medium of ALI-PBEC (Figure 3D). 
Interestingly, mRNA expression and protein secretion of IL-8/CXCL8 was also increased by 
TGF-β1 in ALI-PBEC (Figure 3E,F). This suggests a differential effect of TGF-β1 on WFDC12 
and IL-8/CXCL8 expression, which is in contrast to the effects of TNFα/IL-1β stimulation. 
To further examine whether endogenous TGF-β produced by airway epithelial cells caused 
suppression of WFDC12, the effect of a neutralizing antibody directed against TGF-β1 was 
investigated. In line with our findings following addition of TGF-β1, anti-TGF-β1 increased 
WFDC12 mRNA and protein expression, when compared to an isotype antibody control 
(Figure 3G,H). Overall, these findings suggest that the pro-inflammatory cytokines TNFα/IL-
1β can increase WFDC12 mRNA expression in airway epithelial cells, whereas exogenously 
added or endogenously produced TGF-β1 impairs the expression.
TGF-β1 and WFDC12 are differentially expressed in basal and luminal airway epithelial cells
Increased levels of TGF-β1 have been shown to impair the expression of the polymeric 
immunoglobulin receptor (pIgR) by affecting cell differentiation (18, 19). Therefore, we 
examined the influence of airway epithelial cell differentiation on the expression of WFDC12 
in ALI-PBEC cultures, and furthermore determined expression levels of TGF-β1 mRNA 
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(TGFB1) during differentiation. First, baseline expression of WFDC12 and TGFB1 was 
determined in undifferentiated ALI-PBEC (i.e. confluent layers of PBEC grown in Transwell 
inserts), and cells that were differentiated at the ALI for 1 and 2 weeks. WFDC12 expression 
levels were significantly increased upon 1 and 2 weeks of airway epithelial cell differentiation 
at the air-liquid interface (Figure 4A). In contrast, expression of TGFB1 was significantly 
reduced after 1 and 2 weeks of cell differentiation (Figure 4B). These findings suggest an inverse 
relationship between WFDC12 and TGFB1 expression, which are respectively increased and 
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Figure 3. Effect of TNFα/IL-1β and TGF-β1 on the expression of WFDC12. (A) ALI-PBEC cultures were stimulated 
with TNFα/IL-1β (both 20 ng/ml) and after 24 h incubation expression of WFDC12 was determined. mRNA 
expression is shown as normalized values corrected for the reference genes RPL13A and ATP5B. n=4 independent 
donors. (B) IL-8/CXCL8 mRNA expression was also determined after TNFα/IL-1β (both 20 ng/ml) stimulation. (C) 
ALI-PBEC cultures were stimulated with TGF-β1 (20 ng/ml) for 24 h. After incubation WFDC12 expression was 
determined. mRNA expression is shown as normalized values corrected for the reference genes RPL13A and ATP5B. 
n=4 independent donors. (D) Protein secretion of WFDC12 was assessed in the basal medium of unstimulated or 
TGF-β1 (20 ng/ml) - stimulated ALI-PBEC, 24 h after stimulation. n=3 independent donors. IL-8/CXCL8 (E) mRNA 
and (F) protein secretion was also determined after TGF-β1 (20 ng/ml) stimulation. (G) Differentiated ALI-PBEC 
were incubated for 24 h with an anti-TGF-β1 or isotype control antibody (both 10 µg/ml) that was added to the 
basal compartment. mRNA expression of WFDC12 was determined by qPCR. (H) Secretion of WFDC12 into the 
basal medium was assessed by ELISA. n=3-4 independent donors. Results are shown as mean ± SEM. Analysis of 
differences was conducted with a paired t-test. * p < 0.05, ** p < 0.01.
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whereas differentiated cultures are composed of basal and luminal cells, we next isolated 
enriched luminal and basal cell fractions from fully differentiated ALI-PBEC cultures and 
determined mRNA expression levels in these fractions. We confirmed successful separation 
of both fractions by showing higher expression of the basal cell markers TP63 and KRT5 in 
the basal cell fraction, whereas FOXJ1 (ciliated cells) and SCGB1A1 (club cells) expression 
was more abundant in the luminal cell fraction (Figure 4C). A significantly higher expression 
of WFDC12 in the luminal cell enriched fraction was observed, whereas TGFB1 was more 
abundant in the basal cell fraction. Overall, these findings suggest that constitutive expression 
of WFDC12 in airway epithelial cells is increased during differentiation by formation of 





























































































Figure 4. Airway epithelial cell differentiation regulates WFDC12 and TGF-β1 expression. Airway epithelial cell mRNA 
expression of (A) WFDC12 and (B) TGFB1 was determined in undifferentiated PBEC (-) and ALI-PBEC differentiated 
for 1 or 2 weeks. n=6-9 independent donors. (C) Luminal and basal cell fractions were separated in differentiated 
ALI-PBEC and mRNA expression of WFDC12 and TGFB1 was determined. In addition, the expression of TP63, 
KRT5 (both basal cell markers), FOXJ1 (ciliated cell marker), and SCGB1A1 (club cell marker) was determined. n=4 
independent donors. Results are shown as mean ± SEM. Analysis of differences was conducted with (A,B) a one-way 
ANOVA with a Bonferroni post-hoc test (compared to (-) undifferentiated) and (C) a paired t-test.* p < 0.05.
 203 
WFDC12 EXPRESSION IN COPD AIRWAY EPITHELIAL CELLS
9
Lower expression of WFDC12 in COPD airway epithelial cells 
In previous experiments we used epithelial cells that were not selected based on COPD 
disease status. However, as gene expression may be altered in COPD patients, we further 
examined the expression levels of WFDC12 in cultured ALI-PBEC from COPD patients and 
non-COPD (ex)smokers. Compared to non-COPD cultures, COPD ALI-PBEC displayed a 
significantly lower expression of WFDC12 (Figure 5A). Because of the large spread in mRNA 
expression between individual donors, we further assessed the correlation between lung 
function and WFDC12 levels. A significant correlation was observed between WFDC12 and 
FEV1 (% predicted) (Figure 5B) and FEV1/FVC (% predicted) (Figure 5C). These findings 
suggest lower baseline expression of WFDC12 in COPD cultures compared to non-COPD, 






























































Figure 5. Expression of WFDC12 in COPD and non-COPD ALI-PBEC. (A) Expression of WFDC12 in ALI-PBEC 
cultures from non-COPD (ex)smokers (open circles, n=8) and COPD patients (black circles, n=11). mRNA 
expression is shown as normalized values corrected for the reference genes RPL13A and ATP5B. Individual data 
points are shown with median and interquartile range. Analysis of differences was conducted with a Mann-Whitney 
test. ** p < 0.01. (B) Correlation between FEV1 (% predicted) and WFDC12 expression (r=0.5630, p=0.0150). (C) 




We report a dynamic regulation of WFDC12 expression in airway epithelial cells, which 
increases during cell differentiation, and furthermore is distinct from other WFDC-family 
members. In contrast to the expression of other innate immune mediators (13), WFDC12 
mRNA expression by ALI-PBEC was not affected by stimulation with UV-inactivated NTHi 
or acute exposures to cigarette smoke. We cannot formally exclude that live bacteria or 
prolonged exposures to cigarette smoke could have affected WFDC12 expression. Interestingly, 
UV-inactivated only increased WFDC12 mRNA expression in undifferentiated PBEC, but 
did increase WFDC12 protein secretion in ALI-PBEC cultures suggesting release of stored 
WFDC12. In contrast to differentiated ALI-PBEC, WFDC12 mRNA was further increased in 
undifferentiated S-PBEC exposed to UV-inactivated NTHi. This finding corresponds with an 
earlier study examining the expression of the antimicrobial protein RNase 7 (13), and further 
indicates that differentiated and undifferentiated airway epithelial cells display distinct innate 
immune properties.
The increase in WFDC12 in S-PBEC upon stimulation with NTHi suggests that a pro-
inflammatory environment may increase the expression of WFDC12 in basal cells. Such a 
mechanism may contribute to the regulation of airway epithelial innate immunity upon injury, 
when basal cells may be exposed to respiratory pathogens in the absence of a luminal cell layer 
(20, 21). Examination of the influence of pro-inflammatory cytokines demonstrated that, in 
contrast to NTHi, TNFα/IL-1β stimulation did increase WFDC12 expression in ALI-PBEC. 
This is likely explained by the fact that these cytokines were added to the basal compartment 
of the culture and therefore were readily able to stimulate basal cells. In addition to TNFα/IL-
1β, we have observed in preliminary studies that IL-4 and IL-17 could also increas WFDC12 
expression in undifferentiated S-PBEC (unpublished data). This suggests that a range of other 
cytokines can induce the expression of WFDC12.
We also observed a decrease in WFDC12 expression by TGF-β1, which is similar to earlier 
reports demonstrating that TGF-β1 also impaired expression of SLPI (22-24). It becomes 
more obvious that TGF-β and related growth factor family members play an important role in 
COPD pathogenesis (25). Besides decreasing the expression of WFDC12, TGF-β1 increased 
airway epithelial expression of the pro-inflammatory chemokine IL-8/CXCL8. This suggests 
that TGF-β1 causes imbalances in the expression of anti- and pro-inflammatory factors by the 
airway epithelium that may contribute to the persistence of airway inflammation. Interestingly, 
it was reported that TGF-β did not affect the expression of IL-8 in undifferentiated S-PBEC 
(26). This suggests that airway epithelial responses to TGF-β are also cell differentiation 
dependent.
Supporting our earlier assumption that differentiated ALI-PBEC express WFDC12 in 
sufficient quantities, we observed that WFDC12 mRNA expression became more abundant 
during cell differentiation. We furthermore detected WFDC12 mainly in luminal cells of 
differentiated ALI-PBEC cultures. Indeed, the luminal airway epithelium consists of different 
cell types, i.e. ciliated, goblet and club cells. Therefore, expression of WFDC12 may be more 
restricted to a certain luminal cell type, which requires further study. In line with previous 
studies (27, 28), TGFB1 expression levels were decreased upon mucociliary differentiation, 
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and its expression was mainly observed in the basal cell fraction of ALI-PBEC. This suggests 
an inverse relationship between WFDC12 and TGF-β1 expression during cell differentiation, 
in which a reduction in TGF-β1 may allow an increase in WFDC12. The distinct expression of 
WFDC12 in luminal and basal cells of ALI-PBEC, might be explained by a cell differentiation 
dependent effect of TGF-β. Another explanation for the low expression of WFDC12 by basal 
cells is the quiescent state of the cells in intact ALI-PBEC cultures, whereas expression in 
injured conditions can be elevated by inflammatory stimuli.
Previous studies have revealed impaired defense mechanisms in cultured epithelial cells 
from patients with COPD. This includes a recent report from our group showing that 
COPD epithelial cell cultures display reduced antibacterial activity and expression of the 
antimicrobial mediators hBD-2 and S100A7 (29). In the present study we extend these 
findings by showing that airway epithelial cell expression of WFDC12 is intrinsically lower in 
differentiated ALI-PBEC from COPD patients compared to non-COPD controls. Based on 
the previously described function of the protein as a protease inhibitor and anti-inflammatory 
mediator (2), it can be speculated that the attenuated expression of WFCD12 by airway 
epithelial cells in COPD contributes to enhanced airway tissue injury and inflammation. 




















Figure 6. Proposed model for regulation of epithelial WFDC12 expression. Intact airway epithelium consists of luminal 
cells and basal cells. Release of stored WFDC12 protein by intact epithelium is increased upon exposure to microbes, 
whereas mRNA expression is increased by TNFα/IL-1β, and inhibited by TGF-β1. Injured epithelium consists of 
basal cells that restore the injured epithelial layer and that express WFDC12 upon exposure to microbes. Moreover, 
basal cells express TGF-β1, which inhibit WFDC12. Upon regeneration of the airway epithelium, basal cell numbers 
decrease, resulting in a reduced level of TGF-β1. Inversely, WFDC12 expression increases upon differentiation and is 




is furthermore unknown how comparable the levels of WFDC12 are between epithelial cells 
and macrophages and therefore whether lower levels in COPD epithelium are compensated 
or overruled by the enhanced numbers of inflammatory macrophages in the lungs of COPD 
patients. Further research examining both the functional properties of WFDC12 from airway 
epithelial cells, and studying the expression of this protein in macrophages and other immune 
cells in COPD is therefore required to investigate this. 
Based on our findings, we propose the following model (Figure 6) in which WFDC12 
expression is dynamically regulated in the airway epithelium. In intact epithelium, WFDC12 is 
constitutively expressed in luminal cells, and the protein is released upon exposure to microbes. 
WFDC12 is furthermore induced by TNFα/IL-1β, and suppressed by TGF-β1, which may be 
derived from by the epithelium itself, or by immune or stromal cells. Upon epithelial injury, 
death and/or shedding of luminal cells may result in exposure of the underlying basal cells to 
invading micro-organisms, which may result in the induction of WFDC12 in these basal cells. 
Upon epithelial repair, TGF-β1 initially suppresses airway epithelial WFDC12 expression. 
When repair progresses, TGF-β1 levels decline, whereas WFDC12 expression by luminal cells 
increases. This constitutive expression of WFDC12 in the luminal cells of restored epithelium 
is lower in COPD airway epithelial cells when compared to non-COPD smokers. 
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Respiratory infections are a major clinical problem, and treatment is increasingly complicated 
by the emergence of microbial antibiotic resistance. Development of new antibiotics is 
notoriously costly and slow, and therefore alternative strategies are needed. Antimicrobial 
peptides, central effector molecules of the immune system, are being considered as an 
alternative to conventional antibiotics. These peptides display a range of activities, including 
not only direct antimicrobial activity but also immunomodulation and wound repair. In 
the lung, especially airway epithelial cells and neutrophils contribute to their synthesis. The 
relevance of antimicrobial peptides for host defense against infection has been demonstrated 
in animal models, and is also supported by observations in patient studies, showing altered 
expression and/or unfavorable circumstances for their action in a variety of lung diseases. 
Importantly, antimicrobial peptides are active against micro-organisms that are resistant 
against conventional antibiotics, including multidrug resistant bacteria. Several strategies 
have been proposed to use these peptides in the treatment of infections, including direct 
administration of antimicrobial peptides, enhancement of their local production and creation 
of more favorable circumstances for their action. In this review, recent developments in 
antimicrobial peptides research in the lung and clinical applications for novel therapies of 
lung diseases are discussed.
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INTRODUCTION
Respiratory infections are a major clinical problem. According to the World Health 
Organization (WHO), lower respiratory infection was the fourth leading cause of death 
worldwide in 2012 (1). In addition to pneumonia and bronchitis, lower respiratory tract 
infections also markedly contribute to chronic inflammatory lung disorders such as cystic 
fibrosis (CF), chronic obstructive pulmonary disease (COPD) and asthma. Although antibiotic 
treatment is considered as the most effective medical intervention currently available, there 
is a growing concern regarding the increase of microbial antibiotic resistance. Antibiotic 
resistance is associated with marked morbidity and mortality, and also poses an increasing 
economic burden. Therefore, it is now considered as a top public health threat for which novel 
approaches are needed. In addition to stimulating the prudent use of antibiotics, there is an 
urgent need for new antibiotics. However, it has proven increasingly difficult and extremely 
costly to develop novel antibiotics resulting in a limited pipeline for new antibiotics. Therefore, 
many pharmaceutical companies have put a hold on their antibiotic research activities.
 
Several alternatives for antibiotics have been proposed, and in a back-to-nature approach 
new strategies are being developed, including the use of bacteriophages, probiotics and 
antimicrobial peptides. Antimicrobial peptides (AMPs) are effector molecules of the immune 
system, and research has demonstrated that these peptides may serve as potential alternatives 
for conventional antibiotics. AMPs display broad-spectrum antimicrobial activity against 
bacteria, fungi and viruses, including multidrug resistant (MDR) micro-organisms and those 
present in biofilms. Production of AMPs by e.g. airway epithelial cells and neutrophils is 
one of the varieties of mechanisms used by the lung to deal with the continuous largescale 
exposure to numerous inhaled pathogens. In this review we will discuss the natural role of 
AMPs in lung host defense and their therapeutic potential in the treatment of lung diseases.
 
ANTIMICROBIAL PEPTIDES AND THEIR ROLE IN HOST DEFENSE AGAINST 
RESPIRATORY INFECTIONS AND IN CHRONIC LUNG INFLAMMATION
Originally discovered for their (direct) antimicrobial actions, AMPs are nowadays increasingly 
recognized for their miscellaneous qualities ranging from antimicrobial to anti-biofilm, 
anticancer and immunomodulation. AMPs are part of the evolutionary conserved innate 
immune system, and are abundantly produced in the lung and other mucosal tissues, where 
they act as the first line of defense against infections (2) . Over 2000 naturally occurring AMPs 
have been identified so far (http://aps.unmc.edu/AP/main.php), and also humans express 
various AMPs. These AMPs have overlapping actions, but often are active against different 
pathogens, at different locations in the body with different mechanisms of action. The main 
AMPs that are detected in lung tissues and secretions, are neutrophil α-defensins/human 
neutrophil peptides (HNPs), human β-defensins (hBDs) and the cathelicidin hCAP18/LL-37 
(3, 4). In the lung, not only the smaller AMPs but also other larger antimicrobial proteins are 
produced, including lysozyme, lactoferrin, secretory leukocyte proteinase inhibitor (SLPI), 
elafin and RNase 7 (5) . Several cell types contribute to production of AMPs in the lung. 
Airway epithelial cells represent a major source of these peptides in the lung, producing e.g. 
hBD-1, hBD-2, hBD-3 and LL-37. These AMPs are expressed either constitutively or are 
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induced by microbial exposure, injury, cytokines, growth factors produced during wound 
repair, or (micro)nutrients such as vitamin D 4 . Also, myeloid cells such as neutrophils and 
macrophages, contribute to the presence of AMPs in the lungs. In particular, neutrophils that 
are attracted during inflammation are the primary source of HNPs and LL-37. These AMPs 
act intracellular within the phagolysosome to kill ingested micro-organisms, or are secreted or 
released in complex with DNA in structures known as neutrophil extracellular traps (NETs) 
(6). Recent studies highlight that AMPs such as LL-37 may also stimulate formation of NETs 
and stabilize these by providing protection against nuclease-mediated degradation, and thus 
contribute to this recently identified mechanism of host defense (6, 7). 
The presence of these AMPs contributes to innate lung defense by displaying a variety of 
mechanisms of action, including direct antibacterial and antifungal activity mediated by lysis 
of micro-organisms through formation of transmembrane pores or by impairing bacterial 
viability by affecting processes such as cell wall biosynthesis (8). In addition, AMPs display 
antiviral activity against a range of viruses (9). Besides their direct antimicrobial activity, 
AMPs have an active role in shaping the immune response in the lung, displaying pro- and 
anti-inflammatory properties, chemotactic activity, inducing expression of cytokines and 
chemokines and modulating dendritic cell maturation (10). Moreover, they can promote 
wound healing by enhancing airway epithelial cell repair and promoting angiogenesis  (11, 
12). The detailed contribution of AMPs to innate defenses against infections has been clearly 
demonstrated in a variety of animal model studies. In the fruit fly Drosophila melanogaster, 
which only has an innate immune system, abrogation of microbial induced expression of 
AMPs resulted in enhanced infections and reduced host survival (13). In line with this, aerosol 
treatment with a bacterial lysate or a combination of microbial ligands, provides protection 
against a broad-spectrum of respiratory pathogens in a murine model (14). This protection 
was not dependent on immune cells, but mediated by lung epithelial cells through induced 
expression of AMPs. An example of the importance of microbial induced expression of AMPs 
in host defense is observed in patients with Crohn’s disease that have a polymorphism in 
the gene encoding the cytosolic microbial pattern recognition receptor nucleotide-binding 
oligomerization domain-containing protein 2 (15). This polymorphism impairs intestinal 
expression of AMPs, thereby contributing to enhanced infections and chronic inflammation.
Whereas these studies highlight the relevance of AMPs for host defense in general, a variety 
of studies also provide direct evidence for a protective role of AMPs in lung infections. This 
is well-illustrated by research on the cathelicidin peptide LL-37 and the cathelicidin mouse 
orthologue (cathelicidin-related antimicrobial peptide) CRAMP. Transgenic overexpression 
of LL-37 in mice provided protection against Pseudomonas aeruginosa infection (16). 
Conversely, CRAMP deficient mice were more sensitive to Gram-negative bacterial 
pneumonia (17). Similar in vivo studies also support a role for human LL-37 and murine 
CRAMP in host defense against influenza A respiratory viral infections (18). Moreover, in 
individuals with vitamin D deficiency, reduced expression of LL-37 expression may increase 
susceptibility to tuberculosis infections (19). Similar model studies have highlighted the role 
of e.g. β-defensins in respiratory infections (reviewed in (20)).
In addition to a role in respiratory infections, aberrant expression and activity of AMPs is also 
associated with non-infectious lung diseases (Table 1). Airway epithelial expression of hBD- 
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2 is reduced in smokers, patients with COPD, and CF lung disease, which could be a reason 
for increased microbial colonization and infections in these diseases (21-23). Also allergic 
airways inflammation has been shown to reduce AMP expression (24). Moreover, reduced 
pH of the airway surface liquid as observed in infants with CF, may impair the activity of 
AMPs, as demonstrated in a porcine CF model and in vitro (25, 26). Importantly, not only 
the pH of the local environment but also other local conditions may impair the antimicrobial 
activity of AMPs, including AMP degradation by microbial and host proteases (27, 28), and 
inhibition of AMP activity by salt, microbial polysaccharides, F-actin and DNA from dying 
cells, and mucus (29).










Neutrophils • Asthma: increased systemic expression of HNP-1 in especially 
neutrophilic asthma (58)
• Asthma: increased BAL HNP1-3 levels in RV infection (34)
• Bronchiolitis obliterans syndrome: increased HNP1-3 in BAL(33)
• COPD: HNP-1 and HNP-2 increased in BALF(31); sputum HNP1-
3 associated with COPD severity (30)
• Cystic fibrosis: high levels of HNP1-3 in sputum (59)
β-defensins Mainly airway
epithelial cells
• Acute pneumonia: smoking associated with reduced hBD-2 in 
pharyngeal washings (22)
• COPD: Increased hBD-1 expression in central airways in COPD 
(60) 
• COPD: hBD-2 expression is decreased in central airways (21) and 
sputum and BAL(61), and increased in peripheral lung tissue(62)
• Cystic fibrosis: decreased hBD-2 levels correlate with disease 
severity (23)
• Diffuse panbronchiolitis: increased hBD-2 in plasma and hBD-1 




• Bronchiolitis obliterans syndrome: increased levels in BAL(33)
• COPD: increased expression in small airways in smokers and 
especially smokers with COPD(64)
• Cystic fibrosis: increased levels in BAL correlate with disease 
severity(23)
• Lung cancer: increased expression(65)
In contrast to the impaired expression and activity of airway epithelial AMPs in COPD and 
CF, increased neutrophilic inflammation in these diseases is associated with increased levels 
of neutrophil-derived HNPs and LL-37 (23, 30, 31). Moreover, exacerbations in COPD caused 
by bacterial infections, or induced experimentally upon rhinovirus infection, are associated 
with further increased levels of neutrophil-derived AMPs in the lung (28, 32). Similar to 
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COPD and CF, increased neutrophilic inflammation correlated with enhanced levels of 
neutrophil-derived AMPs in neutrophilic asthma, bronchiolitis obliterans syndrome, and 
interstitial lung disease (33-35). In these diseases, especially neutrophil-derived AMPs might 
contribute to lung injury and inflammation through their pro-inflammatory activity and 
cytotoxic properties at high concentrations. These studies illustrate that both insufficient as 
well as excessive levels of AMPs may contribute to lung disease development and progression. 
Low levels of AMPs or impairment of their activity may increase susceptibility to infection, 
alter the microbiome and impair wound repair, inflammation and immunity. In contrast, 
highly increased levels of AMPs may contribute to inflammation, uncontrolled immune cell 
recruitment, tissue injury and an altered microbiome. This illustrates that homeostasis of 
AMPs in the lung is important and that lack or excess of AMPs both have detrimental effects. 
Therefore, monitoring levels of AMPs in respiratory secretions or tissue in inflammatory lung 
diseases may provide important information on disease pathogenesis. Furthermore, when 
designing clinical trials using AMPs, these consequences of inappropriate levels of AMPs 
need to be taken into consideration.
AMPS AS CANDIDATES FOR DRUG DEVELOPMENT 
Use of AMPs as therapeutics seems a valid option based on their multiplicity of actions 
against multidrug resistant (MDR) pathogens as discussed above. Furthermore, their 
antibiofilm qualities are extremely relevant in a hospital setting where biofilms (including 
those with MDR micro-organisms) on both biotic surfaces (such as the airways) as well as on 
implants or mechanical ventilators are notoriously therapy resistant (36). However, because 
of the variety of antimicrobial and other activities, the therapeutic window of these peptides 
is probably different for each peptide and each disease. As discussed in the previous section 
and illustrated in Figure 1, a relative deficiency as well as excessive AMP expression and/
or activity may be detrimental. Several factors need to be taken into account that could 
affect the therapeutic success of AMP-based therapeutic strategies: 1) type of AMP used, 
2) route of administration and 3) local environment. However, a threat to this use is the 
potential development of pathogenic resistance against these peptides (37). Especially the 
development of resistance against endogenous peptides would be detrimental for the host 
defense against infection. However, as AMPs are ancient molecules that have diverse actions, 
complete resistance as detected in modern antibiotics is not expected to occur (38). Another 
potential risk could be interference of externally administered AMPs with microbiota. This is 
important since the composition of the microbiome is highly relevant to the development and 
progression of chronic lung disease (39). However, especially since the microbiome also needs 
to be protected against unwanted actions of endogenous AMPs, it may not be surprising that 
the healthy microbiome appears to be relatively protected against AMP-mediated killing (40).
 
Proof-of-principal for therapeutic efficacy of endogenous AMPs in lungs has been delivered 
by over-expressing LL-37 in the lungs of mice or by direct administration of this peptide 
to the lungs. This resulted in reduced bacterial load and enhanced survival of the infected 
mice (16, 41). AMPs were also active against P. aeruginosa in a rat model of CF where both 
reduced pathogenic load and anti-inflammatory activity was observed by these peptides 
(42). Alternatively, one could rebalance endogenous production of AMPs, for instance when 
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expression of these are compromised during disease. Several inducers of endogenous AMP 
expression have been discovered over the last 10 years, of which sodium- and phenylbutyrate 
have shown promising activities in clinical trials (43, 44). The success of vitamin D treatment, 
another inducer of AMP expression, may be most pronounced in those patients with severe 
vitamin D deficiency (45, 46) .
Despite the array of naturally occurring AMPs, little progress has so far been made with 
therapeutic development of these endogenous peptides. This may in part be explained by 
AMPs not displaying optimal activity in an inflamed and infected lung. Especially in CF, 
the loss of function of the cystic fibrosis transmembrane conductance regulator (CFTR) has 
multiple consequences that may affect endogenous AMP activity, including direct effects 
on the pH in the airway surface liquid as mentioned before and indirect effects caused by 
inflammation, cell death and mucus hypersecretion. Therefore, the discovery of small 
molecules that restore CFTR function may have important implications for local AMP 
activity in the lungs of CF patients treated with such compounds. Furthermore, in the lung a 
rather different environment exists compared to for example skin, gut or tissue. So peptides 
possibly have to be designed for the specific microenvironment they have to be functional 
in to withstand protease activity or for example unfavorable pH. Furthermore, the local 
environment can also alter AMP activity (47), which is another feature that needs to be taken 
into consideration as AMPs might work in one organ and not in another. 
The limited success of AMP-based therapy so far may also be explained by the fact that these 
AMPs have several disadvantages for therapeutic use in addition to the loss of local activity, 
such as a short half-life and toxicity. An alternative and perhaps also complementary strategy 
is the development of improved substitutes for AMPs. Innate defense regulators (IDRs) are 
a group of synthetic peptides inspired by various naturally occurring peptides with the aim 
to enhance their immunomodulatory activity for therapeutic use (48). So far, IDR peptides 
were shown to reduce pathogen load and inflammation in mice infected with (MDR) M. 
tuberculosis (49) and were successful as a vaccine strategy in mice and cotton rats against 
RSV (50). Furthermore, research also focuses now on alternative compounds based on AMPs 
(e.g. peptidomimetics) for exogenous administration. Peptidomimetics are compounds that 
have favorable qualities compared to AMPs, though at lower production cost and without 
protease sensitivity (51). Both in vitro and in mice, AMPs mimetics have been shown to have 
favourable effects against for example oral candidiasis (51, 52) . 
In addition to the component itself, the route of administration needs to be wisely chosen 
also taking into consideration which activity of the AMP is targeted. When aiming for 
direct antimicrobial activity, most likely inhaled administration is preferred with these 
peptides over systemic administration. The immunomodulatory effects of AMPs seem more 
robust and could probably also contribute to their activity upon systemic administration, 
if toxicity allows this type of delivery. Administration can be further enhanced for example 
by combining AMPs with exogenous surfactant, which was demonstrated to be a promising 
possibility for improved delivery of AMPs to the lung (53). Alternatively, also for the inducers 
of endogenous AMPs, their effectiveness can be improved by enhancing their delivery (54). 
Lastly, combining AMPs with antibiotics shows promising results in the fight against (MDR) 
microorganisms as synergy is observed in their antimicrobial actions (55, 56). This synergy 
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may in part be explained by the ability of AMPs to increase bacterial membrane permeability 
to antibiotics, as recently demonstrated by the ability of LL-37 to potentiate the penetration of 
azithromycin into MDR bacteria (57) . 
Altogether, successful management of an AMP(-based) therapy seem challenging due to the 
high variety of factors that need to be taken into consideration. However research shows 
innovative solutions to optimally target AMPs for therapeutic success. Whereas in the past, 
several clinical trials have evaluated the effect of AMP administration for the treatment 
of respiratory diseases, the current focus in ongoing clinical trials is on treatments, which 
induce the endogenous expression of AMPs (www.clinicaltrials.gov).The encouraging trend 
observed in e.g. studies with vitamin D and phenylbutyrate will hopefully show promising 
results further stimulating research into this direction.
CONCLUSION
Research on AMPs has flourished in the past decades, but so far has not resulted in major 
breakthroughs in the treatment of respiratory infections. This is partly explained by the low 
cost and effectiveness of conventional antibiotics for the majority of patients. As a result, 
new antibiotic strategies are usually reserved for patients with complicated infections, and 
as a result the potential market is still limited. In this review we have highlighted why AMPs 
may be interesting candidates for novel antibiotic strategies, and shown that the multitude of 
activities displayed by AMPs may both be an advantage of their use, but also poses specific 
challenges. There are three promising strategies for their use: direct application of AMPs or 
AMP-inspired compounds, enhancement of local production and improving local conditions 
for AMPs actions (Figure 1). In addition, further research on the mechanisms underlying 
Figure 1. Endogenous functions and possible therapeutic strategies for using AMPs in the treatment of infectious 
or inflammatory lung diseases. Although AMPs offer an attractive alternative to conventional antibiotics, various 
factors that may limit their use need to be considered. AMPs = antimicrobial peptides.
• Antimicrobial and anti-
   parasitic activity
• Immune modulation
• Wound healing
• Administration of AMPs or AMP-
   inspired compounds
• Enhancement of endogenous
   production








Endogenous function Therapeutic strategies
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deficient AMP expression and/or activity in chronic lung diseases is needed, and may also 
lead the way to the discovery of novel treatments. 
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SUMMARY AND GENERAL DISCUSSION
This thesis describes a collection of studies which examined the effects of cigarette smoke 
(CS) and COPD disease status on airway epithelial innate host defense. In this last part, first 
an overview is given of the main findings of this thesis. Next, the role of alterations in airway 
epithelial innate host defense will be further discussed, focusing on its role in microbial 
colonization and infection, airway inflammation, and epithelial remodeling. Finally, a model 
will be proposed in which the role of airway epithelial cells in COPD will be summarized, 
according to the vicious circle hypothesis (1).
OVERVIEW OF THE MAIN FINDINGS IN THE THESIS
Antimicrobial proteins and peptides (AMPs) play an important role in the host defense of the 
lungs. In Chapter 2 (2) it is summarized that this defense mechanism is altered in COPD and 
therefore may contribute to the disease. Excessive neutrophilic inflammation in COPD leads 
to enhanced levels of neutrophil-derived AMPs, i.e. LL-37 and alpha-defensins, which may 
promote inflammation and airway tissue injury and remodeling. In contrast to neutrophils, 
AMPs produced by the airway epithelium are suppressed by smoking or in COPD. Therefore, 
this may contribute to the increased susceptibility to microbial colonization and infections in 
patients. 
In the next series of experimental studies described in this thesis, it was explored how airway 
epithelial expression of AMPs and other host defense mediators are affected by smoking and 
COPD disease status. 
In Chapter 3 (3) it is described that expression of the antimicrobial protein Ribonuclease 
7 (RNase 7) was selectively induced upon microbial stimuli of undifferentiated basal cells 
(BCs) but not in differentiated cell cultures. Moreover, BCs present in differentiated cultures 
also produced RNase 7 upon transient injury caused by CS exposure. This was mediated 
by activation of the epidermal growth factor receptor (EGFR) and the downstream MEK/
ERK1/2 signaling transduction pathway. 
The microbial-induced expression of well described AMPs, i.e. human beta-defensin 2 
(hBD-2), CCL20, LCN2 and S100A7, and antibacterial activity of airway epithelial cells 
was investigated in Chapter 4 (4). Here we first observed an impaired antibacterial activity 
towards non-typeable Haemophilus influenzae (NTHi) in COPD airway epithelial cultures, 
when compared to non-COPD controls. In line with this, we furthermore detected lower 
NTHi-induced mRNA expression of the AMPs hBD-2 and S100A7. Next, we observed that 
CS exposure reduced airway epithelial expression of hBD-2, CCL20, LCN2 and S100A7 in 
both NTHi-stimulated COPD and non-COPD cultures. In contrast, expression of the pro-
inflammatory mediators IL-8 and IL-6 persisted upon epithelial exposure to NTHi and CS. 
This selective impairment of AMPs expression was related to suppression of NFκB signaling, 






Next to microbial-induced AMPs, we further investigated in Chapter 5 the expression of 
constitutively expressed AMPs and other host defense proteins in airway epithelial cells. 
We observed that human beta-defensin 1 (hBD-1) was highly expressed in undifferentiated 
airway epithelial cells, while the expression was reduced upon cell differentiation. In contrast, 
other AMPs and host defense proteins, i.e. SLPI, SPLUNC, LPLUNC, and PIGR, were 
increased in differentiated cultures and were furthermore found to be restricted in luminal 
epithelial cells. Using a chronic CS exposure model, we further demonstrated that impaired 
epithelial differentiation caused by CS was accompanied by a reduced expression of luminal 
cell-restricted host defense proteins. This differentiation-dependent effect could be mimicked 
by blocking the Notch signaling pathway
.
In addition to expression of innate immune mediators, we further determined the effects of 
cigarette smoking on airway epithelial injury and repair, which is described in Chapter 6 
(5). Here we examined the effect of CS on the airway epithelial barrier integrity and wound 
repair using a calcium switch assay and mechanical injury model respectively. CS exposure 
caused a delay in epithelial repair in both models. In contrast, combined epithelial injury and 
CS exposure further enhanced RNase 7 expression. Increased number of BCs were observed 
at the wounded edge of CS exposed injured cultures, thereby suggesting that CS reduced 
BC migration. It was furthermore shown that CS-induced oxidative stress contributed to 
impaired wound repair. Moreover, oxidative stress increased downstream MEK ERK1/2 
signaling independent of EGFR, thereby causing a further increase in RNase 7 expression.
As CS exposure of epithelial cells caused transient impairment in epithelial repair while 
causing low cytotoxic effects, we further examined in Chapter 7 the effect of CS on activation 
of the cytoprotective integrated stress response (ISR) in airway epithelial cells. We observed 
that CS caused transient activation of the ISR in differentiated airway epithelial cells, which 
could be reproduced in undifferentiated cells exposed to CS extract. In addition we observed 
that CS-induced mRNA expression of the ISR target genes GADD34 and CHOP was higher 
in COPD cultures compared to non-COPD controls and negatively correlated with lung 
function. In addition, we described how CS-induced oxidative stress can induce expression of 
GADD34 via an ISR-independent mechanism. In the discussion, we speculated that enhanced 
oxidative stress-dependent expression of GADD34 is needed to promote the production of 
inflammatory mediators by airway epithelial cells, and therefore may contribute to airway 
inflammation in COPD.
Next to epithelial injury and repair, we further explore the potential influence of CS on 
airway tissue remodeling in Chapter 8 (6). Here we described that the surface bound matrix 
metalloprotease ADAM17 contributed to increased mRNA expression and shedding of 
soluble IL-6 receptor (sIL-6R) and amphiregulin (AREG). Basolateral protein shedding of sIL-
6R and AREG mediated by ADAM17 was significantly higher in COPD cultures. In addition 
to ADAM17, we furthermore observed that CS-induced EGFR signaling was involved IL-6R 
and AREG mRNA and protein expression, thereby further demonstrating the importance of 
EGFR in airway epithelial inflammation and repair/remodeling.
 
In Chapter 9 we further examined the expression of the novel innate immune mediators 
WFDC12 in airway epithelial cultures. Similar to RNase 7, WFDC12 expression was only 
observed in undifferentiated cultures upon microbial stimulation. However, CS exposure did 
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not affect the expression in differentiated cell cultures, as was seen with RNase 7. Stimulation 
with the pro-inflammatory cytokines IL-1β and TNFα did however increase the expression 
of WFDC12 in differentiated cells, whereas TGFβ1 attenuated the expression. Constitutive 
expression of WFDC12 increased upon mucociliary differentiation, and was furthermore 
enriched in the luminal airway epithelial fraction of differentiated cell cultures. Moreover, we 
observed lower WFDC12 expression in COPD cultures compared to non-COPD controls, 
which correlated with lung function.
Finally, in Chapter 10 (7) it is discussed how the impaired antimicrobial defense system 
in COPD but also other noninfectious and infectious lung diseases can be therapeutically 
targeted. Here it is mentioned that the COPD patients may be treated with synthetic AMPs, 
AMP–inspired molecules or through induction of endogenous AMPs to prevent microbial 
infections and colonization. 
ROLE OF IMPAIRED AIRWAY EPITHELIAL ANTIBACTERIAL DEFENSE ON 
MICROBIAL COLONIZATION AND INFECTIONS IN COPD
The increased susceptibility of smokers and COPD patients to microbial infections raised the 
question whether airway epithelial innate host defense is attenuated. It has been shown that 
mucociliary clearance is impaired in response to CS and in COPD (8). Although this function 
is indeed critical for airway host defense, it has been shown in primary ciliary dyskinesia 
patients, which display impaired mucociliary clearance, that other host defense mechanisms 
allow sufficient protection against microbes (9). Studies in cystic fibrosis (CF) suggest that 
an additional impaired activity of antimicrobial proteins and peptides (AMPs) causes a more 
severe susceptibility to microbial colonization and infections (10). Therefore, we have focused 
on the airway epithelial defense functions mediated by AMPs, as this mechanism is largely 
neglected in COPD. We have observed that the expression of AMPs is differentially regulated 
in intact epithelial cells, upon microbial exposure, and upon injury and repair. CS and COPD 
disease status have different effects on the expression of these different classes of AMPs, which 
will be discussed further.
Constitutively produced AMPs
As shown in the seminal study by Smith et al., the airway surface liquid of differentiated 
airway epithelial cultures from healthy individuals displayed intrinsic antibacterial activity 
towards respiratory pathogens (11).This defense against low number of microbes was seen 
without prior stimulation with pro-inflammatory mediators, suggesting that differentiated 
airway epithelial cells have a constitutive expression of mediators that provide baseline 
antibacterial defense. In line with this it is shown in Chapter 5 that several AMPs, i.e. SLPI, 
SPLUNC1 and LPLUNC1, are highly expressed at a steady-state level in differentiated airway 
epithelial cells and allocated to the luminal airway epithelial cells. Similar to mucociliary 
clearance, alterations in luminal airway epithelial cell differentiation or composition may 
affect the expression of constitutively produced AMPs in COPD. We have shown that chronic 
CS exposure attenuated the expression of luminal cell-restricted AMPs by suppressing cell 
differentiation. In contrast to the effects of CS, we did not observe differences in the expression 
of constitutively produced AMPs and baseline antibacterial activity between COPD and non-




patients, whereas in more severe (GOLD IV) patients the expression might be abrogated due 
to persistent epithelial remodeling in culture (12, 13). 
Persistent epithelial remodeling, i.e. basal cell hyperplasia and squamous metaplastic lesions, 
may attenuate expression of luminal cell-specific AMPs. Moreover, goblet cell metaplasia, for 
instance mediated by the cytokines IL-13, IL-4, IL-17 (14), may alter the expression of AMPs 
that are restricted to a specific luminal cell type. A previous study in our laboratory has shown 
that SLPI is not significantly altered in goblet cell enriched cultures (15). However, it was 
shown by others that SPLUNC1 and LPLUNC1 are respectively absent or restricted to goblet 
cells (16). In addition to the AMPs examined in this thesis, Tanabe et al. have also shown 
that the antibacterial protein sPLA2 is increased upon ciliated cell differentiation and lost in 
goblet cell enriched cultures (17). Moreover, as shown in a secretome analysis of differentiated 
airway epithelial cultures (18), also other antimicrobials such as dermcidin are constitutively 
produced by differentiated airway epithelial cells (19). This further suggests that a broader 
spectrum of other AMPs are also regulated by cell differentiation and restricted to luminal cells. 
Further research is therefore required to understand the broad composition of constitutively-
produced AMPs in differentiated airway epithelium and how epithelial remodeling may affect 
this. This for instance may explain the selective colonization of certain microbes in remodeled 
airway lesions, which might be caused by a favorable micro-environment shaped by altered 
expression of constitutively produced AMPs (20). In conclusion, alterations in airway 
epithelial differentiation due to smoking and persistent epithelial remodeling in COPD may 
result in a weakened constitutive host defense due to impaired expression of luminal cell-
restricted AMPs. This may lead to onset of microbial outgrowth and early colonization of 
opportunistic respiratory pathogens in the lungs of smokers and COPD patients.
Microbial- and cytokine-induced AMPs
Next to constitutively produced AMPs, microbial infection may lead to the further induction 
of other types of AMPs in the airway epithelium upon activation of patter recognition 
receptors and downstream innate immune signaling pathways. In previous studies it was 
shown that CS exposure reduced the antibacterial defense against opportunistic pathogens 
of cultured airway epithelial cells (21). This finding corresponded with impaired expression 
of the AMP hBD-2 in CS-exposed cultures and with the attenuated expression of hBD-2 
in tracheal washing of smokers with pneumonia. Extending these findings, we have shown 
in Chapter 4 (4) that COPD airway epithelial cells displayed reduced antibacterial activity 
compared to non-COPD smokers, which corresponded with impaired expression of several 
microbial-induced AMPs including hBD-2. This finding was furthermore in agreement 
with observational studies in bronchial tissues from COPD patients, in which lower hBD-2 
expression persisted after smoking cessation (22). We were unable to identify the molecular 
mechanism causing a reduced antibacterial activity of COPD airway epithelial cells, and 
therefore further research remains needed to determine this. However, we did gain more 
insight in the mechanisms underlying the impaired antibacterial activity of airway epithelial 
cells in response to CS. First, we observed that not only expression of hBD-2 was attenuated 
by CS, but also a panel of other AMPs (4). This suggests that the attenuated antibacterial 
activity of airway epithelial cells by smoking is the result of abrogation of several microbial-
induce AMPs in addition to hBD-2. Next to impaired expression in response to microbial 
stimuli, we also observed that CS impaired the expression of AMPs upon stimulation with 
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TNFα and IL-1β (unpublished data). This suggests that attenuated expression of AMPs is not 
due to effects of CS at the receptor level, but due to alterations in common downstream innate 
immune signaling pathways. Supporting this, we found that CS impaired the NFκB signaling 
pathway, which in previous studies was shown to be critical in regulating epithelial expression 
of several AMPs (23-25). In a previous study it was shown that CS-induced oxidative stress 
contributed to impaired expression of hBD-2 (26). Therefore it is likely that reactive oxygen 
species (ROS) mediates suppression of NFκB signaling via post-translational modifications 
of upstream kinases (27, 28). It has previously been shown that reduced hBD-2 expression 
in the airways of COPD patient was localized in the upper, but not in the lower airways (22). 
This might be explained by differences in the density of cigarette smoke particles to which 
the upper and lower airways are exposed, and suggests that a certain threshold is present at 
which antibacterial defense is impaired. It has been shown that diesel exhaust may also impair 
expression of hBD-2 in differentiated airway epithelial cells (29). Therefore, attenuation of 
the inducible antibacterial defense system in airway epithelial cells may be a common target 
of air pollutants. In summary, the microbe-induced expression of AMPs is a second defense 
mechanism that may prevent the further outgrowth of microbes when the constitutive airway 
epithelial defense system is overwhelmed. Attenuation of this defense system in COPD, 
because of smoking or exposure to air pollutants, may increase the susceptibility to microbial 
infection. This mechanism may therefore contribute to microbial infections in smokers or 
COPD patients during disease exacerbations.
Injury and repair-induced AMPs
Although airway BCs are normally quiescent, findings in Chapter 3 (3) and 5 suggested unique 
host defense responses by these cells in the context of epithelial injury and repair (30). hBD-1 
has been described in previous study as a constitutively expressed AMP (21). Although this 
is indeed the case, we observed that hBD-1 was highly expressed in undifferentiated cultures 
and relatively reduced upon differentiation. This suggests that BCs display a high expression of 
hBD-1 upon initial phases of epithelial regeneration that may contribute to epithelial defense 
upon injury. Interestingly, when comparing COPD and non-COPD cell cultures, we observed 
that hBD-1 expression was significantly higher in COPD cultures (unpublished data). This 
corresponded with an observational study, which demonstrated enhanced levels of hBD-1 in 
sputum samples of COPD patients compared to healthy controls (31). Similar to hBD-1, we 
furthermore described in Chapter 3  (3) that the antimicrobial protein RNase 7 was highly 
expressed by cultured BCs. Although we did not observe a significant higher expression of 
RNase 7 in COPD cultures (unpublished data), we observed that CS exposure increased 
RNase 7 expression in BCs of differentiated cells. This was related to a transient impairment 
in the epithelial barrier integrity, and could be further enhanced upon epithelial wounding as 
described in Chapter 6 (5). This, also suggests that RNase 7 is a damage-induced AMP, which 
is increased in activated BCs. Indeed, stimulation of undifferentiated airway epithelial cells 
with NTHi, increased the expression of RNase 7 and other microbial-induced AMPs, i.e. hBD-
2, CCL20, LCN2 (Chapter 3 (3)). Therefore, BCs in damaged epithelium may display more 
broad antimicrobial activity that may prevent microbial colonization and infection during 
wound repair. In summary, increased epithelial injury in COPD and smoking is reflected by 
the enhanced expression of BC-produced AMPs. Moreover, the epithelial restricted expression 
of hBD-1 and RNase 7 in BCs of damaged epithelium, suggests that these proteins may be 




functional contribution of hBD-1 and RNase 7 on the antibacterial defense in the injured lung 
requires further investigation. However, it can be speculated that the enhanced expression of 
these AMPs in smokers and COPD may contribute to a favorable micro-environment that 
leads to selective microbial outgrowth as mentioned in 2.2 (20). Another explanation, is that 
hBD-1 and RNase 7 do not provide sufficient protection, as the expression of other AMPs is 
reduced. For instance CS suppresses microbial- and cytokine-induced AMPs. Furthermore, 
cigarette smoke may modulate vitamin D3-induced antibacterial responses, which require 
further study. Interestingly, it has been shown that EGFR activation in keratinocytes leads to 
expression of human beta-defensin 3  and LCN2 (32). These responses are lacking in airway 
epithelial cells exposed to CS. This differential response between keratinocytes and airway 
epithelial cells might be due to tissue dependent EGFR-mediated responses. However, another 
explanation is that CS selectively modulates downstream EGFR signaling transduction, 
leading to a selective impaired expression of certain AMPs.
AIRWAY EPITHELIAL INFLAMMATORY RESPONSES 
In addition to AMPs, we furthermore determined the expression of pro-inflammatory 
mediators as indicator of epithelial inflammatory responses. In particular the role of the 
chemoattractant CXCL8/IL-8 is of importance, as it reflects the contribution of airway 
epithelial cells in neutrophilic inflammation in COPD (33, 34). In this section the role of 
CS-induced airway inflammation will be discussed, highlighting the importance of epithelial 
injury and repair as cause of inflammation, and the contribution oxidative stress.
Cigarette smoke-induced inflammation as part of epithelial repair
In line with previous studies (35, 36), we have shown that CS exposure increases IL-8 expression 
in airway epithelial cells via activation of ADAM17/EGFR signaling transduction (Chapter 
3,6,8 (3, 5, 6)). In contrast to RNase 7, we observed IL-8 expression in both luminal and basal 
cells of differentiated cell cultures (3). It has been shown that EGFR is selectively expressed by 
BCs (37). Therefore, it can be speculated that luminal epithelial IL-8 expression is indirectly 
mediated via currently uncharacterized BC-interactions. EGFR-dependent release of secreted 
factors from BCs may for instance cause induction of inflammatory responses in the luminal 
airway epithelium. Further research is needed to understand the potential basal-luminal 
cross-talk, which might be targeted to dampen the inflammatory response in the epithelium. 
We furthermore showed that combined exposure of CS with either microbial stimuli or injury 
further enhanced IL-8 expression (Chapter 4 and 6 (4, 5)). Microbe-induced activation of 
the innate immune system mediates pro-inflammatory responses by airway epithelial cells in 
large part via NFκB signaling transduction. However, also based on observations by others 
(38-40), it can be questioned if the NFκB system has an important role in airway epithelial 
inflammatory responses during cigarette smoking. As discussed in paragraph 2.3, the NFκB-
dependent innate immune responses seems to be suppressed by CS, thereby contributing to 
microbial colonization and infections. In contrast, sustained activation of MAPK signaling 
and the downstream AP-1 family of transcription factors have likely a more prominent role in 
the expression of inflammatory mediators in the airway epithelium.
EGFR and MAPK/AP-1 have a critical role in mediating tissue recovery after injury of 
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epithelial tissues. Therefore, it can be speculated that CS-induced inflammation is part of the 
epithelial repair mechanism, whereas immune cells such as neutrophils normally contribute 
to airway host defense at the site of injury. Although epithelial recovery and resolution of 
inflammation would normally occur, the repetitive injury caused by cigarette smoking will 
prevent this from happening. This may help to explain chronic neutrophilic inflammation 
in smokers, and its contribution to COPD development. Sustained expression of IL-8 in 
regenerating airway epithelium, is supported by previous studies showing elevated expression 
of IL-8 in a xenograft model (41). Also in Chapter 6 (5), we observed enhanced expression of 
IL-8 in CS-exposed airway epithelial cells with an impaired barrier integrity. In addition, we 
have shown in Chapter 5 that IL-8 expression is elevated upon chronic exposure of airway 
epithelial cells during cell differentiation. This furthermore suggests a relation between an 
injured or repairing state of the airway epithelium and expression of pro-inflammatory 
cytokines. 
In addition to the role of epithelial repair mechanisms, inflammatory responses may also 
result from a loss of anti-inflammatory mediators expressed by the luminal airway epithelium, 
i.e. SLPI and CC10/CC16 (42, 43). These secreted factors may normally act in intact epithelial 
layers as inhibitory signals to maintain airway homeostasis, while loss of these mediators 
upon luminal cell depletion may act as a negative signal to promote inflammatory responses 
in BCs, but also stromal and immune cells. Similar to SLPI and CC10, WFDC12 described in 
Chapter 9 may also act as such an anti-inflammatory mediator, based on its high expression 
in differentiated luminal cells. However, further research is needed to evaluate this.
We did not detect differences in CS- and microbial-induced inflammatory mediator expression 
between COPD and non-COPD airway epithelial cultures (44). Since these cultures were 
derived from current and former smokers, it needs to be noted that we did not compare these 
cultures to those of healthy never-smokers, and possibly the induction of these mediators is 
lower in healthy airway epithelium. Moreover, it possible that in contrast to differentiated 
cells, enhanced inflammatory responses may persist in undifferentiated cultures. This was 
shown in a previous study by Schulz et al. (45), which observed enhanced inflammatory 
mediator expression of undifferentiated airway epithelial cells from COPD patients compared 
to non-COPD smokers. Similar findings have also been reported in studies comparing airway 
epithelial cultures from CF patients and non-CF controls, whereas it was shown that enhanced 
inflammatory responses were only seen in undifferentiated CF airway epithelial cells (46, 
47). This raises the interesting possibility that especially in injured epithelium, dominated 
by basal cells, differences between epithelium from patients and controls becomes apparent. 
Therefore, further studies are required, in which the importance of airway epithelial repair 
and differentiation status will be determined in the expression of inflammatory mediators 
in COPD cultures, as this will further reflect the importance of injured on airway epithelial 
inflammatory responses.
Role of CS-induced oxidative stress in inflammation
Reactive oxygen species present in smoke, and induction of oxidative stress may also 
contribute to airway inflammation upon smoking and in COPD. CS-induced oxidative 
stress causes a delay in epithelial repair as shown in Chapter 6 (5) and therefore may lead to 




can increase MAPK signaling, thereby enhancing the expression of inflammatory mediators 
via these pathways. As speculated in Chapter 7, oxidative stress may furthermore control the 
translation of inflammatory mediators through induction of GADD34. In previous studies, it 
has been shown that GADD34 controls protein translation of IL-6 and interferons upon viral 
infection by temporary suppression of the integrated stress response (48, 49). Similar to this, 
CSC-induced oxidative stress may promote the translation of pro-inflammatory cytokines in 
airway epithelial cells via MAPK p38-dependent expression of GADD34. This mechanism 
may explain our recent findings in which airway inflammation is reduced in CS-exposed 
GADD34 deficient animals (unpublished data). However, further research is needed to 
confirm the contribution of GADD34 in regulating airway epithelial inflammatory responses 
after cigarette smoke exposure.
AIRWAY EPITHELIAL REMODELING
The airway epithelium is distinct from other mucosal tissues by its low steady-state turn-
over in the lungs of healthy individuals (50). This is reflected by the quiescent state of BCs, 
which act as the main progenitor cells. Observations made in airway tissues from smokers, 
demonstrated that BCs have an enhanced turn-over (51), and it is hypothesized that the 
renewal capacity of airway BCs is limited (52). Smoking may therefore accelerate the aging 
of the airway epithelial tissues (53), as impaired regenerative capacity of BCs may underlie 
epithelial remodeling in smokers and COPD.
As mentioned in previous sections, EGFR has a prominent role in airway epithelial responses 
upon CS exposure. EGFR expression is largely restricted to BCs and plays a key role in wound 
repair (37, 54). Different ligands can activate EGFR, i.e. epidermal growth factor (EGF), 
amphiregulin (AREG), transforming growth factor-alpha (TGFα), and ligand-dependent 
activation of EGFR has been shown in recent studies to have a prominent role in airway 
epithelial remodeling. EGF and AREG are both enhanced in the airway epithelium of 
smokers, however the cells that express the ligands are different. EGF is mainly expressed by 
ciliated airway epithelium, whereas AREG is mainly expressed in BCs (37, 55). It has been 
shown in vitro that AREG and EGF are both critical in affecting airway epithelial remodeling. 
EGF is released by cultured epithelial cells upon exposure to CS extract, moreover exogenous 
stimulation of airway epithelial cells with EGF during differentiation causes a squamous cell 
phenotype (37). We have demonstrated in Chapter 8 (5) that CS exposure of airway epithelial 
cells enhanced mRNA expression and ADAM17-dependent shedding of AREG protein, 
which was more prominent in COPD epithelial cultures. This enhanced release of AREG 
may further contribute to epithelial remodeling, as it has been shown by that AREG released 
by BCs, together with EGF, may affect epithelial differentiation by promoting basal cell 
hyperplasia and goblet cell metaplasia (55). These observations made in vitro were supported 
by a transcriptome analysis, demonstrating EGFR-dependent remodeling of the small airways 
of smokers and COPD patients resulting in a more proximal airway epithelial phenotype in the 
distal airways(56). Despite enhanced EGFR signaling, and aberrant epithelial differentiation 
during chronic CS exposure, we did not observe goblet cell metaplasia in our experimental 
model in Chapter 5. This might be due to a the lack of EGF expression in the luminal airway 
epithelial cells, which we have not addressed. Moreover, the experimental setup of the chronic 
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CS exposure model could have been to restricted. In our model, we observed transient and 
mild injury induced by CS exposure with no differences in the epithelial barrier integrity. EGF 
released from luminal airway epithelial cells may only affect BCs upon extensive injury, as has 
been shown in the case of Neuregulin (57). Therefore, it would be interesting to determine the 
effect of additional epithelial injury on epithelial differentiation in the chronic CS exposure 
model. This could for instance be achieved by incubating cells with calcium-free medium to 
abrogate the epithelial barrier integrity or by mechanical wounding. In addition, we did not 
determine the influence of chronic cigarette smoke exposure on airway epithelial cell cultures 
that were well-differentiated. This may lead to different alterations in epithelial differentiation 
compared to chronic smoke exposure in undifferentiated cells, and therefore requires further 
study.
Microbial products have also been shown to contribute to goblet cell metaplasia, and these 
were absent in our model which may help to explain the lack of goblet cell metaplasia in 
our CS-exposed cultures. Another explanation for the lack of goblet cell metaplasia might 
be the additional contribution of immune cells in airway epithelial remodeling, which are 
absent in our in vitro system. Indeed, it has been well established that cytokines such as IL-
13, IL-4 and IL-17, derived from T-lymphocytes or innate lymphoid cells, may induce goblet 
cell differentiation (14). However, also neutrophils, the predominant cell type attracted by 
smoking may contribute to epithelial remodeling. As discussed in Chapter 2 (2), neutrophils 
produce the AMPs LL-37 and alpha-defensins, which have been shown to modulate airway 
epithelial cell responses. LL-37 has been shown to mediate transactivation of EGFR by 
mediating matrix metalloprotease dependent shedding of EGFR-ligands (58). The ligands 
responsible for this are unclear, however it is possible that LL-37-mediated EGFR activation 
may contribute to epithelial remodeling. In addition, expression of HNPs was associated 
with squamous lesions in airway tissues from smokers, and it has been shown that HNPs can 
induce mucin expression and promote proliferation in airway epithelial cell lines (59-61). 
Therefore, further research examining the influence of neutrophil-derived secreted factors, 
together with CS exposure, may give further insight in the mechanisms underlying epithelial 
remodeling in smokers and in COPD. 
THE VICIOUS CIRCLE HYPOTHESIS REVISITED: ROLE OF THE AIRWAY 
EPITHELIUM 
Collectively, the studies presented in this thesis support an important role for the modulatory 
effect of CS on airway epithelial function in the development and progression of COPD. It is 
speculated that progressive impairment of airway epithelial host defense, resulting from smoke 
exposure, may act as an important driver in the onset of COPD in susceptible smokers. Such 
a suppression of constitutive expressed AMPs in luminal airway epithelial cells together with 
impaired mucociliary clearance may allow early microbial colonization. Microbial outgrowth 
and/or changes in the airway microbiota subsequently leads to activation of microbe-
induced innate immune responses. Smoking may causing an imbalance in inflammation 
and host defense, thereby selectively decreasing microbe-induced expression of AMPs while 
enhancing inflammatory responses. This may be more pronounced in COPD patients, since 




additional damage caused by microbes or immune cells leads to further damage to the airway 
epithelium. This results in extensive injury, leading to loss of luminal cells and activation of 
BCs. In part via EGFR, activation in BCs further promotes inflammatory responses while 
wound repair is delayed due to smoking. Moreover, the combined effect of smoking on EGFR-
mediated repair and immune cells leads to aberrant epithelial differentiation. This process 
will take place repeatedly until the airway epithelial tissues are persistently altered, as seen in 
severe COPD patients, likely due to epigenetic imprinting.
CONCLUDING REMARKS
Collectively, the studies presented in this thesis emphasize that inflammation, host defense 
and epithelial repair are interconnected processes that are affected by smoking and disturbed 
in COPD. Furthermore, the studies suggest that in particular targeting epithelial repair in 
COPD may have beneficial outcomes on inflammation and host defense and may be an 
effective approach to halt COPD progression. Since inflammation in COPD is at least part 
resistant to steroid treatment (62), and steroids are known to impair wound repair and lung 
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Onze longen hebben de essentiële taak om via de ademhaling te zorgen voor de uitwisseling 
van zuurstof en koolstofdioxide. Deze uitwisseling van gassen is verstoord in patiënten met 
COPD (chronic obstructive pulmonary disease; chronische obstructieve longziekte), een 
longziekte die wordt gekenmerkt door blijvende schade aan de longblaasjes en luchtwegen, 
en vaak gepaard gaat met een ophoping van slijm in de luchtwegen. Deze beide ziektebeelden, 
die leiden tot een afname in de functie van de longen, worden respectievelijk emfyseem en 
chronische bronchitis genoemd. Roken is de voornaamste risicofactor voor de ontwikkeling 
van COPD. Echter, niet alle rokers ontwikkelen de ziekte, wat aanduidt dat bijkomende 
genetische en omgevingsfactoren een rol spelen. Naast symptomen als kortademigheid, 
vermoeidheid en ophoesten van slijm, wordt COPD gekenmerkt door een verhoogde 
gevoeligheid voor luchtweginfecties. Infecties door schadelijke bacteriën (en virussen) 
dragen bij aan de ontwikkeling van ontsteking en blijvende schade aan het longweefsel. Het 
oplopen van een luchtweginfectie kan daarnaast leiden tot een longaanval, waarbij de functie 
van de longen in zeer korte tijd scherp achteruitgaat en zelfs kan leiden tot de dood van een 
patiënt. Naast patiënten met COPD hebben ook rokers een verhoogd risico op het krijgen 
van een luchtweginfectie. Dit suggereert dat er een causaal verband is, waarbij roken zorgt 
voor een onderdrukking van afweermechanismen in de longen. Welke afweermechanismes 
verstoord zijn, is echter grotendeels onduidelijk. Om deze reden is fundamenteel onderzoek 
naar de moleculaire en cellulaire afweerprocessen in de longen en de luchtwegen van groot 
belang. Dit is ook belangrijk omdat het kan leiden tot nieuwe inzichten hoe infecties in COPD 
behandeld kunnen worden.
In gezonde longen zorgt het slijmvlies van de luchtwegen voor de voornaamste afweer tegen 
bacteriën. Het slijmvlies bestaat uit een laag luchtwegepitheel, dat zorgt voor het filteren van 
ingeademde lucht tijdens het transport naar de longblaasjes. Het luchtwegepitheel bestaat 
uit verschillende soorten cellen met ieder een eigen unieke functie. Secretoire epitheelcellen, 
bestaande uit slijmbeker (goblet)- en clubcellen, zorgen voor de aanmaak van een dunne 
laag slijm op het oppervlak van het epitheel. Aan dit slijm blijven bacteriën en andere 
ingeademde micro-organismen en deeltjes kleven, wat leidt tot het zuiveren van ingeademde 
lucht. Trilhaarepitheelcellen zorgen voor het verwijderen van het slijm uit de luchtwegen 
naar de keel, een continu “zelfreinigend” proces dat vergelijkbaar is met de werking van een 
lopende band. Naast de aanmaak en het verwijderen van slijm, bieden luchtwegepitheelcellen 
ook bescherming tegen infecties door het produceren van antimicrobiële eiwitten. Dit zijn 
moleculen die bacteriën doden of de groei van bacteriën remmen, en die dus kunnen worden 
gezien als de lichaamseigen antibiotica. Naast de aanmaak van een beperkte hoeveelheid 
antimicrobiële eiwitten door epitheel dat niet wordt geprikkeld, vertoont het epitheel 
een verhoogde productie van deze eiwitten na het herkennen van bacteriën door speciale 
receptoren. Deze verhoogde productie treedt voornamelijk op bij de nesteling en groei van 
bacteriën in de luchtwegen en deze bacteriën en andere micro-organismen zorgen ook voor 
de aanmaak van ontstekingsfactoren door het epitheel. De ontstekingsfactoren zorgen voor 
het aantrekken van afweercellen uit het bloed naar het ontstoken weefsel. Deze afweercellen 
voorkomen de verdere verspreiding van een luchtweginfectie naar het longweefsel, door 




In intact epitheel zorgen secretoire- en trilhaarcellen voor de voornaamste verdediging door 
het epitheel. Ernstige schade aan het epitheel, bijvoorbeeld door roken of tijdens een infectie, 
kan echter leiden tot celdood van secretoire- en trilhaarcellen. Herstel van het epitheel is 
in dit geval cruciaal, om infecties van het onderliggende longweefsel te voorkomen. Naast 
secretoire- en trilhaarcellen, bestaat het epitheel ook uit een groep stamcellen. Deze cellen 
bevinden zich op het basaal membraan, de scheidlijn tussen het epitheel en het onderliggende 
bindweefsel, en worden daarom basaal cellen genoemd. In tegenstelling tot secretoire en –
trilhaarcellen, kunnen basaal cellen zich vermenigvuldigen en transformeren tot nieuwe 
secretoire- en trilhaarcellen, aan de hand van een proces wat differentiatie genoemd wordt. In 
onbeschadigd epitheel zijn basaal cellen niet actief, echter bij epitheelschade zorgen ze voor 
herstel van de epitheel laag en tevens voor het aantrekken van afweercellen uit het bloed. Bij 
het herstel van het epitheel zorgen basaal cellen eerst voor het sluiten van een epitheelwond, 
door cel migratie en vermenigvuldiging van het aantal basaal cellen. Daarna differentieert een 
aantal basaal cellen tot secretoire- en trilhaarcellen. 
Het luchtwegepitheel heeft dus een zeer belangrijke rol in de afweer tegen bacteriën in 
gezonde longen. De vraag is of onderdrukking van de functies van epitheel een rol speelt 
in de ontwikkeling van COPD. Eerder onderzoek heeft aangetoond dat verstoring van 
de aanmaak en verwijdering van slijm in de luchtwegen (vooral in de kleine luchtwegen) 
een belangrijke oorzaak is van de ontwikkeling van COPD door chronische bronchitis. 
Een verhoogde slijmproductie en afname in de trilhaarfunctie van het epitheel, die samen 
leiden tot de ophoping van slijm in de luchtwegen, wordt in eerste instantie geprikkeld door 
het roken van sigaretten. Echter na verloop van tijd zijn deze veranderingen als het ware 
geprogrammeerd in de epitheelcellen, wat leidt tot een blijvende ophoping van slijm in de 
luchtwegen. Er wordt verondersteld dat dit plaatsvindt door het aanhouden van een vicieuze 
cirkel van roken, infecties en longschade. In deze vicieuze cirkel zorgt slijmophoping door 
roken voor de nesteling en groei van bacteriën in de luchtwegen. De daaropvolgende detectie 
van bacteriën door receptoren op het epitheel leidt tot de productie van ontstekingsfactoren, 
die zorgen voor de aantrekking van afweercellen uit het bloed. Alhoewel deze cellen normaal 
gesproken cruciaal zijn voor de afweer tegen micro-organismes, zorgen ze tijdens chronische 
ontsteking voor schade aan het longweefsel. Veranderingen in de aanmaak en afvoer van 
slijm door het epitheel vormen dus een belangrijk mechanisme in de ontwikkeling van 
COPD. Het is evenwel onduidelijk hoe bacteriën de luchtwegen kunnen koloniseren, ondanks 
de aanwezigheid van afweercellen uit het bloed. Dit kan mogelijk verklaard worden door 
een verandering in de aanmaak van antimicrobiële eiwitten door het luchtwegepitheel. Of 
en hoe dit proces verstoord is tijdens de ontwikkeling van COPD, is grotendeels onduidelijk. 
In dit proefschrift is daarom onderzocht of het roken van sigaretten leidt tot een afname in 
de productie van antimicrobiële eiwitten door het luchtwegepitheel, en of epitheelcellen van 
COPD patiënten een verminderde antibacteriële activiteit hebben. Naast deze vraagstelling 
is onderzocht of het epitheel nog andere afweerfuncties heeft die mogelijk verstoord zijn 
in COPD patiënten of door het roken van sigaretten. Dit is onderzocht door verschillende 
vormen van afweer door het epitheel te bestuderen: i) epitheel afweerfuncties die continu 
actief zijn en dus voor een basale vorm van afweer zorgen, ii) een afweer na nesteling en groei 




De afweer door het luchtwegepitheel is onderzocht aan de hand van experimenten met 
gekweekte cellen. Naast celkweken met alleen basaal cellen, is er ook gebruik gemaakt 
van een kweekmodel met gedifferentieerde luchtwegepitheelcellen. Hierin worden basaal 
cellen gekweekt in lucht-blootgestelde condities, wat leidt tot differentiatie in secretoire en 
trilhaarcellen. De afweerfuncties van het gekweekte epitheel zijn bestudeerd na blootstelling 
aan sigarettenrook, stimulatie met bacteriën en na het beschadigen van het epitheel. Door 
epitheelcellen van COPD patiënten te vergelijken met het epitheel van rokers zonder COPD, 
probeerden we meer inzicht te krijgen in het eventuele verschil tussen deze twee groepen.
In hoofdstuk 2 is er literatuur vooronderzoek gedaan naar de rol van antimicrobiële eiwitten 
in de ontwikkeling van COPD. Eerdere studies wijzen erop dat het luchtwegepitheel mogelijk 
minder antimicrobiële eiwitten produceert door schadelijke effecten van het roken. Dit was 
medebepaald aan de hand van experimenten met gekweekt luchtwegepitheel, blootgesteld 
aan sigarettenrook. Daarnaast is in studies met luchtwegweefsels van COPD patiënten 
aangetoond dat ook na het stoppen met roken er een verlaagde expressie van antimicrobiële 
eiwitten waarneembaar was. In tegenstelling tot de productie van antimicrobiële eiwitten door 
het epitheel, is er een toename van vergelijkbare eiwitten geproduceerd door afweercellen uit 
het bloed. Dit is het gevolg van chronisch ontsteking in de luchtwegen van COPD patiënten. 
Het type antimicrobiële eiwitten van afweercellen uit het bloed en epitheelcellen verschilt 
niettemin van elkaar. Daarnaast wordt verondersteld dat de eiwitten van afweercellen uit het 
bloed bijdragen aan longschade in COPD. Kort samengevat, tonen eerder uitgevoerde studies 
dus aan dat er een verschuiving is in de balans van het type antimicrobiële eiwitten in de 
longen van rokers en COPD patiënten. Waar, in het geval van het epitheel, een verminderde 
productie mogelijk bijdraagt aan een verhoogde gevoeligheid voor infecties.
Aangezien het onduidelijk was of basaal cellen een andere afweeractiviteit vertonen ten opzichte 
van intact gedifferentieerd epitheel is dit in hoofdstuk 3 onderzocht. Dit onderzoek werd 
uitgevoerd aan de hand van een vergelijking van gekweekte basaal cellen en gedifferentieerd 
luchtwegepitheel, beide gestimuleerd met bacteriën. Zowel basaal cellen en gedifferentieerd 
luchtwegepitheelcellen vertoonden een toename in expressie van bepaalde antimicrobiële 
eiwitten na blootstelling aan bacteriën. Echter naast een overlap, observeerden we dat alleen 
basaal cellen in staat waren om een specifiek antimicrobieel eiwit te produceren. Dit eiwit, 
genaamd RNase 7, was in eerdere studies omschreven als een belangrijke beschermer tegen 
infecties van bacteriën op de huid. Naast een verhoogde expressie na bacterie stimulatie, 
vonden we dat RNase 7 ook geproduceerd werd door basaal cellen na schade van intact 
epitheel door sigarettenrook. Dit proces bleek onderdeel te zijn van het epitheelherstel proces, 
waarbij activatie van een bepaalde receptor, de epidermal growth factor receptor (EGFR), 
betrokken was. Samenvattend hebben we in deze studie aangetoond dat basaal cellen in het 
luchtwegepitheel, naast een stamcelfunctie, ook een mogelijke bijdrage leveren aan de afweer 
tegen bacteriën door de aanmaak van het antimicrobiële eiwit RNase 7.
In hoofdstuk 4 is er onderzocht of de aanmaak van antimicrobiële eiwitten na bacterie 
blootstelling anders was in gedifferentieerd luchtwegepitheel van COPD patiënten, vergeleken 
met cellen van rokers zonder COPD. Bij dit onderzoek bleek inderdaad dat epitheelcellen 
van COPD patiënten een verminderde genexpressie hadden van de antimicrobiële eiwitten 
β-defensin 2 en S100A7. Overeenkomend met dit resultaat, zagen we in andere experimenten 




van rokers zonder COPD. In zowel epitheel van COPD patiënten als van rokers, vonden we 
een remmende werking van sigarettenrook op de expressie van antimicrobiële eiwitten. Maar 
in tegenstelling tot de afname van antimicrobiële eiwitten, veroorzaakte sigarettenrook samen 
met bacterie blootstelling een toename in ontstekingsfactoren. Dit geeft dus aan dat het roken 
van sigaretten een tegengestelde werking heeft op de afweerfunctie van het epitheel, waarbij 
er een afname is in antibacteriële activiteit en een toename in ontsteking. Dit effect komt 
overeen met de toename in de gevoeligheid voor infecties, en chronische ontsteking in de 
luchtwegen, in zowel COPD patiënten als rokers.
Hoofdstuk 5 omschrijft een studie waar de invloed van roken onderzocht werd op de 
productie van antimicrobiële eiwitten tijdens de differentiatie van basaal cellen. In dit 
hoofdstuk tonen we eerst aan dat gedifferentieerde luchtwegepitheelcellen een bepaalde 
groep antimicrobiële eiwitten specifiek aanmaakt, die nauwelijks geproduceerd worden in 
basaal celkweken. Gedurende de differentiatie van basaal cellen onderdrukt sigarettenrook 
niet alleen de epitheeldifferentiatie, maar (daarmee) ook de aanmaak van deze eiwitten, wat 
leidt tot een verminderde antibacteriële activiteit van het epitheel. Deze studie toont dus een 
direct verband aan tussen de onderdrukking van de differentiatie van het luchtwegepitheel 
door sigarettenrook en de afweer tegen bacteriën door antimicrobiële eiwitten. 
In hoofdstuk 6 wordt de invloed van sigarettenrook op het herstel het epitheel verder bestudeerd. 
Hier is gebruik gemaakt van epitheelschademodellen, waarin het epitheel mechanisch 
verwond werd, of waarbij de verbindingen tussen epitheelcellen tijdelijk verbroken werden 
door calcium weg te nemen. In beide modellen vonden we dat sigarettenrook zorgde voor 
een afname in epitheelherstel. In tegenstelling tot deze afname in het herstel, vonden we dat 
sigarettenrook de ontstekingsreactie en afweer door basaal cellen juist verhoogde. Dit werd 
veroorzaakt door oxidatieve stress, veroorzaakt door sigarettenrook. Kort samengevat toont 
deze studie aan dat sigarettenrook een tegengestelde werking heeft op het epitheel tijdens 
schade, waarin het herstel geremd wordt en ontsteking juist toeneemt. 
In hoofdstuk 7 wordt de invloed van roken op activatie van de integrated stress response (ISR) 
in luchtwegepitheelcellen bestudeerd. ISR is een cellulair mechanisme dat mede bepaalt of 
een cel na het oplopen van schade in leven blijft of doodgaat. In het onderzoek vonden we dat 
ISR geactiveerd werd in gekweekt luchtwegepitheel na blootstelling aan sigarettenrook. Dit 
effect was sterker in het epitheel van COPD patiënten dan in het epitheel van rokers zonder 
COPD. Daarnaast vonden we een negatieve relatie tussen de expressie van bepaalde eiwitten 
gerelateerd aan de ISR en de longfunctie van patiënten. Deze bevindingen suggereren dat een 
toename van de ISR door het roken mogelijk een rol speelt in de ernst van COPD. Echter hoe 
dit precies in zijn werk gaat moet nog verder onderzocht worden. 
In hoofdstuk 8 wordt er verder onderzocht hoe sigarettenrook ontsteking- en 
wondherstelresponsen door het luchtwegepitheel beïnvloedt. In dit hoofdstuk hebben we 
specifiek gekeken naar de werking van het eiwit ADAM17, wat betrokken is bij het vrij 
knippen van ontsteking- en groeifactoren die zich op het oppervlak van het epitheel bevinden. 
Blootstelling van luchtwegepitheelcellen aan sigarettenrook bevorderde de activiteit van 
ADAM17, wat leidde tot het vrij knippen van soluble IL-6 receptor (sIL-6R) en amphiregulin, 
respectievelijk een ontstekings- en groeifactor. De activiteit van ADAM17 was hoger in 
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luchtwegepitheel cellen van COPD patiënten ten opzichte van rokers zonder COPD. Daarom 
is het goed mogelijk dat dit mechanisme een rol speelt bij de ontwikkeling van ontsteking en 
verstoring van het epitheelherstel in COPD. 
Naast ontstekingsfactoren produceren luchtwegepitheelcellen ook moleculen die ontsteking 
in de longen kunnen remmen. Hoofdstuk 9 omschrijft een studie waarin de expressie van 
een mogelijk nieuw ontstekingsremmend eiwit, WFDC12, onderzocht is. Basaal cellen, maar 
niet gedifferentieerde epitheelcellen, vertoonden een verhoogde expressie van WFDC12 
na stimulatie met bacteriën. Ten opzichte van basaal cellen hebben gedifferentieerde cellen 
echter een intrinsiek hoge expressie van WFDC12, wat onderdrukt kon worden na stimulatie 
met de groeifactor TGF-β1. Aangezien voorgaande studies hebben aangetoond dat expressie 
van TGF-β1 verhoogd is in luchtwegepitheelcellen van COPD patiënten, is het dus mogelijk 
dat TGF-β1 voor een onderdrukking zorgt van WFDC12 in COPD. Dit wordt ondersteund 
in experimenten waarin we de expressie van WFDC12 hebben vergeleken in gekweekt 
luchtwegepitheel van COPD patiënten en rokers zonder COPD. Uit deze vergelijking bleek 
inderdaad dat de expressie van WFDC12 lager was in celkweken van COPD patiënten ten 
opzichte van rokers zonde COPD. Daarbij vonden we een correlatie tussen de mate van 
WFDC12 expressie en longfunctie. Vervolgonderzoek is nodig om te onderzoeken of de 
verlaagde expressie van WFDC12 bijdraagt aan ontstekingsreactie in de luchtwegen van 
COPD patiënten. 
In hoofdstuk 10 is uiteengezet hoe een afname in de expressie en functie van antimicrobiële 
eiwitten in COPD en andere longziekten behandeld zouden kunnen worden. Hier wordt 
aandacht besteedt aan mogelijk therapieën met synthetische antimicrobiële eiwitten of 
daarvan afgeleide moleculen. Daarnaast wordt de mogelijkheid besproken om de productie 
van antimicrobiële eiwitten door cellen in de longen therapeutisch te bevorderen. 
De studies in dit proefschrift hebben geleid tot nieuwe inzichten in de afweermechanismen van 
het luchtwegepitheel. Hierin kunnen we onderscheid maken in specifieke afweermechanismes 
van gedifferentieerde, secretoire en trilhaarepitheelcellen, en basaal cellen. Er is daarnaast 
onderzocht hoe deze mechanismen beïnvloed kunnen worden door het roken van sigaretten, 
of persistent aanwezig zijn in het epitheel van COPD patiënten. Sigarettenrook onderdrukt 
de expressie van antimicrobiële eiwitten van het gedifferentieerde epitheel. Daarnaast 
hebben luchtwegcellen van COPD patiënten een intrinsiek verlaagde antibacteriële 
activiteit vergeleken met rokers zonder COPD. In tegenstelling tot antimicrobiële eiwitten, 
is de expressie van ontstekingsfactoren verhoogd. Deze bevinding geeft aan dat er in het 
epitheel sprake is van een disbalans in afweermechanismen die bijdragen aan een verhoogde 
gevoeligheid voor infecties en de ontwikkeling van chronische ontsteking in de longen. 
Sigarettenrook zorgt naast veranderingen in de afweerreacties en verstoring van deze balans, 
ook voor schade aan het epitheel. Ondanks onderdrukking van epitheel herstelfuncties, is 
er een toename in productie van ontstekingsfactoren, mogelijk door toedoen van de basaal 
cellen. Deze bevindingen geven aan dat de ontwikkeling van ontsteking selectief in stand 
wordt gehouden tijdens schade en herstel van het luchtwegepitheel. 
In navolging van ophoping van slijm, is er dus ook een onderdrukking van andere 
afweermechanismes door het luchtwegepitheel, die mogelijk bijdragen aan de verhoogde 




het bloed worden aangetrokken door ontstekingsfactoren, blijft desondanks in stand. Het 
roken van sigaretten zorgt dus voor de ontwikkeling van de vicieuze cirkel van infecties, 
ontsteking en schade, waarbij het luchtwegepitheel een centrale rol speelt. Een afname in 
directe afweermechanismen, en een toename in productie van ontstekingsfactoren, lijken 
beide direct verbonden met het oplopen van schade en afwijkend herstel van het epitheel 
door roken. Therapieën die gericht zijn op de bevordering van het herstel van het epitheel 
kunnen dus mogelijk leiden tot een verlaagde gevoeligheid voor infecties en onderdrukking 
van ontsteking. Ter aanvulling kan de verminderde expressie van antimicrobiële eiwitten 
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